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Abstract 
 
Pain is a multidimensional experience with sensory-discriminative and motivational-affective 
dimensions. Neuropathic pain is caused by a primary lesion or dysfunction of the nervous tissue 
that leads to an anomalous nociceptive processing in pain centers. It results from a process of 
peripheral and central sensitization and is characterized by prolonged hyperalgesia, allodynia and 
spontaneous pain. The maintenance of these nerve injury-induced symptoms depends on 
abnormal discharge from peripheral nerves and pronociceptive changes in spinal and supraspinal 
mechanisms mediating and modulating pain-related signals. The aims of this work were: first, to 
elucidate what is the relative contribution of rostroventromedial medulla (RVM) ON- and OFF-cells 
to hypersensitivity observed in neuropathic pain; second, to evaluate if emotional disturbances 
and structural alterations in the amygdala (AMY) observed in human patients, were produced 
when inducing neuropathic pain to rats; third, to determine if structural alterations of the 
amygdala, associated to the peripheral nerve injury, influences RVM regulation of nociception; 
and finally, to analyze the alterations in response properties of amygdala nociceptive neurons to 
peripherally-evoked stimulation and what is the cortical influence in the neuropathic process.  
In this work, we provide evidence that reinforce data indicating that RVM ON-cells are the 
main responsible for neuropathic hypersensitivity. Although both ON- and OFF- RVM cells were 
found to respond significantly more in neuropathic animals at a basal state, only ON-cell 
response was significantly different from Sham animals following noxious and non-noxious 
stimulation. The peripheral stimuli applied were: tail pinch and cold, since clinical studies 
indicate that hypersensitivity to these somatic stimuli are frequent after traumatic nerve injuries; 
and colo-rectal distention (CRD), because not much is known about the influence of somatic 
neuropathy on visceral processing. As RVM ON-cells are considered to be pronociceptive, they 
should have a major contribution in the hypersensitivity to peripheral stimulation observed in 
neuropathic animals. 
We have demonstrated, for the first time, that animals with a peripheral neuropathy show 
depressive-like behaviour associated to AMY neuroplasticity. Importantly, AMY structural changes 
are mediated, at least in part, by an increase in the number of neurons, as a result of cell 
proliferation. Besides depressive-like behaviour, we also observed an increase in affective pain-
related behaviour in neuropathic animals, assessed through the aversive place-conditioning test, 
which reinforces the association between prolonged neuropathic pain and altered emotional 
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behaviour. Moreover, emotional pain-related behaviour increased after AMY administration of a 
metabotropic glutamate receptor 1 and 5 (mGluR1/5) agonist and decrease after the local injection 
of a metabotropic glutamate receptor 1 (mGluR1) antagonist. The AMY administration of an 
mGluR1/5 agonist has also induced an increase in the discharge rate of ON-cells in the RVM of 
nerve-injured animals, which was mainly due to the activation of mGluR1. In what concerns the 
activity of AMY neurons, plastic alterations were present after neuropathy, with an increased 
spontaneous activity and a general decrease after peripheral stimulation.  
When evaluating the cortical influence upon nociceptive behaviour of the neuropathic rat, the 
injection of glutamate (Glu) and of an NMDA-receptor (NMDA-r) antagonist in the rostral anterior 
cingulate cortex (rACC) produced, respectively, an increase and a decrease in affective pain-
related behaviour. When evaluating AMY neuronal discharge rate after the injection of the same 
reported drugs in the ACC, only glutamate had a significant effect, inducing an increase of AMY 
neuronal activity. 
The set of studies performed for this thesis allowed the following conclusions: I) the activity of 
both RVM ON- and OFF-cells in neuropathic animals is altered towards promoting pronociception, 
but only ON-cell type appears to be a major role in the increased hypersensitivity observed; II) the 
structural plasticity observed in the AMY of nerve-injured animals - increased AMY volume as a 
result of local newborn neurons – is paralleled with the development of depressive-like behaviour; 
III) emotional pain-related behaviour in neuropathic animals is dependent, at least in part, on the 
activation of mGluR1/5 in the AMY and of NMDAr in the ACC; IV) the activation of mGluR1 in the 
AMY of neuropathic animals causes an increase in the activity of pronociceptive RVM ON-cells.  
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Resumo 
 
A dor é uma experiência multidimensional desagradável, envolvendo não só uma componente 
sensorial mas também uma componente emocional. A dor neuropática resulta de uma lesão 
primária ou disfunção do tecido nervoso, que origina o envio incorrecto de sinais para os centros 
de modulação da dor. A dor neuropática origina hiperalgesia e alodínia prolongadas e dor 
espontânea, e resulta de um processo de sensitização periférica e central. A continuidade dos 
sintomas induzidos pela lesão nervosa depende de descargas anormais dos nervos periféricos e 
de alterações pronociceptivas nos mecanismos espinhais e supraspinhais de mediação e 
modulação da nocicepção. Os objectivos deste trabalho consistiram em: primeiro elucidar qual a 
contribuição relativa das células “ON” e “OFF” do bolbo rostral ventromedial (RVM) para a 
hipersensibilidade observada em animais com dor neuropática; segundo, avaliar se a indução de 
dor neuropática no rato resultava simultaneamente em distúrbios emocionais e alterações 
estruturais na amígdala (AMY), tal como no Homens; terceiro, determinar se a plasticidade 
neuronal da AMY, associada à lesão nervosa periférica influenciava o papel do RVM na regulação 
da dor; finalmente, avaliar as alterações nas respostas dos neurónios nociceptivos da AMY a 
estímulos periféricos induzidos pela neuropatia e, adicionalmente, avaliar a influência de 
estruturas corticais na dor neuropática.  
Neste trabalho confirmámos a ideia já existente de que as células pronociceptivas do RVM, as 
células “ON”, são as principais responsáveis pela hipersensibilidade observada em animais 
neuropáticos. Embora ambos os tipos de células “ON” e “OFF” tenham maior actividade 
espontânea no estado basal, a aplicação de estimulação nóxica e não-nóxica alterava apenas a 
resposta das células ON de modo significativo. Dado que há evidências clínicas indicativas de 
que a hipersensibilidade a estímulos mecânicos e de frio é comum depois de lesões nervosas 
traumáticas, e dado que há pouca informação sobre a influência da neuropatia somática em 
percepção visceral, os estímulos periféricos aplicados foram o beliscadura da cauda, o frio e a 
distensão colo-rectal. Como as células ON são consideradas pronociceptivas, podemos assumir, 
a partir dos nossos resultados, que estas células deverão ter um papel relevante na 
hipersensibilidade à estimulação periférica observada nos animais neuropáticos.  
Aqui demonstrámos pela primeira vez, que animais com neuropatia periférica apresentam 
alterações estruturais na AMY associadas, simultaneamente, à expressão de um comportamento 
tipo depressivo. É de salientar que a plasticidade observada na AMY resultou, pelo menos em 
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parte, do número de neurónios, resultante de proliferação celular. Foi também observado um 
aumento do comportamento afectivo relativo à dor, avaliado através do teste aversivo de 
condicionamento-de-lugar. Este comportamento aumentou depois da administração, na AMY, de 
um agonista de receptores metabotrópicos do glutamato 1 e 5 (mGluR1/5) e diminuiu depois da 
administração de um antagonista de receptores metabotrópicos do glutamato 1 (mGluR1). A 
administração de um agonista de mGluR1/5 provocou também um aumento na actividade das 
células “ON” do RVM dos animais neuropáticos, causado principalmente pela activação dos 
receptores metabotrópicos tipo 1 do glutamato (mGluR1). O outro modo de plasticidade 
observada foi a alteração na taxa de actividade da AMY que, nos animais neuropáticos, 
aumentou nos níveis basais e diminuiu após estimulação periférica.  
Na avaliação da influência cortical na neuropatia dos ratos, verificou-se que a injecção de 
glutamato (Glu) e de um antagonista do receptor NMDA (NMDAr) no cortex cingulado anterior 
rostral (rACC) provocou, respectivamente, um aumento e uma diminuição no comportamento 
afectivo relativo à dor nos animais neuropáticos, também avaliado pelo teste aversivo de 
condicionamento-de-lugar. Ao analisar a actividade neuronal da AMY depois da injecção dos 
mesmos fármacos no ACC, verificámos que apenas o glutamato teve um efeito significativo, 
provocando um aumento dessa actividade.  
Depois de realizado este trabalho, podemos concluir que: I) a actividade das células “ON” e 
“OFF” do RVM está alterada nos animais neuropáticos no sentido de promover a pronocicepção, 
mas apenas as células ON aparentam ser as responsáveis pelo aumento de hipersensibilidade 
associada à neuropatia; II) há plasticidade estrutural na AMY dos animais neuropáticos – 
aumento de volume, resultante de neurónios recém-formados, que ocorre em paralelo com 
comportamento do tipo depressivo; III) nos animais neuropáticos, o comportamento afectivo 
relativo à dor depende, pelo menos, da activação dos mGluR1/5 na AMY e dos NMDAr no ACC; IV) 
a activação dos mGluR1 na AMY provoca um aumento da actividade das células ON nos animais 
neuropáticos. 
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1.1 Pain Control 
1.1.1 Pain definition 
Pain is usually defined as an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage or described in terms of such damage [International 
Association for the Study of Pain (IASP) - 1994 definition, reviewed in 2008]. Pain 
unpleasantness exists so the body can recognize that something is threatening it and leads to 
behaviour that will remove the organism from the source of potential injury (Landrieu et al., 
1990). Individuals congenitally insensitive to pain are easily injured and most of them die at an 
early age (Nagazako et al., 2003). Pain is a key process for our nervous system to learn from and 
react to the environment (King et al., 1997). Actual pain, or the threat of it, usually leads to 
behavioural arousal, endocrine responses and sympathetic activation which, together with 
temporary antinociception, allows escaping from harmful situations that may potentially be life 
threatening (Millan, 1986; Wiertelak et al., 1994; Traub, 1997). 
 
1.1.2 Pain pathways  
Peripheral afferent fibers (PAF) can be classified in three main types on the basis of their 
diameter, structure and conduction velocity: 1) C, thin (0.4-1.2 m in diameter), unmyelinated 
and slowly-conducting (0.5-2.0 m sec-1); 2) A, medium (2-6 M), myelinated and of intermediate 
velocity (12-30 m sec-1). 3) A, large (>10 M), myelinated and fast (30-100 m sec-1) (Millan, 
1999). Each of these classes of PAF encodes sensory information, but they are differentially 
sensitive to noxious and innocuous stimuli; although all these three types of fibers can transmit 
non-nociceptive information, only C and A fibers transmit nociceptive information (nociceptors; 
Giordano, 2005). 
Nociception is defined as the neural process that encodes and processes a noxious stimulus 
(Loeser and Treede, 2008) and that can be measured with electrophysiological techniques.  
(Schaible and Richter, 2004). Noxious stimuli activate primary nociceptive neurons with free 
nerve endings (Aδ and C nociceptors) at the periphery. Most nociceptors respond to noxious 
mechanical, thermal (heat or cold) and chemical stimuli (polymodal; Belmonte and Cervero 
1996). Nociceptors can also have efferent functions in the injured tissue through the release of 
neuropeptides [substance P (SP), calcitonin gene-related peptide (CGRP)] from their endings, 
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inducing neurogenic inflammation (Lynn 1996; Schaible et al. 2005). Nociceptors project to the 
spinal cord and form synapses with second order neurons in the grey matter of the dorsal horn. 
A proportion of second-order neurons have ascending axons and project to the brainstem or to 
the thalamocortical system, triggering the production of the conscious pain response by relaying 
nociceptive input to the limbic system and sensory cortex (Millan, 1986).  
There are two major ascending pathways that make different contributions to the various 
components of pain perception (Figure 1a): the lateral pain system, which projects through 
specific lateral thalamic nuclei to the somatosensory cortex and the medial pain system, which 
projects though medial thalamic nuclei to the anterior cingulate cortex and insula (Treede et al., 
1999). The lateral system mediates the sensory-discriminative component of pain, while the 
medial system is responsible for processing the affective response to a painful stimulus (Carlsson 
et al., 2006). Loss of peripheral afferents would be expected to cause deficits in both the sensory 
discrimination of pain and in the affective response to it. However, a localized abnormality, such 
as a lesion in a specific brain region, might selectively impair only one component of pain 
processing and cause a more subtle deficit in pain perception (Ploghaus et al., 1999). 
Descending tracts reduce or facilitate the spinal nociceptive processing, thus influencing pain 
processing. Descending projections are formed by pathways that originate from brainstem nuclei 
and descend mainly in the dorsolateral funiculus of the spinal cord (Willis and Westlund, 1997; 
Millan, 1999; Almeida et al., 2006). Pain control results, at least in part, from the balance 
between descending inhibitory and facilitatory modulation actions upon spinal nociceptive 
transmissions (Urban and Gebhart, 1999; Porreca et al., 2002; Vanegas and Schaible, 2004). 
 
1.1.3 Pain modulation 
In the present state-of the art, pain modulation is explained by two theories that complement 
each other: the "Gate Control" theory (Melzack and Wall, 1965) and the neuromatrix model of 
pain (Melzack, 1999). 
The "Gate Control" theory was proposed by Melzack and Wall in 1965 and originally proposed 
that ramifications of the large sensory fibers (Afibers) that transmit innocuous cutaneous 
sensory information activates spinal inhibitory interneurons, which will partially inhibit nociceptive 
transmission carried by nociceptors. Thus, nociception (and pain) is suppressed by non-noxious 
stimuli, which “close the gate” to nociceptors activated by noxious stimulation.  
4
  
The endogenous pain modulatory system is a complex network of brain areas that control 
nociceptive transmission at the spinal cord by inhibitory and facilitatory actions. Impulses 
descend from brain stem nuclei to the spinal cord and modulate the transmission of nociceptive 
signals at the dorsal horn (Fields and Basbaum, 1978; Ossipov and Porreca, 2005; Figure 1b). 
The periaqueductal grey matter (PAG), a key region in descending inhibition, projects to the 
rostral ventromedial medulla (RVM), which includes the serotonin-rich nucleus raphe magnus 
(NRM), the nucleus reticularis gigantocellularis pars alpha and the nucleus paragigantocellularis 
lateralis (Fields et al. 1991), and receives inputs from the hypothalamus, cortical regions and the 
limbic system (involved in the processing of emotion, behaviour, cognition) (Ossipov and Porreca, 
2005). Concerning their response to nociceptive stimuli, RVM cells are classified as ON-cells, if 
they give an excitatory response to noxious stimulation just prior to nociceptive withdrawal reflex 
(considered to have a pronociceptive role), OFF-cells, if give an inhibitory response to noxious 
stimulation (considered to have an antinociceptive role) (Heinricher et al., 1994; Fields et al., 
2006) and NEUTRAL-cells, if give no response to noxious stimulation (Mason, 2006). RVM ON- 
and OFF-cells then project, through the spinal dorsolateral funiculus, to the dorsal horn (Field et 
al., 1995), where they cause facilitation and/or inhibition of nociceptive transmission (Fields et 
al., 1991). Therefore, the RVM is a brain area that is capable of causing antinociception and/or 
facilitation of spinal nociceptive transmission (Gebhart, 2004; Ossipov and Porreca, 2005), an 
effect that can be directly exerted by descending projections to the spinal dorsal horn, where the 
nociceptors synapse (D'Mello and Dickenson, 2008). The complexity of nociceptive modulation at 
dorsal horn level is further increased due to the multiple synaptic connections that descending 
fibers and nociceptors make with both excitatory and inhibitory local spinal interneurons (Millan, 
1999).  
5
  
   
 
 Figure 1 – Pathways of pain transmission and modulation. a) The two major ascending pain pathways: the lateral 
pain system (green arrow) projects through specific lateral thalamic nuclei (LT) to the somatosensory cortex (SC) and 
the medial pain system (red arrow) projects through the parabrachial nuclei (PB) to the central nuclei of amygdala 
(CeA) and ventromedial hypothalamic nuclei (VMH); b) The descending pain pathway: the CeA and the VMH project 
to the periaqueductal grey matter (PAG), which projects to the rostroventromedial medulla (RVM) ON and OFF cells, 
which in turn project to the spinal cord dorsal horn. 
 
 
1.1.4 Types of pain  
Pain can be primarily classified as acute and chronic. Although there are additional 
differences between these two types of pain than their time extent, acute pain is defined for 
having a short duration, whereas chronic pain must be present for more than three-six months to 
be classified as such (Russo and Brose 1998). Acute pain arises suddenly in response to a 
specific injury, has a predictable prognosis, and treatment usually includes analgesics (Viallona et 
al., 2008). It protects tissue from being (further) damaged because withdrawal reflexes are 
usually elicited and body protection is triggered. On the other hand, most chronic pain cases 
a) b) 
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have an unpredictable prognosis, a possibly unclear pathology, and treatment, when existent, 
should be multidisciplinary, since analgesics are inefficient, and pain control involves drugs like 
antidepressants and anticonvulsants (Buchner et al., 2007; Scascighini et al., 2008). In many 
chronic pain states there is no causal relation between nociception and pain, which persists 
beyond local recovery/healing and thus does not reflect tissue damage (Cervero and Laird, 
1991). In contrast, emotional and cognitive factors seem to influence pain in acute pain states 
(Rhudy and Meagher, 2000) and mainly in complex cases of chronic pain (Kendall, 1999; Choi 
et al., 2007; Price, 2000), by neuroendocrine dysregulation, fatigue, dysphoria, and impaired 
physical and mental performance (Chapman and Gavrin 1999).  
Regarding its origin, pain can be classified as nociceptive and neuropathic. Nociceptive pain 
arises from activation of nociceptors after noxious stimulation, following detection by specialized 
transducers inserted in the plasma membrane of A and C fibers (Schaible, 2007). Therefore, 
nociceptive information is transmitted by normal physiologic pathways, and also during reversible 
inflammatory processing. Nociceptive pain can be somatic or visceral, the first originating from 
an irritation or damage to the soma (e.g., skin, muscle or joints), and the second being diffused, 
poorly localized, and often referred to a soma (Dunckley et al., 2005; Fairhurst et al., 2007 
Schaible, 2007). The term, nociceptive pain, is applied when pain is perceived as proportional to 
tissue damage and chronic nociceptive pain is thought to be the result of continuous activation of 
nociceptors (Usunoff, 2006).  On the other hand, when the tissue is inflamed or injured, 
pathophysiological nociceptive pain develops (Schaible and Richter, 2004). It may result in 
spontaneous pain (pain in the absence of any identifiable stimulation), hyperalgesia and/or 
allodynia. Hyperalgesia is the higher pain intensity felt upon an already painful noxious 
stimulation (Marchand et al., 2005), whereas allodynia is the sensation of pain elicited by stimuli 
that are normally below pain threshold (Wasner et al., 2007). 
On the other hand, neuropathic pain arises as a direct consequence of a lesion or disease 
affecting the somatosensory system (IASP, 2008). While nociceptive pain is elicited by 
stimulation of the sensory endings in the tissue, neuropathic pain results from injury or disease of 
neurons in the peripheral or central nervous system (Schaible and Richter, 2004). This type of 
pain usually occurs within days, weeks, or months after the injury and tends to occur in waves of 
frequency and intensity (Biondi, 2006). The main signs of neuropathic pain are spontaneous 
and/or evoked pain (Rasmussen et al., 2004): spontaneous components include usually electric-
7
  
like and paroxysmal pain, burning pain (constant and superficial) and aching pain (Herr, 
2004); evoked pain components include hyperalgesia and allodynia. As compared to acute pain, 
less is known about the etiology of chronic pain, as it often occurs with the presence of no illness 
or after its healing is completed.   
 
1.1.5 Neuropathic pain  
Neuropathic pain processing begins after nerve injury, with the degeneration of the axon distal 
to the site of transaction, the Wallerian degeneration. It consists in an initial reaction at the site of 
injury followed by progressive degeneration and phagocytosis of myelin and axons distal to the 
injury (Stoll et al., 2002). Wallerian degeneration is fundamental to neuropathology and it is 
tightly correlated with the development of neuropathic pain (Myers et al., 2006). Following 
Wallerian degeneration, nociceptors become increasingly sensitized to external mechanical and 
thermal stimuli (peripheral sensitization). Injured C-fiber nociceptors can also develop new 
adrenergic receptors and sensitivity, which helps to the sympathetic maintenance of pain.  
Additionally, there is neurogenic inflammation (vasodilation, plasma protein extravasation, release 
of vasoactive peptides), which leads to the release of several neurotransmitters [e.g., 
norepinephrine, serotonin, SP, neurokinin A (NKA), and CGRP] from nociceptive afferent fibers 
and resulting in chemosensitivity contributing to peripheral sensitization.  
Peripheral nerve injury also results in central sensitization, which relates to changes within the 
spinal cord that increase the output of neurons within the nociceptive pathway (Woolf, 1983). The 
firing of C-fibers releases glutamate, activating alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPA), kainate and postsynaptic metabotropic glutamate 
(mGLU) receptors (Jones and Sorkin, 2003). The group I mGLU (mGLU1 and mGLU5; Conn and 
Pin, 1997) links to intracellular guanosine nucleotide proteins (G-proteins), potentiating the 
effects of AMPA/kainate receptor activation and contributing to the development of hyperalgesia 
(Meller et al., 1993; Meller and Gebhart, 1994). Aditionnally, higher stimulus intensities induce 
increased release of SP and NKA from primary afferent terminals (Duggan et al., 1990, 1995), 
which activate spinal neurokinin 1 (NK-1) receptors (McLean et al., 1993; Radhakrishnan and 
Henry, 1995, 1997; Hastrup and Schwartz, 1996) and mediate nociceptive transmission and 
spinal sensitization (Traub, 1996; Abbadie et al., 1997; Doyle and Hunt, 1999). Consequently, 
there is a polymodal depolarization of postsynaptic neurons, facilitating the removal of a voltage-
dependent magnesium ion (Mg2+) block from the glutamate ionotropic NMDA receptor (NMDAr). 
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This, in turn, results in additional neuronal depolarization by large calcium-ion (Ca2+) influx 
through the NMDAr channel (Jones and Sorkin, 2003). Calcium then acts as an important 
secondary messenger, leading to immediate early gene expression (e.g., c-fos), and 
phosphorylation of numerous receptors at the level of the dorsal horn, including NMDA receptors, 
which leads to a decreased threshold of dorsal horn neurons (Ji, 2004; Zimmermann, 2001).   
Neuropathic pain can have are numerous causes (Table 1), the most common having a 
peripheral origin. These include axotomy, nerve plexus damage, metabolic diseases such as 
diabetes mellitus, or herpes zoster. Damage to central neurons (e.g. in the thalamus) can result 
in central neuropathic pain. 
 
 
 
 
1.1.6 Animal models  
As the mechanisms underlying neuropathic pain are still not entirely understood, the search 
for new animal models that reproduce, as close as possible, this painful condition in humans, 
still continues (Kim et al., 1997). These animal models must reproduce sensory deficits 
(allodynia, hyperalgesia, and spontaneous pain) over a sustained period of time to allow 
evaluation by sensory testing (Dowdall et al., 2005). There are several animal models using 
mechanical peripheral nerve injury. The first model was developed by Wall and colleagues 
Table 1– Summary and some examples of Neuropathic Pain causes 
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(1979). It involved complete transection (CT) of the sciatic nerve at midthigh level, and resulted 
in autotomy, used to quantify the degree of neuropathic pain. However, due to animal health care 
issues, this model is rarely used. The chronic constriction injury (CCI) model (Bennett and Xie, 
1988), involves four ligatures loosely tied around the sciatic nerve proximal to the sciatic 
trifurcation. This constriction of the nerve leads to intraneural oedema, a focal ischemia, and 
Wallerian degeneration. This model results in chemical and heat-evoked hyperalgesia, cold and 
mechanical allodynia and some symptoms of spontaneous pain that extend for more than 2 
months (Bennett and Xie, 1988; Attal et al., 1990). Seltzer et al. (1990) developed the partial 
sciatic nerve ligation (PSL) model by tightly ligating 1/3 to 1/2 of the sciatic nerve with a single 
ligature. The result is mechanical allodynia, heat-evoked hyperalgesia, and spontaneous pain, 
present for up to 7 months. The spinal nerve ligation (SNL) model, developed by Kim and Chung 
(1992), results from a tightly ligation of the L5 and L6 spinal nerves close to their respective 
ganglia. Mechanical and heat-evoked hyperalgesia together with spontaneous pain lasting at least 
4 months are observed (Choi et al., 1994). Lee and colleagues (2000) developed a model where 
different combinations of the three branches of the sciatic nerve are transected (tibial, sural, and 
common peroneal), in order to investigate which combination produced the most robust and 
stable degrees of allodynia and hyperalgesia. Reportedly, sectioning the tibial and sural nerves 
resulted in the largest amount of mechanical allodynia, chemical hypperreactivity, and 
spontaneous pain. Almost simultaneously, Decosterd and Woolf (2000) developed the spared 
nerve injury model (SNI), which consists of an axotomy and ligation of the tibial and common 
peroneal nerves leaving the sural nerve intact. The SNI model produces mechanical allodynia, 
mechanical hyperalgesia, no change in thermal heat threshold, a hyper-responsiveness to a 
suprathreshold heat stimulus and cold allodynia, considered to be representative of many of the 
symptoms present in human patients with neuropathic pain (Woolf and Mannion, 1999). 
 
1.2 Amygdala and pain 
1.2.1 Limbic system  
The limbic system was first defined by Paul Broca (1878), mainly to designate the areas 
included in this convolution: the great limbic lobe, the limbic fissure, the superior or inferior 
limbic arch. Later, functional studies by Klüver and Bucy (1939) started to show an association 
between the limbic lobe and complex emotions and motivational processes. In the early 1950s, 
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MacLean (1949, 1954) named these cortical and subcortical systems and their fibers as the 
‘‘limbic system’’.  
The limbic system is constituted by a group of brain structures considered to be evolutionarily 
primitive, located on top of the brainstem and basal to the cortex (Franks, 2006): amygdala, 
hippocampus, hypothalamus, thalamus, fornix, parahippocampal gyrus, cingulate gyrus, olfactory 
cortex, orbitofrontal and medialfrontal cortices (medial prefrontal cortex, mPFC), septal nucleus, 
ventral tegmental area, and some brainstem nuclei. These brain structures have major roles in 
the processing of the emotions, motivations and even pleasure, particularly when those are 
related to survival, like fear, anger, and emotions related to sexual behavior and feeding (Burgdorf 
and Panksepp, 2006). The limbic system also has important functions in memory processing: 
the amygdala is responsible for determining which memories are kept and where they are stored 
in the brain (this determination is based on how big an emotional response is invoked by an 
event; Markowitsch, 1995; Paz et al., 2006); the hippocampus sends memories out to the 
appropriate part of the cerebral hemisphere for long-term storage and retrieves them when 
necessary (damage to this area of the brain may result in an inability to form new memories; 
Dash and Moore, 2007). The hippocampus sends information through the fornix to the mamillary 
bodies, which then project to the anterior nucleus of the thalamus in the mamilothalamic tract, 
path that is classically known as the circuit of Papez (Amaral and Witter, 1995). 
The limbic system also includes the diencephalon, which is located in the subcortical region 
and contains the thalamus and hypothalamus (Jacobson and Marcus, 2008). The thalamus is 
involved in sensory perception and regulation of motor functions (i.e., movement; Basso et al., 
2005). The hypothalamus is also a component of the diencephalon and plays a major role in 
regulating hormones, the pituitary gland, body temperature, the adrenal glands, and many other 
vital activities (Butler and Hodos, 2005).  
The septal nuclei are composed of medium-sized neurons and have a role in autonomic 
function and in emotional behavior (Panksepp, 1986). Lesions of the septal nuclei cause a 
variety of behavioral changes, like alterations in sexual behaviour, foraging behaviour and 
emotional behaviour (Date et al., 1998). The mPFC collects and integrates of behaviorally 
relevant information and has constant plasticity, allowing the adaptation to new tasks. Therefore, 
it has the properties needed to sustain cognitive processing.  The mPFC contributes to the 
regulation of affective behaviors, namely through efferent projections to the AMY, which regulate 
AMY plasticity and responses to previously conditioned stimuli (Rosenkranz et al., 2003). 
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1.2.2. Amygdala  
1.2.2.1 Anatomy and functional significance 
It is known that, in humans, the experience of pain is enhanced by unpleasant emotional 
states (Chapman and Gavrin, 1993; Melzack and Chapman, 1975), and reduced by pleasant 
emotions (Chaves and Barber, 1974; Zillmann et al., 1996). The amygdala (AMY), as part of the 
limbic system, plays a key role in the affective and autonomic aspects of behavior, the evaluation 
of the emotional significance of sensory stimuli, emotional learning and memory, fear, anxiety 
and depression, and stress responses (Cahill, 1999; Davidson et al., 1999; Davis 1994, 1998; 
Gallagher and Chiba, 1996; Gallagher and Schoenbaum, 1999; Rasia-Filho et al., 2000; Rolls, 
2000). 
The AMY is includes approximately 12 different regions, which can be divided into several 
subregions (LeDoux, 2000). Different systems have been used to classify the amygdala areas, 
most of them are very similar. Amaral and colleagues (1992) classified AMY of the primate brain, 
and this classification has been widely used since then, and even applied to the rat brain 
(Pitkänen et al., 1997; LeDoux, 2000). In this classification, the most relevant areas are the 
lateral (La), basal (B), accessory basal (AB), and central (CeA) nuclei and the connections 
between them. In Paxinos and Watson classification (1998; Figure 2), Amaral’s B is named 
basolateral nucleus (BL), and AB is the basomedial nucleus (BM). The term basolateral complex 
is sometimes used to refer the La and B (and sometimes AB) together. The CeA is the same in 
both classifications. Since the Paxinos and Watson classification (1998) was completely 
performed in adult rats, this was the classification used in all studies presented in this thesis. 
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Figure 2 – AMY division as in Paxinos and Watson classification (1998). In this section, we can find the most 
relevant nuclei: central (CeA), lateral (La), basolateral anterior (BLA), posterior (BLP) and ventral (BLV), basomedial 
(in its anterior part, BMA) and medial (Me) nuclei.  
 
The CeA modulates various effector systems involved in the expression of emotional 
responses through widespread connections with the forebrain and brainstem (Cassell et al. 
1986; Krettek and Price 1979; LeDoux 2000; Price and Amaral 1981). The CeA receives a wide 
range of sensory information from descending cortical inputs and ascending thalamic and 
brainstem inputs (Fallon and Moore, 1978). More specifically, the CeA receives inputs from main 
and accessory olfactory systems (Pitkänen et al., 1997;  Canteras et al., 1992; Petrovich et al., 
1996), from mPFC, agranular insular and ventral subicular (Ottersen, 1982) cortical regions, 
from the solitary tract (Ricardo and Koh, 1978) and parabrachial nuclei (Bernard et al., 1993), 
and from the perigeniculate thalamus (probably transmitting somatosensory and auditory 
information; LeDoux et al., 1990; Yasui et al., 1991). Additionally, CeA receives inputs from the 
thalamic paraventricular nucleus (Moga et al., 1995) and from the LA and BLA. The latter also 
project to widespread, differentiated regions of the striatum, including the caudoputamen, 
nucleus accumbens and CeA (Swanson and Petrovich, 1998). These connections between La, 
BLA, and CeA were extensively studied and confirmed through studies in diferent species, 
including rats, cats, and primates (Pitkänen et al., 1997; Paré et al., 1995; Amaral et al., 1992; 
Cassell et al., 1999).  
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It is known that the BLA modulates memory consolidation by interacting with other brain 
areas (McGaugh, 2004). BLA has been described essential to memory-modulatory effects of 
drugs infused into other brain regions, including the hippocampus (Roozendaal and McGaugh, 
1997; Roozendaal et al; 1999), entorhinal cortex (Roesler et al.; 2002), medial prefrontal cortex 
(Roozendaal et al.; 2004), insular cortex (Miranda & McGaugh, 2004) and nucleus accumbens 
(Roozendaal et al; 2001).  
 
1.2.2.2 Role in pain modulation 
The AMY is a major receiver of nociceptive information through the spino-parabrachio-amygdaloid 
pain pathway, which originates from lamina I neurons in the spinal cord and trigeminal nucleus 
caudalis and provides purely nociceptive input to the CeA (Bernard and Bandler, 1998; 
Bourgeais et al., 2001). Aditionally, spinal neurons in the deep dorsal horn and/or the area 
around the central canal form monosynaptic connections with AMY neurons and may provide 
sensory, including nociceptive, input to the AMY (Burstein and Potrebic, 1993; Newman et al., 
1996; Wang et al., 1999). Finally, the CeA also receives nociceptive information from thalamic 
and cortical areas through connections with the lateral (La) and basolateral (BLA) amygdaloid 
nuclei (Bourgeais et al., 2001; Doron and LeDoux, 1999; LeDoux, 2000; Linke et al., 1999; 
Pitkanen et al., 1997; Savander et al., 1995; Shi and Cassell, 1998; Smith et al., 2000). The 
latero-capsular part of the CeA has been defined as the ‘nociceptive amygdala’ because of its 
high content of nociceptive neurons (Han and Neugebauer, 2004; Bernard et al., 1996; 
Neugebauer and Li, 2002). Lesion or inactivation of the AMY decreases emotional pain reactions 
(Borszcz, 1999; Calvino et al., 1982; Werka 1997), without affecting normal behavior or baseline 
nociceptive responses (Calvino et al., 1982; Fox and Sorenson, 1994; Helmstetter, 1992; 
Helmstetter and Bellgowan, 1993; Pavlovic et al., 1996a; Tershner and Helmstetter, 2000; 
Watkins et al., 1993, 1998). Thus, the AMY plays a major role in the processing of the 
motivational-affective component of pain. As the output nucleus for major amygdala functions, 
the CeA has important projections that terminate in several brainstem centers, which modulate 
pain through descending projections to the spinal dorsal horn and control of spinal transmission; 
these include the PAG (Vianna and Brandão, 2003), the RVM (Pavlovic et al., 1996b; Helmstetter 
et al., 1998), the dorsal reticular nucleus (DRt; Almeida et al., 1996, 1999, 2002) and the 
nucleus of the solitary tract (NST; Gamboa-Esteves et al., 2001). 
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Although it has not been entirely clarified, BLA seems also to have a role in pain modulation. 
Hasanein and colleagues suggested the existence of a cannabinoid-mediated inhibitory system in 
the BLA, which normally has no tonic effect on the response threshold to acute and tonic noxious 
stimuli, but that decreases the response to these stimuli when activated (2007). Additionally, it 
has been recently shown that opioid receptors are also involved in the CGRP-induced 
antinociception in the BLA (Li et al., 2008). 
 
1.3 Affective disorders and persistent pain 
1.3.1 Chronic pain and depression 
It has been clearly demonstrated that pain has a negative impact upon the quality of life of a 
person (Hunfeld et al., 2001). Pain impairs the capacity to concentrate, work, socialize, perform 
daily tasks and sleep, which usually results in isolation, loss of self esteem and depression. Since 
chronic pain encloses not only its physical symptoms (like allodynia and hyperalgesia), but also 
mood disorders like depression, these should be carefully evaluated in all patients with chronic 
pain (Dworkin and Gitlin, 1991). In 1993, Magni and colleagues developed a study based on US 
household survey, where estimated rates of depression were of 16.4% in individuals with chronic 
pain, compared with 8% in individuals without chronic pain. A survey in the UK demonstrated that 
psychological distress is more frequent in persons with chronic low back pain than pain-free 
individuals (Croft et al., 1995). Additionally, data from a World Health Organization (WHO) study 
on psychological conditions in primary care (Sartorious et al., 1996) showed that 32% of patients 
with a somatosensory pain disorder also met criteria for a depressive disorder (Von Korff and 
Simon, 1996). These epidemiological studies clearly show that depression is more common in 
persons with chronic pain. 
On the other hand, evidences have also shown that depressed patients are not only more 
prone to develop pain (Dickens et al., 2003), but also have significantly lower pain tolerance 
(Willoughby et al., 2002). It has been reported that depression symptoms are both emotional and 
physical (Stahl, 2002). The fact the depressed patients feel more pain is thought to be related 
with a common pathway between the two, which involves serotonin (5-HT) and norepinephrine 
(NE) neurotransmitter systems (Delgado, 2004). Ascending serotonergic and noradrenergic 
pathways mediate the emotional symptoms of depression and can be targets for serotonin and 
norepinephrine reuptake inhibitors to obtain relief of these symptoms (Stahl and Briley, 2004). 
Descending serotonergic and noradrenergic pathways may regulate the painful physical 
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symptoms of depression, and when targeted by serotonin and norepinephrine reuptake inhibitors 
(like antidepressants), these symptoms are also relieved (Stahl and Briley, 2004).  
Drepressive-like behaviour has been previously observed associated with chronic mild stress 
(Bessa et al., 2008), acute stress (Simmons and Broderick, 2005), drug addiction (Cryan et al., 
2003) and even maternal separation (Marais et al., 2008) in the rat. However, the simultaneous 
evaluation of pain and depressive like behaviour in rats is sparse, if not absent. Zeng and 
colleagues (2008) have recently reported that a subset of Wistar-Kyoto (WKY) rats, a genetic 
variation of the Wistar strain (Porsolt et al., 1978) that has been used as preclinical model of 
depression, showed an increase in mechanical allodynia in WKY rats with chronic pain (induced 
by CCI; 2008). In comparison with normal Wistar rats, WKY rats demonstrate hormonal, 
behavioural, and physiological changes similar to those found in patients with clinical depression.  
 
1.3.2 Neuroplasticity induced by chronic pain 
As mentioned before, peripheral and central sensitization contributes to chronic pain 
development. Previous experimental research has shown that long-term plastic changes 
occurring along sensory pathways after an insult are the main origin of chronic pain (Flor, 2008; 
Nichols et al., 1999; Svendsen et al., 1999). These plastic changes (e.g., increased activity, loss 
of grey matter) take place in peripheral nociceptors, spinal dorsal horn, subcortical areas (ex.: 
thalamus) and also in cortical areas (ex.: insular cortex, primary and secondary somatosensory 
cortex, mPFC, ACC) that are involved in the processing of painful information (Zhuo, 2008; 
Apkarian et al., 2004; Schmidt-Wilcke et al.; 2006). Prior studies have shown that in neuropathic 
pain, there is a decrease in the discriminative physiological function of pain (Hofbauer et al., 
2006; Witting et al., 2006; Pukall et al., 2005; Kwan et al., 2005). One of the advantages of 
human studies is that they allow the determination of brain activity during spontaneous pain in 
patients. In one of these studies, Stern and colleagues (2006) showed that sustained high levels 
of spontaneous pain result in increases in activity within the mPFC, including the ACC. Phantom 
pain, a form of neuropathic pain physically caused by amputation, is believed to be due to 
cortical plasticity and reorganization (studies performed in animals; Wei and Zhuo, 2001; Kaas et 
al. 1999; Flor et al., 2006). It has been reported that chronic back pain is associated with the 
decrease of gray matter in the prefrontal, thalamus, brainstem, somatosensory cortex, ACC and 
mPFC (Apkarian et al. 2004; Schmidt-Wilcke et al. 2006, Kuchinad et al., 2007). Higher 
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activation is consistently reported in cortical areas (S1, parietal, hindlimb, cingulate and 
retrosplenial cortical areas) related to pain processing in patients with phantom pain or other 
forms of chronic pain (Paulson et al., 2000; Mao et al., 1993). However, it is still unclear if these 
structural changes are a consequence of chronic pain or, on the other hand, changes are due to 
affective disorders related to chronic pain, such as depression (Zhuo, 2008).  
In the AMY, the first observation of synaptic plasticity was performed by Racine and 
colleagues (1983) in awake, behaving rats. In this study, tetanic long-term potentiation was 
induced in the amygdala though the application of high-frequency electrical stimuli to the 
pyriform cortex. Since then, different studies demonstrated that AMY exhibits a high degree of 
synaptic plasticity in models of tetanic and pharmacologically induced plasticity (McKernan and 
Shinnick-Gallagher, 1997; Maren, 1999; Wang and Gean, 1999; LeDoux, 2000; Bauer et al., 
2001; Blair et al., 2001; Lin et al., 2001). Neugebauer and colleagues have also consistently 
reported that the AMY exhibits long-term modification of synaptic transmission in rats with 
kindling or knee-joint input (Neugebauer et al., 1997, 2000, 2003). Additionally, plasticity in AMY 
(changes in volumes) has also been reported in humans with affective disorders (Altshuler et al., 
1998, Altshuler et al., 2000; Mervaala et al., 2000; Sheline et al., 1998; Strakowski et al., 1999; 
Tebartz van Elst et al., 2000). Increased amygdala volumes have been reported also in patients 
with temporal lobe epilepsy and comorbid depression (Tebartz van Elst et al 2000), and in 
patients with bipolar disorders (Altshuler et al., 1998; Strakowski et al., 1999). Furthermore, 
studies performed in humans have shown that the amygdalar volume was enlarged in patients 
with depressive disorders, as opposed to the controls (Frodl et al., 2002, 2003; Lange and Irle, 
2004).  
 
1.4 Aims and Methodology 
Neuropathic pain development entails significant changes in pain pathways. These changes 
are translated in significant alterations in the pain modulation systems peripherally, spinally and 
supra-spinally. At the supraspinal level, RVM ON- and OFF-cells have pronociceptive and 
antinociceptive action, respectively; however, their precise contribution for neuropathy 
hypersensitivity is not clearly known (Burgess et al., 2002). Additionally, neuropathic pain is 
strongly related with mood disorders, like depression (Strouse, 2007). Plastic changes have been 
observed in the limbic system, namely in AMY, which is implicated in both emotion and pain 
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processing, both in neuropathic pain and depressive patients. Importantly, until now, no studies 
have analyzed these changes at the structural level in brains of patients (or animals) with 
peripheral neuropathy and depression. Moreover, it is yet to clarify how these changes in the 
AMY influence pain processing and modulation, namely at the level of the supraspinal pain 
control system. 
 
In summary, this thesis aims to: 
 
1. Assess the contribution of RVM ON- and OFF-cells to acute and prolonged neuropathy 
induced by the spared nerve injury (SNI) model, through an electrophysiological study (Chapter 
2.1), in which four groups of animals were included: (i) Sham group tested 1 week after 
operation; (ii) sham group tested 8 weeks after operation; (iii) SNI group tested 1 week after 
operation; and (iv) SNI group tested 8 weeks after operation. The surgery consisted in the 
unilateral axotomy and ligation of the tibial and common peroneal nerves was performed under 
pentobarbitone anaesthesia (50 mg ⁄ kg i.p.) as described in detail earlier (Decosterd & Woolf, 
2000). In each animal of these groups, the development of hypersensitivity was verified daily for 
2–3 days after the surgery, through mechanical hyperalgesia and allodynia assessement. In 
order to perform the electrophysiological recordings, the animals were under anaesthesia, 
induced by pentobarbitone and then placed in a standard stereotaxic frame. The microelectrode 
was lowered to the RVM [according to the atlas of Paxinos & Watson (1998)] and, after a single 
cell has been found, its spontaneous activity was recorded for 2–3 min. Additionally, the activity 
was recorded after application of peripheral stimulati to the lateral side of the hind paw 
innervated by the sural nerve: cold stimulation (peak stimulus temperature, 4ºC; baseline 
temperature, 35ºC) and mechanical stimulation of the skin (applied through an a haemostatic 
clamp to the tail for 5 s), and noxious visceral stimulation [colorectal distension (CRD) at a 
noxious intensity (80 mmHg) (Ness et al., 1991)]. At the end of the experiment, an electrolytic 
lesion was made in the RVM recording site, the animals were given a lethal dose of 
pentobarbitone and the brains were removed for verification of recording sites.  
 
2. Evaluate if chronic pain induces emotional disturbances that are associated with 
neuroplasticity of the amygdaloid complex (Chapter 2.2), through behavioural, structural and 
immunohistochemical analysis. The animals were subjected to the SNI model of chronic 
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neuropathic pain (Decosterd and Woolf, 2000), and tested for mechanical allodynia and 
hyperalgesia a day before and two days after the surgery procedure, followed by testing every two 
days then forward, during the two months of experimental period. Anxiety-like behaviour was 
evaluated by the elevated plus-maze (EPM) test, depression-like behaviour by the forced 
swimming test (FST), and motor activity and exploratory behaviour through the open field (OF) 
test. Structural studies performed were: a) stereological analysis of the AMY, which was 
subdivided in its nuclear components - CeA, La, BLA, BLP, BMA and BMP nuclei (Paxinos and 
Watson (1998); b) nuclei volume and cell number estimation of AMY, obtained through the 
Cavalieri's principle and optical fractionator method; c) 3D-morphologycal analysis of dendrites 
through the observation, at the optical microscope, of brain sections stained with the Golgi-Cox 
method, analysis of completely stained AMY neurons, and drawing of their dendrites and spines. 
In the immunohistochemical analysis of the AMY nuclei, all quantifications of markers for cell 
division and neuronal fate were performed in the AMY, positive controls were confirmed analyzing 
the subgranular zone (SGZ) of the hippocampus, and to achieve negative controls, the primary 
antibody was not included in the protocol of each reaction. The immunohistochemistry reactions 
were performed to reveal the following markers: (i) bromodeoxyuridine (BrdU; an analogue of 
thymidine, incorporated into the newly synthesized DNA of replicating cells), (ii) BrdU and GFAP 
(glial fibrillary acidic protein; a marker of astrocyte glial cells) double-labeling, (iii) BrdU and NeuN 
(protein expressed exclusively in mature neurons) double-labeling and (v) BrdU and Calb 
(Calbindin; a calcium binding protein present in functional mature neurons) double-labeling. The 
cells that stained positively to the referred markers were localized and counted in the AMY and 
nearby telencephalic areas. 
 
3. Reproduce the behaviour results obtain in Chapter 2.2 and elucidate the actual origin of 
the newborn neurons observed in the AMY (Chapter 2.3). Eight weeks after SNI model induction 
to a group of animals, behavioural tests were performed to assess mechanical allodynia (von 
Frey filaments), hyperalgesia (pin-prick test), depressive-like behaviour (forced swimming test) 
and anxiety-like behaviour (elevated plus-maze). Immunohistochemical analysis were then 
performed in order to detect cells staining the following markers: doublecortin (DCX; protein 
expressed in migrating and differentiating neurons) + Ki-67 (nuclear protein expressed in 
proliferating cells in all phases of the active cell cycle); PSA-NCAM (specifically expressed in 
committed neuronal precursors present in regions that are undergoing some kind of structural 
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plasticity) + GFAP (glial fibrillary acidic protein); and nestin (protein markers for immature neural 
cells) + GFAP.  
 
4. Determine if neural plasticity of the AMY induced by peripheral nerve injury (SNI model) 
influences RVM regulation of pain using an electrophysiological approach (Chapter 2.4). After SNI 
induction, the development of hypersensitivity was verified daily for 2–3 days after the surgery 
through mechanical hyperalgesia and allodynia assessment. In order to perform the 
electrophysiological recordings, anaesthetized animals were placed in a standard stereotaxic 
frame according to the atlas of Paxinos & Watson (1998) and had a guide cannula for drug 
administration inserted into the AMY ipsilateral to the SNI or sham-operated limb (left side), 
except for one group that had the cannula contralateral to the nerve injury (right side), and a 
control group that had the cannula in the hippocampus. Additionally, a group of animals tested in 
behavioral experiments only had a bilateral guide cannula for drug injections into the central 
nucleus of the amygdala. The microelectrode was lowered to the RVM and, after a single cell had 
been found, its spontaneous activity was recorded for 2–3 min. Then different drugs (a 
glutamatergic agonist or a glutamatergic antagonist) or saline (control) was then administered in 
a determined order to the amygdala and the spontaneous activity was recorded for up to 30 min. 
Finally, and in order to obtain a measure of affective pain induced by mechanical stimulation of 
the neuropathic hind paw, the place avoidance test was performed in three experimental groups 
of rats i) SNI animals with amygdaloid injections ipsilateral to the nerve injury, ii) SNI animals 
with bilateral amygdaloid injections, iii) sham-operated animals with amygdaloid injections 
ipsilateral to the sham operation.  
 
5. Evaluate the response properties of amygdala nociceptive neurons in peripherally-evoked 
stimulation and what is the cortical influence upon their activity in the neuropathic rat (Chapter 
2.5). The animals were subjected to SNI surgery and, under the same light anaesthesia, a 
cannula was placed in the rostral anterior cingulate cortex (rACC) of all animals, according to the 
atlas of Paxinos & Watson (1998). Nociceptive tests were performed a day before (baseline) and 
every two days after the surgery procedure, in order to verify the development of hypersensitivity. 
The place escape/avoidance testing was performed one or eight weeks after surgical 
implantation of the cannulas. Finally, the spontaneous activity and the peripherally-evoked 
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noxious stimulation response of BLA and CeA neurons was recorded using the electrophysiology 
technique described previously. 
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Abstract
The spared nerve injury (SNI) model of peripheral neuropathy produces a robust and long-lasting hypersensitivity. Previous
behavioural studies suggest that brainstem–spinal pathways originating in or relaying through the rostroventromedial medulla (RVM)
contribute to neuropathic hypersensitivity. We determined whether SNI induces changes in response properties of RVM neurons that
might influence descending modulation of nociception. RVM neurons included in the study were classified into presumably
pronociceptive ON-cells and antinociceptive OFF-cells (giving excitatory or inhibitory responses to noxious stimulation, respectively).
Spontaneous activity and the response to cold, pinch and colorectal distension were assessed under light anaesthesia in the rat,
1 week and 8 weeks following nerve injury or sham operation. Spontaneous activity was increased 1 week but not 8 weeks after
nerve injury in ON-cells but decreased in OFF-cells at both time points. In the SNI group, cold-evoked responses were enhanced
particularly in ON-cells, independent of the postoperative time point. Responses of ON-cells to pinch and visceral stimulation were
enhanced 8 weeks but not 1 week following nerve injury, whereas OFF-cell responses to pinch or colorectal distension were not
changed. The results indicate that SNI induces pronociceptive changes in spontaneous activities of ON-cells and OFF-cells and
peripherally evoked responses of ON-cells that vary with the postoperative time point. Increased ON-cell activity and decreased
OFF-cell activity in the RVM are likely to enhance spinal nociception in a tonic fashion, whereas increased responses of ON-cells
to peripheral stimulation are likely to enhance ascending nociceptive signals by a positive feedback following peripheral
noxious stimulation.
Introduction
Peripheral nerve injuries may produce long-lasting neuropathic pain
and hypersensitivity that is particularly prominent with mechanical
and cold stimulation of the skin (Scadding & Koltzenburg, 2006). The
maintenance of these nerve injury-induced symptoms depends on
abnormal discharge from peripheral nerves (Devor, 2006) and
pronociceptive changes in the spinal segmental mechanisms mediating
and modulating pain-related signals (Woolf & Salter, 2006). Addi-
tionally, changes in descending pain modulation contribute to
neuropathic symptoms (Pertovaara, 2000; Porreca et al., 2002;
Ossipov et al., 2006). The rostroventromedial medulla (RVM),
consisting of the raphe magnus and its adjacent reticular nuclei, is a
ﬁnal common pathway for many descending pathways and is involved
in descending facilitation as well as inhibition of pain-related spinal
responses (Gebhart, 2004; Vanegas & Schaible, 2004). Among the
various cell types of the RVM, one giving an excitatory response to
noxious stimulation just prior to nociceptive withdrawal reﬂex
(ON-cell) is considered to have a pronociceptive role, whereas one
giving an inhibitory response to noxious stimulation (OFF-cell) is
considered to have an antinociceptive role (Fields et al., 2006). A
third cell type of the RVM giving no response to noxious stimulation
(NEUTRAL-cell) has a less clear role, although it has been proposed
to contribute to tonic modulation of various spinal processes (Mason,
2006), possibly including nociception. Whereas there is accumulating
behavioural evidence indicating that the RVM contributes to neuro-
pathic hypersensitivity through descending pathways, the contribution
of various cell types of the RVM to hypersensitivity during an early
vs. a later phase of neuropathy is only partly known (see Discussion
for references).
In this study, we assessed the contribution of presumably pro- and
antinociceptive RVM cells to acute and prolonged neuropathy by
determining their response properties at two different postoperative
time points in sham-operated controls vs. in animals with a spared
nerve injury (SNI) model of peripheral neuropathy (Decosterd &
Woolf, 2000). This model of neuropathy provides stable and long-
lasting symptoms mimicking those observed in clinical conditions.
Materials and methods
The experiments were performed in adult, male Hannover-Wistar rats
weighing 180–190 g at the beginning of the experiment (Harlan,
Horst, The Netherlands). The experimental protocol was accepted
by the Institutional Ethics Committee and the experiments were
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performed according to the guidelines of European Communities
Council Directive of 24 November 1986 (86 ⁄ 609 ⁄ EEC).
Techniques for producing neuropathy
The unilateral axotomy and ligation of the tibial and common
peroneal nerves was performed under pentobarbitone anaesthesia
(50 mg ⁄ kg i.p.) as described in detail earlier (Decosterd & Woolf,
2000). Brieﬂy, the skin of the lateral surface of the thigh was incised
and a section made directly through the biceps femoris muscle
exposing the sciatic nerve and its three terminal branches. Following
ligation and removal of 2–4 mm of the distal nerve stumps of the
tibial and common peroneal nerves, muscle and skin were closed in
two layers. In sham-operated animals, the surgical procedure was
identical, except that the tibial and common peroneal nerves were
not ligated or sectioned.
Behavioural verification of neuropathy
Development of hypersensitivity was veriﬁed behaviourally in
animals habituated to the experimental conditions 1–2 h daily for
2–3 days. For assessment of tactile allodynia, the hind limb
withdrawal threshold was determined by stimulating the sural nerve
area in the hind paw of the operated limb with monoﬁlaments. The
calibrated series of monoﬁlaments used in this study produced
forces ranging from 0.16 to 15 g (North Coast Medical, Inc. Morgan
Hill, CA, USA). The monoﬁlaments were applied to the foot pad
with increasing force until the rat withdrew its hind limb. The
lowest force producing a withdrawal response was considered the
threshold. The threshold for each hind paw of each rat was based on
three separate measurements and the median of these values was
considered to represent the threshold. Threshold values £1 g were
considered to represent hypersensitivity. It should be noted that the
currently used strain of rats delivered by Harlan (Horst, The
Netherlands) has an exceptionally low withdrawal threshold to
monoﬁlament stimulation in the baseline (unoperated) condition: in
10 unoperated control animals, the lowest withdrawal threshold was
only 4 g, and therefore the criterion for hypersensitivity was set to
as low as £1 g in this study.
Electrophysiological recordings
For electrophysiological recordings, the anaesthesia was induced by
pentobarbitone at a dose of 50 mg ⁄ kg i.p. and the animal was placed
in a standard stereotaxic frame according to the atlas of Paxinos &
Watson (1998). Anaesthesia was maintained by infusing pentobarbi-
tone (15–20 mg ⁄ kg ⁄ h). The level of anaesthesia was frequently
monitored by observing the size of the pupils and by assessing
withdrawal responses to noxious stimulation. When necessary, the
infusion rate of pentobarbitone was increased. The rats were
spontaneously breathing. A warming blanket was used to maintain
body temperature within the physiological range. Peripheral perfusion
was checked by evaluating the colour of ears and extremities. The
skull was exposed and a hole drilled for placement of a recording
electrode in the RVM. The desired recording site in the RVM was 1.8–
2.3 mm posterior from the ear bar, 0.0–0.9 mm lateral from the
midline, and 8.9–10.7 mm ventral from the dura mater.
Single neuron activity was recorded extracellularly with lacquer-
coated tungsten electrodes (tip impedance 3–10 MW at 1 kHz) and
then ampliﬁed and ﬁltered using standard techniques. Data sampling
was performed with a computer connected to a CED Micro 1401
interface and using Spike 2 software (Cambridge Electronic Design,
Cambridge, UK).
Actual recordings did not start until the animal was under light
anaesthesia; that is, the animals gave a brief withdrawal response to a
noxious pinch, but the pinch did not produce any longer-lasting motor
activity, and nor did the animals have spontaneous limb movements.
Neurons were classiﬁed on the basis of their response to noxious pinch
of the tail with a haemostatic clamp. This stimulus was painful when
applied to the ﬁnger of the experimenters. Neurons giving excitatory
responses to pinch were considered ON-cells, those giving inhibitory
responses were considered OFF-cells and neurons showing no or only
a negligible (<10%) change in their discharge rates as a response to
pinch were considered NEUTRAL-cells. This classiﬁcation scheme of
medullary neurons was modiﬁed from that described by Fields et al.
(2006). A noteworthy difference is that we did not verify whether
pinch-evoked responses of RVM neurons were associated with spinal
reﬂex responses as in the original classiﬁcation scheme (Fields et al.,
2006). Therefore, the populations of ON- and OFF-cells in this study
may not be identical with those in a study in which cells are classiﬁed
strictly according to the classiﬁcation scheme of Fields et al. (2006).
Our previous results suggest, however, that there is only little
difference in the classiﬁcation of RVM neurons whether or not spinal
reﬂex responses are concurrently measured in lightly anaesthetized
animals (Pertovaara et al., 2001).
Peripheral test stimuli
In electrophysiological experiments, cold stimuli (peak stimulus
temperature, 4 C; baseline temperature, 35 C; rate of stimulus
temperature decrease, 4 C ⁄ s; duration of the peak temperature of
4 C, 10 s) were applied with a feedback-controlled Peltier device
(LTS-3 Stimulator; Thermal Devices Inc., Golden Valley, MN, USA)
to the lateral side of the hind paw innervated by the sural nerve.
Whereas some models of neuropathy may be associated with
signiﬁcant skin temperature changes that provide a confounding
factor to assessment of thermal responses, particularly when using
radiant heat for stimulation (Luukko et al., 1994), applying thermal
stimuli with a contact thermostimulator and starting from a standard
adapting temperature reduces the possibility that a neuropathy-
associated change in skin temperature will inﬂuence the results.
ON- and OFF-neurons in the RVM typically have very large
receptive ﬁelds covering almost the whole body and allowing
testing of not only responses evoked by stimulating the operated
limb but also responses evoked by the nonoperated region within
the same neurons. In this study, responses evoked by stimulating
the tail and the viscera were assessed to observe potential nerve
injury-induced changes outside of the injured region. Mechanical
stimulation of the skin consisted of applying a haemostatic clamp to
the tail for 5 s. When applied to the experimenter’s hand, this
stimulus produced a painful pinch sensation. Noxious visceral
stimulation consisted of colorectal distension (CRD) at a noxious
intensity (80 mmHg) (Ness et al., 1991). CRD was applied for 10 s
by inﬂating with air a 7–8-cm ﬂexible latex balloon inserted
transanally into the descending colon and rectum. The pressure in
the balloon was controlled by an electronic device (Anderson et al.,
1987).
When the stimulus-evoked responses were analysed, the baseline
discharge frequency recorded during a corresponding period just
before the stimulation was subtracted from the discharge frequencies
determined during stimulation; that is, positive values represent
excitatory responses evoked by peripheral stimulation and negative
ones inhibitory responses.
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Course of the study
Four groups of animals were included in the electrophysiological
study: (i) sham group tested 1 week after operation; (ii) sham group
tested 8 weeks after operation; (iii) SNI group tested 1 week after
operation; and (iv) SNI group tested 8 weeks after operation. In each
of these groups, behavioural assessment of sensitivity to monoﬁlament
stimulation was performed before the start of the electrophysiological
experiment.
After induction of anaesthesia, the microelectrode was lowered to
the RVM. After a single cell had been found, its spontaneous activity
was recorded for 2–3 min. Then, cold stimulation was applied to the
sural nerve area in the operated limb followed by pinch of the tail and
CRD at 1-min intervals. The testing procedure, including the order of
testing different submodalities of nociception, was the same in all
experimental groups. To minimize serial effects, every other animal
tested in this series belonged to the sham group and every other to the
SNI group.
At the completion of the study, an electrolytic lesion was made in
the recording site, the animals were given a lethal dose of pentobar-
bitone and the brains were removed for veriﬁcation of recording and
microinjection sites.
Statistics
Data are presented as mean ± SEM. For assessment of differences in
incidence of various types of neurons in different experimental
conditions, the chi-squared test was used. Two-way anova followed
by the Student–Newman–Keuls test was used for assessing differences
in neuronal responses between the experimental conditions. P < 0.05
was considered to represent a signiﬁcant difference.
Results
All animals with SNI showed mechanical hypersensitivity both
1 week and 8 weeks following surgery, as indicated by hind limb
withdrawal thresholds that were £1.0 g ipsilateral to the nerve injury.
In contrast, sham-operated animals did not develop mechanical
hypersensitivity and their hind limb withdrawal thresholds were
signiﬁcantly higher than those in the SNI group (F1,28 ¼ 40,
P < 0.0001), independent of the postoperative time point (1 or
8 weeks, Fig. 1).
In general, ON-cells gave excitatory and OFF-cells inhibitory
responses to noxious stimulation. Their receptive ﬁelds covered
bilaterally wide areas of the body and all extremities. NEUTRAL-
cells, in contrast, gave no marked responses to noxious stimulation of
the extremities, and they were not further studied here. Distributions of
RVM cells with different types of response properties were not
signiﬁcantly different between SNI and sham groups at either 1 week
or 8 weeks following surgery (chi-square test; Table 1).
Spontaneous activity
The spontaneous discharge rate of ON-cells was signiﬁcantly changed
from 1 week to 8 weeks postoperatively (F1,69 ¼ 8.9, P < 0.005;
Fig. 2A), and the change in the discharge rate varied with the
experimental group (Sham vs. SNI animals; F1,69 ¼ 4.8, P < 0.04).
One week following the operation, the spontaneous discharge rate of
ON-cells was signiﬁcantly higher in the SNI than in the Sham group.
By the 8-week postoperative time point, the spontaneous discharge
rate of ON-cells was signiﬁcantly decreased in the SNI group only.
Consequently, the spontaneous discharge rate of ON-cells 8 weeks
following the operation was no longer higher in the SNI than in the
Sham group, but was, if anything, the opposite.
The spontaneous discharge of the OFF-cells tended to increase from
the 1-week to the 8-week postoperative time point (F1,69 ¼ 14.8,
P < 0.0005; Fig. 2B). The spontaneous discharge rate of OFF-cells
was signiﬁcantly lower in the SNI group than in the Sham group
(F1,69 ¼ 8.5, P < 0.005; Fig. 2B), independent of the postoperative
time point (1 week vs. 8 weeks; F1,69 ¼ 14.8, P < 0.0005).
Peripherally evoked responses
Application of cold (4 C) to the sural nerve area in the operated hind
limb evoked markedly stronger excitatory responses in ON-cells of the
SNI than of the Sham group (F1,87 ¼ 116, P < 0.0001; Figs 3 and
4A), independent of the postoperative time point (F1,87 ¼ 0.67). Cold-
evoked responses of ON-cells did not vary with elapsed time from the
surgery (1 week vs. 8 weeks; F1,87 ¼ 0.9). Cold stimulation induced
stronger inhibitory responses in the OFF-cells of the SNI than in the
Sham group (F1,53 ¼ 64.6, P < 0.0001; Fig. 4B). Postoperative time
(1 week vs. 8 weeks) did not inﬂuence the magnitude of the cold-
evoked inhibitory response in OFF-cells (F1,53 ¼ 0.8).
Noxious tail pinch produced signiﬁcantly stronger excitatory
responses in ON-cells of the SNI than of the sham group
(F1,87 ¼ 54, P < 0.0001; Figs 5 and 6A), and this difference in the
response magnitude was signiﬁcantly larger at 8 weeks than at 1 week
after the operation (F1,87 ¼ 17.4, P < 0.0001). There were
no signiﬁcant differences in pinch-evoked inhibitory responses of
Fig. 1. Hind limb withdrawal thresholds evoked by monoﬁlament stimulation
of the operated limb determined in nerve-injured (SNI) and sham-operated
(Sham) animals 1 week and 8 weeks following the operation. Thresholds were
determined prior to induction of anaesthesia. The error bars represent SEM
(n ¼ 7–9). ***P < 0.005 (Student–Newman–Keuls test).
Table 1. Numbers of different types of rostroventromedial medullary neurons
studied in different experimental groups
ON-cells OFF-cells Neutral-cells
Sham
1 week 17 11 6
8 weeks 27 18 10
SNI
1 week 18 12 5
8 weeks 29 16 8
SNI, spared nerve injury; Sham, sham operation; 1 week and 8 weeks refer to
the postoperative time point of the study.
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OFF-cells between the SNI and the Sham groups (F1,53 ¼ 3.2;
Fig. 6B). Pinch-evoked inhibitory responses in OFF-cells, however,
were stronger at 8 weeks than at 1 week after the operation
(F1,53 ¼ 6.7, P < 0.02), independent of nerve injury (F1,53 ¼ 0.4).
CRD at a noxious intensity (80 mmHg) evoked signiﬁcantly
stronger excitatory responses in ON-cells of the SNI than of the
Sham group (F1,87 ¼ 7.2, P < 0.01; Figs 6C and 7), and this
difference in the response magnitudes was signiﬁcantly larger at
8 weeks than at 1 week following the operation (F1,87 ¼ 10.7,
P < 0.005). One week following the operation, ON-cell responses
evoked by CRD were minor ones and not different between the
experimental groups, whereas at 8 weeks following operation, the
CRD-evoked ON-cell response was signiﬁcantly increased in the SNI
group only (see Fig. 6C for detailed results of post hoc tests). In OFF-
cells, the inhibitory response evoked by CRD was not signiﬁcantly
different between the SNI and Sham groups (F1,53 ¼ 2.4; Fig. 6D),
and the magnitude of the response evoked by CRD in OFF-cells was
not signiﬁcantly different when assessed 1 week vs. 8 weeks postop-
eratively (F1,53 ¼ 1.8).
Recording sites
Figure 8 shows the recording sites in the medulla.
Discussion
The results indicate that the SNI model of peripheral neuropathy
induces marked pronociceptive changes in response properties of cells
in the RVM, a nucleus with an important role in descending
modulation of pain (Pertovaara & Almeida, 2006). These plastic
changes vary with elapsed postoperative time and they are likely to
contribute to maintenance of neuropathic hypersensitivity.
Spontaneous activity and peripherally evoked responses
Spontaneous discharge rate of RVM ON-cells, which are known to
have an excitatory effect on nociceptive transmission (Fields et al.,
2006), was signiﬁcantly increased 1 week but not 8 weeks after nerve
injury. The spontaneous discharge rate of RVM OFF-cells, which have
an inhibitory effect on nociceptive transmission (Fields et al., 2006),
was decreased both 1 week and 8 weeks following nerve injury.
Taken together, these ﬁndings suggest that both ON- and OFF-cell
Fig. 3. Examples of original recordings of cold-evoked responses of ON-cells
in a sham-operated animal and a nerve-injured (SNI) animal 8 weeks following
the operation. Cold stimulation was applied to the skin of the sural nerve area in
the operated limb. The peristimulus time histogram of the neuronal response
(above) and the change of stimulus temperature from 35 C to 4 C (below) are
shown for each neuron. The calibration bar for the peristimulus time histogram
represents 10 impulses ⁄ s and the horizontal calibration bar represents 25 s for
the Sham condition and 20 s for the SNI condition.
Fig. 2. Mean spontaneous activities of ON-cells (A) and OFF-cells (B) in
the RVM of sham-operated (Sham) and nerve-injured (SNI) animals 1 week
and 8 weeks following sham operation or nerve injury. The error bars represent
SEM (n ¼ 11–29). *P < 0.05 (Student–Newman–Keuls test; reference, the
corresponding value in the Sham group), +P < 0.05 (Student–Newman–Keuls
test; reference, the corresponding value in the 1-week group).
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activities in the RVM promote neuropathic hypersensitivity in a tonic
fashion during the ﬁrst week following nerve injury. At a later phase of
neuropathy, however, only the OFF-cell activity has a tonic prono-
ciceptive effect, as a result of its decreased activity.
When assessing responses of RVM cells to peripheral stimulation,
we focused on mechanical and cold stimulation, because clinical
studies indicate that hypersensitivity to mechanical stimulation and
cold are frequent and prominent symptoms after traumatic nerve
injuries, whereas hyperalgesia to heat occurs only occasionally under
neuropathic conditions (Scadding & Koltzenburg, 2006). Importantly,
hypersensitivity to cold and mechanical stimulation is also a
prominent ﬁnding in rats with the SNI model of neuropathy
(Decosterd & Woolf, 2000). Because very little is known about the
possible inﬂuence of somatic neuropathy on visceral sensations, we
also determined responses of RVM cells to CRD.
The results indicate that SNI produced a signiﬁcant hypersensitivity
to cold in both ON- and OFF-cells throughout the observation period
of 8 weeks. It should be noted, however, that the increase of excitatory
responses to cold was considerably stronger in ON-cells than the
increase of inhibitory ones in OFF-cells. Possibly, the SNI-induced
reduction in the spontaneous activity of OFF-cells limited the amount
of a further stimulus-evoked inhibition of OFF-cells. Responses to
cutaneous pinch and visceral stimulation were markedly enhanced in
ON-cells 8 weeks but not 1 week following nerve injury, whereas
OFF-cell responses to pinch or visceral stimulation were not
inﬂuenced by SNI. The present ﬁnding that hypersensitivity to
peripheral stimulation was observed predominantly in presumably
pronociceptive ON-cells of the RVM is in line with the hypothesis that
a positive feedback loop involving ON-cells in the RVM is involved in
promoting neuropathic hypersensitivity to peripheral stimulation. This
hypothesis is further supported by the earlier behavioural ﬁndings
indicating that nerve injury-induced hypersensitivity to mechanical
stimulation (Pertovaara, 2000; Porreca et al., 2002) and cold (Urban
et al., 2003) is dependent on descending facilitatory inﬂuence from the
RVM. Moreover, it is noteworthy that although behaviourally assessed
mechanical hypersensitivity develops within 24 h in the SNI model of
neuropathy, it may not be fully developed until the second postop-
erative week (Decosterd & Woolf, 2000), whereas hypersensitivity to
cold is fully developed within a week (Allchorne et al., 2005). These
behavioural ﬁndings parallel the present neurophysiological results
with ON-cells. However, when considering the potential behavioural
signiﬁcance of SNI-induced changes in stimulus-evoked responses of
RVM neurons in the present study, one should note that assessments of
neuronal responses to noxious peripheral stimulation were not
Fig. 4. Mean changes of ON-cell (A) and OFF-cell (B) discharge rates
induced by cold applied to the sural nerve area in the operated limb 1 week and
89 weeks following the operation. SNI, spared nerve-injury group; Sham,
sham-operated group. **P < 0.01, ***P < 0.005 (Student–Newman–Keuls
test; reference, the corresponding Sham group). The error bars represent SEM
(n ¼ 11–29).
Fig. 5. Examples of original recordings of tail pinch-evoked responses of
ON-cells in a sham-operated animal and a nerve-injured (SNI) animal
8 weeks following the operation. The arrows show the duration of stimulation
(5 s). The vertical calibration bars represent 20 impulses ⁄ s.
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accompanied by simultaneous assessments of corresponding behavio-
ural responses. Moreover, behavioural responses of SNI animals to
two of the currently used stimuli (pinch of an uninjured tail and CRD)
have not been assessed in any previous study.
Comparison with previous studies
In line with the present ﬁndings, it has been shown earlier that
ON-cells in the RVM have a pronociceptive role in acute inﬂammation
as indicated by the association of their discharge rate with heat
hypersensitivity induced by mustard oil (Kincaid et al., 2006;
Xu et al., 2007). Previous studies addressing the contribution of
RVM cells to neuropathic hypersensitivity have given partly contra-
dictory results. It has been reported that chemical ablation of RVM
cells expressing the l-opioid receptor both prevents and reverses
Fig. 7. Examples of original recordings of CRD-induced responses of ON-cells
in a sham-operated animal and a nerve-injured (SNI) animal 8 weeks following
the operation. The peristimulus time histogram of the neuronal response (above)
and the change of stimulus intensity from 0 mmHg to 80 mmHg and back
(below) are shown for each neuron. The calibration bar for the peristimulus time
histogram represents 30 impulses ⁄ s. The duration of the CRD is 10 s.
Fig. 8. Schematic diagram showing recording sites in the RVM.
Fig. 6. Mean changes of ON-cell (A and C) and OFF-cell (B and D) discharge rates induced by noxious pinch of the tail or CRD at a noxious intensity (80 mmHg)
1 week and 8 weeks following sham operation or nerve injury. SNI, spared nerve-injury group; Sham, sham-operated group. ***P < 0.005 (Student–Newman–
Keuls test; reference, the corresponding Sham group). +++P < 0.005 (Student–Newman–Keuls test; reference, the corresponding group 1 week following operation).
The error bars represent SEM (n ¼ 11–29).
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spinal nerve ligation-induced experimental neuropathy (Porreca et al.,
2001). Because ON-cells are the only RVM neurons responding
directly to l-opioid agonists (Heinricher et al., 1992), the selective
reversal of neuropathic hypersensitivity by ablation of medullary cells
expressing l-opioid receptors suggests, in line with the present results,
that ON-cells promote neuropathic hypersensitivity. On the other
hand, the results of our previous electrophysiological study (Pertova-
ara et al., 2001) suggested that spinal nerve ligation-induced
neuropathy of 2–3 weeks’ duration may not produce as marked
pronociceptive changes in response properties of RVM cells as the
SNI model of neuropathy in the present study or acute inﬂammation in
other studies (Kincaid et al., 2006; Xu et al., 2007). Among possible
explanations of the difference between the results of our present and
earlier study (Pertovaara et al., 2001) are the differences in the genetic
background of the animals, model of neuropathy, and postoperative
time point of study. Interestingly, the sciatic constriction-induced
model of neuropathy had no signiﬁcant inﬂuence on response
properties of RVM cells giving excitatory responses to noxious
stimulation (Luukko & Pertovaara, 1993), whereas complete dener-
vation of the sciatic area, as opposed to incomplete denervation in the
present study, produced an enhancement of excitatory responses of
RVM cells to peripheral stimulation of the adjacent intact skin area
(Pertovaara & Kauppila, 1989). Together, these ﬁndings support the
hypothesis that the magnitude or time course of the change in the
response properties of RVM cells may vary with the model of
peripheral neuropathy, with models involving sectioning of the
peripheral nervous system resulting in strong neuropathic changes of
the supraspinal pain control system. As anatomical feedback loops
implicated in the crosstalk between the brainstem and spinal cord are
essential for pain modulation (Almeida et al., 2006), the drastic
changes associated with the afferent barrage of nociceptive messages
after nerve ﬁbre sectioning may have a role in the differences observed
between models. In the speciﬁc case of the RVM, a clear anatomical
basis for reciprocal interaction exists, as it receives direct projections
from the spinal cord (Chaouch et al., 1983) and ON- and OFF-cells are
known to project directly to dorsal horn laminae I–II and V (Fields
et al., 1995) and modulate spinal nociceptive transmission (Fields
et al., 2006).
Various models of peripheral neuropathy may increase spontaneous
discharge rates and responses to somatic stimulation in nociceptive
spinal dorsal horn neurons (e.g. Palecek et al., 1992; Laird & Bennett,
1993; Takaishi et al., 1996; Pertovaara et al., 1997), whereas their
responses to visceral stimulation were not inﬂuenced 2–3 weeks after
spinal nerve injury (Kalmari et al., 2001). It remains to be studied
whether the SNI-induced changes in response properties of RVM cells
observed in the present study reﬂect corresponding changes in
response properties of spinal dorsal horn neurons, changes in
supraspinal processing of nociceptive signals, or both.
Conclusions
The SNI model of peripheral neuropathy induced pronociceptive
changes in response properties of RVM neurons that are considered to
have an important role in descending regulation of pain. These
pronociceptive changes included an increased baseline discharge rate
in presumably pronociceptive ON-cells and a decreased baseline
discharge rate in presumably antinociceptive OFF-cells. Moreover,
responses to mechanical stimulation and cold were markedly enhanced
in the pronociceptive cell type. It is proposed that the SNI-induced
changes in spontaneous discharge rates of ON- and OFF-neurons of
the RVM make a tonic contribution to maintenance of neuropathic
hypersensitivity, whereas the enhanced responses of pronociceptive
ON-cells to peripheral stimulation promote hypersensitivity via a
positive feedback loop.
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Depressive-like behaviourith the development of affective disorders but the underlying mechanisms are not
fully understood. Changes in brain centres implicated in both emotional and pain processing are likely to be
critical in the interplay of pain control and affective emotional behaviour. In the present study, we assessed
emotional behaviour and performed a structural analysis of the amygdala (AMY) in neuropathic rats after two
months of hyperalgesia and allodynia, induced by the spared nerve injury model (SNI). When compared with
Sham-controls, SNI animals displayed signs of depressive-like behaviour. In addition, we found an increased
amygdalar volume in SNI rats. No alterations were found in the dendritic arborizations of AMY neurons but,
surprisingly, the amygdalar hypertrophy was associated with an increased cell proliferation [bromodeoxyur-
idine (BrdU)-positive cells] in the central (CeA) and basolateral (BLA) amygdaloid nuclei. The phenotypic
analysis of the newly-acquired cells revealed that they co-label for neuronal markers (BrdU+NeuN and BrdU+
Calbindin), but not for differentiated glial cells (BrdU+glial ﬁbrillary acidic protein).
We demonstrate that neuropathic pain promotes generation of newneurons in the AMY. Given the established
role of the AMY in emotional behaviour, we propose that these neuroplastic changes might contribute for the
development of depressive-like symptoms that are usually present in prolonged pain syndromes in humans.
© 2008 Elsevier Inc. All rights reserved.IntroductionPain is a multidimensional experiencewith sensitive–discriminative
and motivational-affective dimensions (Anand and Craig, 1996).
Persistent pain, including chronic pain syndromes (Tal and Bennett,
1994), is a commoncondition associated to awide spectrumof disorders
including cancer, inﬂammation and neuropathic pain. Neuropathic pain
(NP) is caused by a primary lesion or dysfunction of the nervous tissue
(Merskey and Bogduk, 1994) and results in prolonged hyperalgesia,
allodynia and spontaneous pain (Devor, 2006). NP results froma process
of peripheral and central sensitization that generates an enhanced
transmission of nociceptive input to the brain (Gao et al., 2005; Ren and
Dubner, 1996), which may impair the endogenous supraspinal pain
control system (Danziger et al., 2001; Kauppila et al., 1998; Pertovaara,
2000; Rasmussen et al., 2004; Tal and Bennett, 1994).
The amygdala (AMY) is a central component of the limbic system
and plays a crucial role in behavioural responses to emotional stimuli
(Davis and Whalen, 2001; Han and Neugebauer, 2004; Neugebauer
and Li, 1992). Moreover, the AMY is deeply involved in processing the
emotional component of pain, probably through a modulatory rolemeida).
eurc/index.htm (A. Almeida).
l rights reserved.upon major supraspinal pain control centres (SPCC) (Manning and
Mayer,1995; Manning,1998; Manning et al., 2001). On the other hand,
it is possible that neuroplasticity in higher centres controlling SPCC
may contribute to alterations in the ﬁne control of pain. In fact, an
imbalance between inhibiting and facilitating descending modulation
of nociceptive transmission may underlie, at least in part, the
development of chronic pain (Almeida et al., 2006; Lima and Almeida,
2002; Pertovaara, 2000; Porreca et al., 2002; Schaible et al., 1991).
Accordingly, arthritic and neuropathic pain enhance synaptic trans-
missionof nociceptive-speciﬁc input to theAMY (Han andNeugebauer,
2004; Neugebauer and Li, 1992; Neugebauer et al., 2003), which
reinforces the potential role of AMY in SPCC alterations resulting from
prolonged pain syndromes.
Chronic pain induces mood disorders, including depression and
anxiety (Rasmussen and Rummans, 2002). In addition, the adverseness
of pain is ampliﬁed or reduced depending on the emotional environ-
ment (Merskey, 1965), and conditions of increased anxiety (Rhudy and
Meagher, 2000) anddepression (Merskey,1965;Willoughbyet al., 2002;
Zelmanet al.,1991) are usually associatedwithdecreasedpain tolerance.
This vicious circle may trigger, or even result from, neuronal changes in
the limbic system. Accordingly, imaging studies indicate that gross
structural changes may occur in the AMY in situations of major
depression (Altshuler et al., 2005; Bremner et al., 2000; Frodl et al.,
2002; Strakowski et al., 1999; Tebartz van Elst et al., 2000).57
Fig. 1. Mechanical allodynia assessed by von Frey ﬁlaments (A) and mechanical
hyperalgesia assessed by the pin-prick test (B) before and after surgery in SNI and
Sham groups (dotted line indicates the day of SNI surgery). (A) Note that the pre-
surgery threshold to von Frey ﬁlaments was similar in both SNI and Sham groups and
in both hind paws; after surgery, the withdrawal threshold of the SNI group decreased
within 24 h and remained low until the end of the 2 month experimental period. In
Sham animals, the withdrawal threshold to von Frey ﬁlaments was decreased during
the ﬁrst postoperative days but returned to baseline values. (B) In the pin-prick test,
SNI animals showed a strong hyperalgesia from the ﬁrst postoperative day onwards,
whereas Sham animals showed no hyperalgesia. The symbols and error bars represent
mean+S.D.
49L. Gonçalves et al. / Experimental Neurology 213 (2008) 48–56As a rationale for the present study, we hypothesized that chronic
pain induces emotional disturbances that are associated with
neuroplasticity of the amygdaloid complex. To assess this hypothesis,
we performed behavioural, stereological and immunocytochemical
analysis during or after the induction of a two month neuropathy
following themodel of Decosterd andWoolf (2000). Part of the present
results have already been published in abstract form (Gonçalves et al.,
2006).
Materials and methods
Animals
All procedures were performed on adult (200–250 g, 55–65 days)
male Wistar–Han rats. Animals were housed under standard labora-
tory conditions (12 h light cycle; 22 °C, 55% humidity; food and water
available ad libitum). Experiments were conducted in accordance with
local regulations, European Union Directive 86/609/EEC, NIH guide-
lines on animal care experimentation and IASP ethical guidelines for
pain experimentation on awaken animals (Zimmermann, 1983). Sixty
animalswere divided in twomain experimental groups of 30 rats each:
spared nerve injury (SNI) and sham operated (Sham). A set of rats
(n=18 each group) received one injection of the cell proliferation
marker bromodeoxyuridine (BrdU; Miller and Nowakowski, 1988),
50 mg/kg body weight, i.p. (Sigma, St. Louis, MO) for three consecutive
days before their death (see below), twomonths after SNI induction or
Sham surgery.
Spared nerve injury surgery
The SNImodel of chronic neuropathic pain included an axotomy and
ligation of two of the three peripheral ramiﬁcations of the sciatic nerve,
the tibial and common peroneal nerves and leaving the sural nerve
intact, as described elsewhere (Decosterd andWoolf, 2000). The animals
were lightly anesthetized with pentobarbital 0.5% (Eutasil, Ceva Saúde
Animal, Portugal). The common peroneal and tibial nerves were tight-
ligated with 5.0 silk and sectioned distal to the ligation, removing 2–
4 mm of the distal nerve stump. Great care was taken to avoid any
contactwithor stretchingof the intact sural nerve.Muscle and skinwere
closed in two layers. Sham-controls involved exposure of the sciatic
nerve and its branches without performing any manipulation.
Nociceptive tests
Nociceptive testswere performed in all animals a day before and two
days after the surgery procedure, followed by testing every two days
then forward, during the two months of experimental period. Both the
ipsilateral (right hind paw) and the contralateral hind paw were tested
in order to evaluate the presence of “mirror pain”, described elsewhere
as present in neuropathic pain pathologies (Tal and Bennett, 1994).
Mechanical allodynia
Animals were placed on an elevated wire grid and the lateral
plantar surface of the paw stimulated with a series of ascending force
von Frey monoﬁlaments. The nociceptive threshold was taken as the
lowest force that evoked a brisk withdrawal response to one of ﬁve
repetitive stimuli (Tal and Bennett, 1994).
Mechanical hyperalgesia
With the animals on the elevated grid, a pin-prick test was
performed using a safety pin. The lateral part of the plantar surface
of the paw was brieﬂy stimulated at intensity sufﬁcient to touch but
not penetrate the skin (Decosterd et al., 1998). The duration of paw
withdrawal was measured, with an arbitrary minimal time of
0.5 seconds (s) (for the brief normal response) and maximal cut-off
of 20 s (Tal and Bennett, 1994).58Assessment of emotional behaviour
All behavioural tests were performed ﬁve days preceding animal
sacriﬁce during light period (9am to 6pm) in a restricted group of
animals (n=18 each group).
Anxiety-like behaviour — elevated plus-maze test (EPM)
Anxiety-like behaviour was evaluated in the EPM test through
an apparatus consisting of two open and two closed arms (50.8×
10.2×40.6 cm each arm) (MedAssociates Inc., St. Albans, Vermont,
USA). Each rat was placed in the centre of the elevated plus-maze
facing one of the open arms, and the time spent (s) in the open or
closed arms was recorded during a 5-min test period (Mesquita et al.,
2006; Sousa et al., 2006). The elevated plus-maze was carefully
cleaned with 10% ethanol before each animal was placed on the
equipment.
Depressive-like behaviour — forced-swimming test (FST)
The test was performed as in the original method described
elsewhere (Porsolt et al., 1977, 1978). On day 1 (conditioning, pre-
test session), rats were individually placed in a clear Plexiglass
cylinder (29 cm in diameter and 50 cm in height) containing 30 cm
of water (25+0.5 °C) and left to swim for 5 min. The rats were then
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for 5 min, and ﬁnally returned to their home cage. Twenty-four
hours later, the rats were tested under the same conditions for 5 min
(test session). Rats were judged to be immobile when both hind legs
were not moving, and the rat was slightly bent forward (Mesquita
et al., 2006).
Locomotion and exploratory behaviour — open ﬁeld test (OF)
Motor activity and exploratory behaviour were evaluated by
placing the rat into an infrared photobeam controlled open ﬁeld
activity test chamber in a brightly illuminated (white light) room.
Animals were tested for 10 min in an arena (43.2 cm×43.2 cm
transparent acrylic walls and white ﬂoor) (MedAssociates Inc., St.
Albans, Vermont) thatwas divided into a central and a peripheral zone.
The time spent by each animal in the central and peripheral (residual)
zone and its vertical activity (rearings) were the parameters evaluated
in this test (Mesquita et al., 2006). Environmental odours were
removed with 10% ethanol solution.
Tissue preparation
Both the SNI and Sham groups were divided as follows: i) in the
ﬁrst group (n=6 each), designated to stereological analysis, the
animals were anaesthetized with pentobarbital and perfused with
4% paraformaldehyde (PFA), the brains were removed, embedded in
2-hydroxyethyl glycol methacrylate, serially sectioned in a micro-
tome at 30 μm and stained with Giemsa; ii) in the second group (n=6
each), designated to 3D-morphologycal analyses of dendritic arbo-
rization of AMY neurons, the animals were anesthetized with pento-
barbital, perfused with saline and the brains were removed and
processed for posterior staining following the Golgi-Cox method
(Gibb and Kolb, 1998) and slicing in a vibratome at 100 μm; iii) in
the third group (n=18 each), processed for immunocytochemistry
for detection of BrdU, GFAP (glial ﬁbrillary acidic protein), NeuNFig. 2. Performance of SNI and Sham groups during behavioural tests. No differences were obse
closedarms. In the FST (B), the timeof activitywas lower inSNI animals,which indicates thepres
of the parameters evaluated.(neuronal nuclei) and Calb (Calbindin), the animals were decapi-
tated, the brains dissected, frozen in liquid nitrogen and sectioned in
a cryostat (−14 °C).
Stereological procedures
The amygdaloid complex was subdivided in its nuclear compo-
nents as in Paxinos and Watson (1998): central (CeA), lateral (La),
basolateral anterior (BLA) and posterior (BLP), basomedial anterior
(BMA) and posterior (BMP) nuclei. The nuclei volume and cell number
estimation in AMY nuclei in every 8th section stained with Giemsa
was obtained through the Cavalieri's principle and optical fractionator
methods using the Stereoinvestigator software (MicroBrightField, Inc.,
Williston, VT, USA).
3D-morphologycal analysis of dendrites
The brain sections stained with the Golgi-Cox method were
observed at the optical microscope and multipolar and bipolar AMY
neurons completely and perfectly stained (Cerqueira et al., 2007) were
considered for further analysis using the Neurolucida software
(MicroBrightField, Inc., Williston, VT, USA). The dendrites and spines
of 6 AMY neurons per animal were drawn.
Immunohistochemical procedures
All quantiﬁcations of markers for cell division and neuronal fate
were performed in the AMY. Positive controls for histochemical
reactions were conﬁrmed by analysing the subgranular zone (SGZ) of
the hippocampus, since neuronal proliferation is known to occur in
this area (Gould et al., 1999a). As negative controls of immunocyto-
chemical reactions, the primary antibody was not included in the
protocol of each reaction; no speciﬁc immunoreaction was observed
following negative controls.rved between the two groups in the EPM test (A), neither in the time spent in the open or
enceof depressive-likebehaviour.Nodifferenceswere observed for theOF test (C, C′) in any
59
Fig. 3.Morphological analysis of AMY nuclei. (A) Volumes of different AMY nuclei were
higher in neuropathic animals when compared to Sham, with differences being
statistically signiﬁcant for the CeA and BLA nuclei. (B) Cell number is also higher in all
amygdalar nuclei of SNI animals, with differences being signiﬁcant again in the CeA and
BLA nuclei. (C) Structural analysis through Golgi-Cox method showed no differences in
cell body volume and dendrite length of AMY neurons between SNI and Sham groups.
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Bromodeoxyuridine (BrdU; an analogue of thymidine, incorpo-
rated into the newly synthesized DNA of replicating cells) incor-
poration was detected by immunocytochemistry on every 8th serial
brain section containing the amygdaloid complex. Brieﬂy, sections
were ﬁxed in 4% PFA for 30 minutes (min), permeabilized for
10 min in a solution containing 0.2% Triton X-100 in Tris buffer
saline (TBS) after a 3×3 min wash in TBS, heated during 20 min in
citrate buffer 0.1 M following a 3×3 min wash and acidiﬁed in HCl
2 M for 30 min after rinsing in distillated water. Endogenous per-
oxidase activity was blocked with 3% H2O2 in TBS for 10 min after a
3×3 min wash in TBS, followed by immersion in 4% bovine serum
albumin (BSA) in TBS for 30 min (to block non-speciﬁc staining)
after a 3×3 min wash. After another 3×3 min wash in TBS, the tissue
was incubated overnight with a primary monoclonal anti-BrdU
antibody raised in mouse (1:50, Dako, Glostrup, DK) and stained
cells were detected using a universal detection system (BioGenex,
San Ramon, CA, USA) and diaminobenzidine (DAB 0.025% and H2O2
0.5% in Tris–HCl 0.05M pH 7.2), after a 3×2 min wash in TBS and a
1×3 min wash in Tris–HCl, followed by counterstaining with
haematoxylin. BrdU-positive cells were counted throughout the
entire AMY area.
Immunoﬂuorescence and quantiﬁcation of double-labelled cells
Double-staining immunoﬂuorescent reactions were performed in
order to reveal three different groups: (i) BrdU andGFAP (glialﬁbrillary
acidic protein; a marker of astrocyte glial cells; Reeves et al., 1989), (ii)
BrdU and NeuN (protein expressed exclusively in mature neurons;
Mullen et al., 1992) and (iii) BrdU and Calb (Calbindin; a calcium-
binding protein present in functional mature neurons; Meguro et al.,
2004). The following primary antibody dilutions were used: rat anti-
BrdU (1:500, Accurrate,Westbury,MA),mouse anti-GFAP (1:500, Dako
Glostrup, Denmark), mouse anti-NeuN (1:500, Chemicon Interna-
tional, Temecula, CA, USA) and rabbit anti-Calb (1:200, Chemicon
International, Temecula, CA, USA). The initial protocol procedure (until
the primary antibody incubation) was the same in the ﬁrst three
groups and similar to that described above for revealing BrdU. The
following speciﬁc procedures for each double-staining method are
explained brieﬂy and separately for each group.
Brain sections were mounted in slides with Vectashield (Vector
Laboratories, Burlingame, CA, USA) to delay ﬂuorescence decay, and
observed two days later in a ﬂuorescence microscope. Data were con-
ﬁrmed posteriorly using confocal microscopy (Olympus FluoViewTM
FV1000, OLYMPUS).
i) BrdU and GFAP
After overnight incubation with the primary antibody anti-BrdU
raised in rat, sectionswerewashed 3×2min in TBS and then incubated
with a ﬂuorescent Alexa 568 secondary antibody (goat anti-rat, 1:200;
Molecular Probes, Eugene, OR, USA) for 1 h. Following a 3×3minwash
in TBS, sections were incubated during 3 h with the primary antibody
mouse anti-GFAP, followed by the ﬂuorescent Alexa 488 secondary
antibody (goat anti-mouse, 1:100, Molecular Probes, Eugene, OR, USA)
for 1 h. The sections were ﬁnally washed 2×2 min in TBS and 2 min in
distillate water before being mounted in slides.
ii) BrdU and NeuN
Sections were incubated overnight with the primary antibody anti-
BrdU raised in rat followed by the ﬂuorescent Alexa 568 secondary
antibody (goat anti-rat, 1:200; Molecular Probes, Eugene, OR, USA) for
1 h, after a 3×3minwash in TBS. Then, sections were immersed for 3 h
with the primary antibody anti-NeuN raised in mouse (1:500) and
washed 3×3 min. Subsequently, they were incubated with biotiny-
lated secondary antibody anti-mouse (1:200) for 1 h and, after a
3×3 min wash, incubated with Alexa Streptavidine 488 (1:100,
Molecular Probes, Eugene, OR, USA) for one ﬁnal hour. The sections60were washed in TBS and distillate water as above and mounted in
slides.
iii) BrdU and Calb
Sections were incubated overnight with the rat anti-BrdU and
mouse anti-Calb primary antibodies. In the next day, after a 3×3 min
wash in TBS sections were ﬁrstly incubated with ﬂuorescent Alexa 568
(goat anti-mouse, 1:200) secondary antibody for 1 h and then with
ﬂuorescent Alexa 488 (goat anti-rat, 1:200; Molecular Probes, Eugene,
OR, USA) secondary antibody, after a 3×3minwash. The sections were
washed in TBS and distillate water and mounted in slides.
Statistic analysis
For the analysis of baseline thresholds of SNI/Sham and ipsi/
contralateral hind paws in the von Frey and pin-prick tests, one-way
analysis of variance (ANOVA) was performed. Considering that in the
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performed, the Student's t test was used to analyse the results
of all tests and procedures. The results were considered to be
statistically different when pb0.05. Data are presented as mean±
standard deviation (SD).
Results
The spared nerve injury model induces hypersensitivity for at least
2 months
Assessment of mechanical allodynia and hyperalgesia using,
respectively, von Frey ﬁlament and pin-prick tests, were performed
twice before the SNI surgery (baseline measurements) and every two
days afterwards (during a two month period). Both neuropathic (SNI
group) and sham-control (Sham group) animals presented a similar
baseline withdrawal threshold measured by von Frey ﬁlaments (SNI:
ipsilateral 38±6.1 g, contralateral 25±8.2 g; Sham: ipsilateral 36±7.3 g,
contralateral 35±5.1 g; Fig. 1A). A bilateral decrease in nociceptive
threshold was observed in neuropathic animals within 24 h after
surgery. This threshold decrease reached the level of 0–5 g four days
after the surgery, a value that remained constant until the end of the
twomonth experimental period. These data showed that the SNI group
developed and maintained a strongmechanical allodynia in both hindFig. 4. Cell fate resulting from amygdalar neuroplasticity. (A) The number of cells that were BrdU
number of BrdU+GFAP double-labelled cells between SNI and Sham groups. (A′) Representati
double-labelled cells were present only in AMY nuclei, being absent in Sham animals. (B′) Re
double-stained cells were also present only in neuropathic animals. (C′) Representative images ofpaws, as a consequence of the surgery. On the contrary, nociceptive
threshold in Sham animals decreased slightly with the sham surgery,
returning to baseline values within a week, never reaching thresholds
as lowas those presented by SNI animals (Fig.1A). Inwhat concerns the
pin-prick test, the baseline duration of hyperalgesic behaviourwas less
than 1 s in all animals, and there were no differences between groups
(SNI: ipsilateral 0.17±0.17 s, contralateral 0.11±0.8 s; Sham: ipsilateral
0.13±1.11 s, contralateral 0.2±0.2; Fig. 1B). Within 24 h from the
surgery, SNI animals reached the maximal duration of hyperalgesic
behaviour in both hind paws (20 s) whereas no changeswere observed
in Sham animals (Fig. 1B). These data showed that the SNI group
developed and maintained a clear hyperalgesic state during virtually
the entire experimental period. In summary, data on pain-related
behaviour demonstrated that SNI animals developed a clear neuro-
pathy that extended throughout the complete experimental period.
Neuropathic animals develop a depressive-like behaviour but do not
display signs of increased anxiety
Emotional behaviour was assessed seven weeks after the surgery.
EPM was performed to evaluate anxious behaviour, FST to assess
depressive-like behaviour and the OF test to determine locomotion
and exploratory behaviour (Mesquita et al., 2006). In the EPM, no
differences were found in the behavioural responses between SNI and-positivewas signiﬁcantly superior in SNI animals, but no differences were observed in the
ve images of GFAP, BrdU and GFAP+BrdU (double-stained)-positive cells. (B) BrdU+NeuN
presentative images of BrdU, NeuN and NeuN+BrdU double-stained cells. (C) Calb+BrdU
BrdU, Calb and Calb+BrdU double-stained cells. Magniﬁcation bar: 60 μm (A′), 20 μm (B′, C′).
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unaltered by induction of SNI. On the other hand, the FST revealed
signiﬁcant differences between experimental groups (Fig. 2B): while
Sham animals were active for 230±27 s, SNI animals only tried to
escape/swim for 180±38 s (p=0.012), which indicates the presence
of a learned helplessness (depressive-like) behaviour in neuropathic
animals. Since FST test includes movement of the paws and
neuropathic animals are hyperalgesic and allodynic in both ipsilateral
and contralateral hind paws, the OF test was performed in order to
validate the FST test. This test revealed that the SNI group had no
differences in the locomotion ability when compared with Sham
group and it also revealed that the number of rearings (an indicator of
exploratory behaviour) did not differ between experimental groups
(Figs. 2C,C′). The absence of differences in the time spent in central vs.
peripheral part of the OF arena also indicates the absence of altered
anxiety behaviour in neuropathic animals. In summary, these
behavioural studies demonstrate that a 2 month neuropathy induced
a depressive-like, but not anxious-like, behaviour.
Volume and cell number are increased in amygdaloid nuclei
After animal perfusion, 6 brains of each experimental group were
prepared for stereological analysis and other 6 SNI and Sham brains
were processed for tri-dimensional morphological analysis. For
stereological analysis the AMY was divided in 6 nuclei (Paxinos and
Watson, 1998): central (CeA), lateral (La), basolateral anterior (BLA)
and posterior (BLP), basomedial anterior (BMA) and posterior (BMP).Fig. 5. (A–D) Microphotograph showing examples of BrdU+NeuN double-labelled cells in t
nucleus is outlined by a continuous line. CPu — caudate putamen (striatum); MePD — me
Magniﬁcation bar: 100 μm (A), 20 μm (B–F).
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neuropathic animals, with a signiﬁcant increase being observed in CeA
(p=0.02) and BLA (p=0.019) nuclei (Fig. 3A). In order to determine the
causes for these structural changes of AMY, we analysed potential
alterations in cell numbers and cellular volumes. SNI neuropathic
animals showed a general increase in the number of cells in all AMY
nuclei, with a signiﬁcant difference being present again in CeA
(p=0.015) and BLA (p=0.016) nuclei (Fig. 3B). On the contrary, 3D-
morphological analysis revealed no signiﬁcant differences in dendritic
lengths (Fig. 3C) or perikarya areas (Fig. 3D) between neuropathic and
Sham animals, both in bipolar and multipolar AMY neurons. Taken
together, these results indicate that the signiﬁcant increase observed
in CeA and BLA nuclear volumes of SNI animals was due, at least in
part, to an increase in cell numbers.
Newborn neurons contribute to increased cell numbers in AMY
Rats received one injection of the cell proliferation marker
bromodeoxyuridine (BrdU) in the three consecutive days before
their sacriﬁce. The aim of this procedure was to determine if cell
proliferationwas responsible for the higher number of cells observed
in the CeA and BLA nuclei in SNI animals. Immunohistochemistry
revealed the presence of BrdU-positive cells in the AMY of both
SNI and Sham groups, but with signiﬁcantly higher numbers in
neuropathic animals (p=0.001; Fig. 4A). In order to identify the
phenotype of these newly-acquired cells, two different double-
staining immunohistochemistry reactions were performed: BrdU+he CeA. The rectangle in micrograph A is magniﬁed in ﬁgures B–D; the border of CeA
dial amygdaloid nucleus, posterodorsal part; ic — internal capsule; opt — optic tract.
Fig. 6. Examples of BrdU+NeuN (A) and BrdU+GFAP (B) double-labelled cells (arrows)
obtained in positive-control sections from the subgranular zone of the dentate gyrus of
the hippocampus. Magniﬁcation bar: 20 μm (A), 10 μm (B).
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neuronal marker (NeuN). The number of BrdU+GFAP-positive cells
was similar between the SNI and Sham groups. On the other hand,
BrdU+NeuN double-labelled cells were observed only in the SNI
group; interestingly, they were mainly located in the CeA and BLA
nuclei (Figs. 4B, B′, 5). These ﬁndings indicate the presence of newly
proliferating neurons in the AMY after prolonged SNI, as further
demonstrated by the presence of BrdU+Calbindin-positive cells in
the AMYof neuropathic animals (Fig. 4C,C′). Positive control sections
obtained from the subgranular zone of the hippocampal dentate
gyrus showed the presence of both BrdU+NeuN and BrdU+GFAP
double-labelled cells (Fig. 6).
In summary, data demonstrate not only that recently-divided
newborn neurons are formed in the AMY of chronic pain animals, but
also that these neurons reach a physiologicallymature (i.e., functional)
state.
Discussion
After two months of neuropathic pain, SNI animals exhibited
signs of sustained persistent pain associated with a signiﬁcant
depressive-like behaviour. At the CNS level, a structural reorganiza-
tion of the amygdaloid complex was observed that was associated
with a signiﬁcant increase in the volume of the basolateral (BLA) and
central (CeA) AMY nuclei. The volume increase was due to an in-
creased number of AMY cells, and not to hypertrophy of dendrites or
perikarya of amygdalar neurons. The present study is the ﬁrst dem-
onstrating cell proliferation in a limbic area, as a result of chronic
neuropathic pain. Earlier, only electrophysiological studies have
shown chronic pain-related neuroplasticity of AMY neurons in per-
sistent arthritis, visceral pain (Han and Neugebauer, 2004) or neuro-
pathy (Ikeda et al., 2007). Moreover, this is the ﬁrst study
demonstrating that chronic pain results in depressive-like behaviour
associated with neuroplasticity in a major brain centre implicated in
the control of both emotions and pain.Changes in emotional behaviour and neuroplasticity in the AMY
Morphological plasticity in the AMY was previously suggested in
cases of prolonged emotional disturbance, as shown by increased AMY
volumes measured by structural magnetic resonance in patients with
depression and anxiety (Frodl et al., 2002; Tebartz van Elst et al., 2000).
Clinical data also reveal that prolonged pain conditions are associated
with a high incidence of emotional disorders, including anxiety and
depression (Rasmussen et al., 2004). Herein, we show that in the rat, a
two month neuropathy resulted also in a depressive-like behaviour
measured by the forced-swimming test (FST), but no alterations in
anxiety levels were detected in the elevated plus-maze and open ﬁeld
tests. We also show that increased immobility time in the FST should
not be ascribed to motor impairments as there were no changes in
locomotor activity and exploratory behavior. As in humans, SNI
neuropathy associated with emotional alterations may result from,
or contribute to, the structural changes observed in the AMY. It has
been proposed that the increase in AMY volume observed in de-
pressive patients was a consequence of the continuous prolonged
activation of this area (Frodl et al., 2002). Following the same rationale,
the present increase in AMY volume may result from the continuous
ﬂow of nociceptive information into AMY regions receiving sensory
information (including the BLA) and the consequent prolonged activity
of AMY neurons triggering the appropriate response action (CeA is the
main effector of AMY). Especially relevant is the increase in the CeA
volume, as its latero-capsular part is deﬁned as the ‘nociceptive
amygdala’ due to its high content in neurons implicated in nociceptive
processing (Bernard et al., 1996; Neugebauer and Li, 1992; Neugebauer
et al., 2004).
The volume increase in the AMY after two months of neuropathic
pain may have resulted from one or various different processes: cell
size (soma and dendritic size) increase, cell number (neurons or glial
cells) increase, or increased extracellular volume. However, subse-
quent analysis revealed that the increased volume of the AMY in SNI
animals could not be ascribed to cell size variations, but rather to an
increase in cell number. Interestingly, such increase in cell numbers
was conﬁrmed by the observation of newly proliferating cells in AMY
nuclei of SNI animals. Although the presence of newborn neurons in
the adult brain of mammals is considered to be restricted to two areas,
the subgranular zone (SGZ) of the hippocampus and the subventricular
zone (SVZ) (Doetsch et al., 1997; Gould et al., 1999b; Kempermann and
Gage, 2000), the possibility of neurogenesis in the AMY has already
been raised in a study showing evidence for the presence of newly
generated neurons in the AMY of adult primates, at basal conditions
(Bernier et al., 2002). The results of double-immunoreactions (BrdU+
NeuN) performed in the present study demonstrate that a signiﬁcant
number of these newly-born cells undergo a neuronal phenotype.
Thus, the genesis of newborn neurons is responsible, at least in part,
for the increase in cell number underlying the increase of volume
observed in the AMY of SNI animals. In contrast, the number of cells
stained simultaneously formarkers of cell proliferation (BrdU) and glia
(GFAP) revealed no additional glial cell proliferation in the AMY
following SNI induction; this indicates that SNI results only in ad-
ditional neuronal proliferation, with a similar basal rate of astrocyte
cell division being common to both Sham and SNI animals.
Neurogenesis and the AMY
Our observation of NeuN and BrdU co-localization in AMY cells
indicate that newly generated cells reached neuronal maturation in the
amygdaloid complex. This is in accordance with the time points for
expression of neuronal differentiation markers described by Kemper-
mann et al. (2004) and Steiner et al. (2004): in the hippocampus of adult
mice NeuN expression becomes higher than immature-neuron
markers 3 days after cell division. Additionally, the presence of BrdU+
Calb double-labelled neurons in the AMY conﬁrms the maturation and63
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SNI animals.
Whether these newly-born cells observed in the AMY of SNI rats
result from local progenitor cells or migrate from adjacent neurogenic
regions is still not known. However, several studies have shown that
besides the normal migration of proliferative cells from the SVZ to the
olfactory bulb (through the rostral migratory stream, RMS) or from the
SGZ to other areas of the DG, they can migrate from the SVZ to injured
areas of the brain (Iwai et al., 2003; Parent et al., 2002; Van Kampen
et al., 2004). Therefore, it is possible that the new neurons here
observed have their origin in SVZ progenitor cells that, through
migration, reached the amygdaloid complex following the prolonged
pain syndrome induced by the SNI model. Supporting this hypothesis,
post-natal neurogenesis in the SVZ and SGZ can be regulated positively
through the enhancement of the survival of newly generated cells and
negatively through the down regulation of cell proliferation (Gould
and Gross, 2002) following different stimuli (Jin et al., 2001). On the
other hand, a growing amount of evidence supports the notion that the
CNS itself is not as static as once believed: BrdU-positive cells were
shown to be present in several regions of the adult CNS currently
thought to be mitotically quiescent (Rietze et al., 2000); studies report
that neurogenesis is prone to occur in other areas of adult mammals,
like the neocortex (Gould et al., 1999a; Takemura, 2005), the striatum
(Van Kampen et al., 2004; Bedard et al., 2006), the substantia nigra
(Yoshimi et al., 2005) and the amygdala itself (Bernier et al., 2002).
Taking into account these data, it should not be excluded the possibility
that neural stem cells could be present in the AMY and proliferate
following the prolonged neuropathy resulting from the SNI model.
Further experimental procedures must be performed to elucidate this
issue.
Roles of AMY in pain and emotional processing
Several data implicate the AMY in pain modulation, as shown by
changes in pain tolerance induced by AMY manipulation (Manning,
1998). Moreover, the AMY has a role in both pain inhibition and pain
facilitation (Manning and Mayer, 1995; Manning et al., 2001;
Tershner and Helmstetter, 2000). This dual effect may result from
direct AMY projections to brainstem areas implicated in both de-
scending antinociception and pronociception (Almeida et al., 1999;
Bouhassira et al., 1992; Porreca et al., 2002). As a balance between
descending inhibiting (antinociceptive) and facilitating (pronocicep-
tive) actions upon spinal nociceptive transmission can contribute to
the normal control of pain perception (Lima and Almeida, 2002;
Pertovaara, 2000; Porreca et al., 2002; Ren and Dubner, 1996;
Schaible et al., 1991), the AMY may have a crucial role as a higher
centre modulating the brainstem pain centres responsible for the
ﬁne regulation of the spinal nociceptive transmission. Thus, it is
possible that the here observed amygdalar neuroplasticity may con-
tribute not only to emotional changes but also to alterations in
nociception. In support of this hypothesis, volume changes of AMYwere
already shown in imaging studies of patients with a major depression
(Drevets, 2000) and changes in synaptic function of nociceptive AMY
neurons have been described in sustained pain conditions (Han and
Neugebauer, 2004; Ikeda et al., 2007). Additionally, the neuronal
proliferation observed in AMY areas involved in afferent (BLA) and
efferent (CeA) nociceptive processing may disrupt ﬁne neuronal
networks between high brain centres, which provide a structural basis
for deregulation of emotional behaviour.
Conclusion
In conclusion, this study shows that besidesmechanical hyperalgesia
and allodynia, animals subjected to the SNI model of neuropathic pain
during a two month period developed a depressive-like behaviour
associatedwith an increased volumeof AMYnuclei that results fromcell64proliferation. Importantly, this is the ﬁrst study providing evidence for
the presence of newly-born cells in the amygdaloid complex as a
consequence of a sustained chronic (neuropathic) pain condition. We
hypothesize that these neuroplastic changes of the AMY could be
associated with the development of depressive-like behaviour in
neuropathic animals. Nonetheless, future studies on the origin of
newborn neurons and their integration in the pre-existing synaptic
network shouldbeperformed in order todetermine the relevanceof this
phenomenon.
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Newborn neurons are present in the amygdala after prolonged neuropathic pain: 
evidence for local neurogenesis  
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ABSTRACT  
 
Neuropathic pain is strongly associated with the development of affective disorders like 
depression. The amygdala (AMY) has a significant role in the processing of emotions and is an 
important area in pain modulation and in emotional response to pain. Affective disorders (i.e. 
depression) resulting from chronic pain conditions are associated with structural plasticity in the 
AMY. We have previously described that after eight weeks of neuropathic pain induced by the 
spared nerve injury model (SNI) in rats, newborn neurons are present in the AMY, in association 
with a depressive-like behaviour. The aim of this study was to replicate the behaviour results and 
clarify what is the actual origin of these newborn neurons observed in the AMY. The SNI model 
was induced in a group of animals and prolonged during eight weeks. Behavioural tests were 
performed to assess mechanical allodynia (von Frey filaments), hyperalgesia (pin-prick test), 
depressive-like behaviour (forced swimming test) and anxiety-like behaviour (elevated plus-maze). 
Immunohistochemical analysis was performed in order to detect, in the rat brain, the location of 
different markers: doublecortin (DCX; protein expressed in migrating and differentiating neurons) 
+ Ki-67 (nuclear protein expressed in proliferating cells in all phases of the active cell cycle); PSA-
NCAM (specifically expressed in committed neuronal precursors present in regions that are 
undergoing some kind of structural plasticity) + GFAP (glial fibrillary acidic protein); and nestin 
(protein marker for immature neural cells) + GFAP. Depressive-like behaviour was confirmed, as 
well as the absence of anxious-like behaviour, after eight weeks of induced neuropathy. 
Additionally, we observed in basal and central AMY nuclei DCX+Ki-67-positive cells (co-localizing), 
PSA-NCAM-positive and GFAP-positive cells (not co-localizing), and nestin-positive and GFAP-
positive cells (not co-localizing). These data strongly indicate that the cell division inducing 
newborn neurons in the central nucleus of the AMY after 8 weeks SNI neuropathy took place in 
69
 
 
the amygdalar region and did not result from a long distance migration from other regions of the 
brain. 
 
 
 
 
 
Figure 1 – Some examples of the immunohistochemical reacted sections observed through confocal microscope. A) 
Representative images of Ki-67-positive cells in the central nucleus of the AMY (CeA); B) Representative images of 
DCX-positive cells in the CeA; C) Representative images of Ki-67+DCX-double positive cells in the CeA; D) 
Representative images of GFAP-positive cells in the CeA; E) Representative images of PSA-NCAM-positive cells in the 
CeA; F) Representative images of GFAP+PSA-NCAM-double positive cells in the CeA; G) Representative images of 
GFAP-positive cells in CeA; H) Representative images of nestin-positive cells in the CeA; I) Representative images of 
GFAP+nestin-double positive cells in the CeA. Magnification bar: 20 µm. 
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Descending pathwaysbeen associated with structural and functional changes of the amygdala, a key
player in emotions. Here we study whether peripheral neuropathy inﬂuences pain regulation by the
amygdala. For this purpose, we determined discharge rates of presumably pro- and antinociceptive pain-
regulatory neurons in the rostral ventromedial medulla (RVM) following microinjection of various
glutamatergic compounds into the central nucleus of the amygdala. RVM neurons were recorded in
pentobarbitone-anesthetized rats with a peripheral nerve injury or sham-operation. In a separate
behavioral experiment, we determined whether the inﬂuence of amygdaloid administration of a
glutamatergic compound on affective pain-related behavior, as assessed by an aversive place-conditioning
test, is changed by neuropathy. While glutamate or an NMDA receptor antagonist in the amygdala failed to
induce marked changes in discharge rates of RVM cells, amygdaloid administration of DHPG, a group I
metabotropic glutamate receptor (mGluR) agonist acting on mGluR1 and mGluR5, increased discharge rates
of presumably pronociceptive RVM ON-cells in nerve-injured but not sham-operated animals. This
pronociceptive effect of DHPG was reversed by MPEP (mGluR5 antagonist) and CPCCOEt (mGluR1
antagonist). CHPG, an mGluR5 agonist, failed to inﬂuence ON-cell activity and DHPG failed to inﬂuence
activity of presumably antinociceptive RVM OFF-cells. Amygdaloid administration of DHPG increased and
that of CPCCOEt decreased affective pain-related behavior in nerve-injured animals. The results suggest
that following nerve injury, the amygdaloid group I mGluR, particularly subtype mGluR1, has an enhanced
pronociceptive effect providing a potential mechanism for emotional enhancement of pain in peripheral
neuropathy.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe amygdala is a major player in emotions (Phelps and LeDoux,
2005). It also receives ascending nociceptive signals (Bernard et al.,
1996) and it has efferent projections to structures that are involved in
pain modulation (e.g., Rizvi et al., 1991; Van Bockstaele et al., 1996).
These ﬁndings, together with chemical or electrical stimulation and
lesion studies (see below), indicate that the amygdala has a role in
pain modulation. Interestingly, the role is a dual one varying from
antinociception (Helmstetter and Bellgowan, 1993; Helmstetter et al.,
1998; Manning and Mayer, 1995; McGaraughty and Heinricher, 2002;
Mena et al., 1995; Nandigama and Borszcz, 2003) to pronociception
(Greenwood-Van Meerveld et al., 2001; Manning, 1998; Quin et al.,
2003).
Sustainednociceptionproduces synaptic plasticity in the amygdala.
This has been shown in electrophysiological recordings performed in
animals with inﬂammatory pain (Neugebauer et al., 2004; Neuge-
bauer, 2006) and in control animals following tetanic stimulation ofovaara).
l rights reserved.the parabrachial nucleus that relays nociceptive inputs to the amygdala
(Lopez de Armentia and Sah, 2007). Peripheral nerve injuries may
cause chronic neuropathic pain that is associated with plastic changes
in pain-mediating (Woolf and Salter, 2006) and -regulating (Almeida
et al., 2006; Pertovaara, 2000; Porreca et al., 2002) pathways. Recent
studies indicate that peripheral nerve injury induces neural plasticity
in the amygdala, as shown by increased postsynaptic currents evoked
by ascending inputs (Ikeda et al., 2007) and generation of new
amygdala neurons (Gonçalves et al., 2008). These ﬁndings still leave
open whether the pain regulatory role of the amygdala is changed by
peripheral nerve injury.
In the present study we test a hypothesis that peripheral nerve
injury inﬂuences pain regulation by the amygdala. Partial support for
this hypothesis is provided by a recent ﬁnding showing that
amygdaloid activation by glutamate suppressed presumably antino-
ciceptive neurons in the noradrenergic locus coeruleus of nerve-
injured animals (Viisanen and Pertovaara, 2007). To test further this
hypothesis, we determined whether administration of glutamatergic
compounds into the amygdala has a differential inﬂuence on
discharge rates of putative pain-regulatory neurons in the rostroven-
tromedial medulla (RVM) of nerve-injured versus sham-operated73
Fig. 1.Microelectrode recording sites in the RVM (left column) and microinjection sites
in the amygdala (right column). The upper row shows an example of an electrolytic
lesion made by the recording electrode in the RVM (left) and the track of the injection
cannula in the amygdala (right). The rectangle and the circle in the schematic graphs of
the lower row indicate the dorsolateral extent of areas, across several anteroposterior
sections, in which the tips of medullary recording electrodes and amygdaloid
microinjection cannulae were located, respectively. RVM=rostroventromedial medulla,
CeA=central nucleus of the amygdala, Rmg=raphe magnus.
67O.B. Ansah et al. / Experimental Neurology 216 (2009) 66–74animals. For this purpose, we recorded discharge rates of presumably
pronociceptive ON-cells and antinociceptive OFF-cells in the RVM
(Fields et al., 2006). Moreover, we assessed whether the effect by
amygdaloid administration of a glutamatergic compound on affective
pain-related behavior in an aversive place-conditioning test is
changed following peripheral nerve injury.
Materials and methods
The experiments were performed in adult, male Hannover-Wistar
rats weighing 180–190 g at the beginning of the experiment (Harlan,
Horst, the Netherlands). The experimental protocol was accepted by
the Institutional Ethics Committee and the experiments were
performed according to the guidelines of the European Communities
Council Directive of 24 November 1986 (86/609/EEC). All efforts were
made to minimize animal suffering and to use only the number of
animals necessary to produce reliable scientiﬁc data.
Techniques for producing neuropathy
The unilateral axotomy and ligation of the tibial and common
peroneal nerves was performed under pentobarbitone anesthesia
(50 mg/kg i.p.) as described in detail earlier (Decosterd and Woolf,
2000; Gonçalves et al., 2007). Brieﬂy, the skin of the lateral surface of
the thigh was incised and a section made directly through the biceps
femoris muscle exposing the sciatic nerve and its three terminal
branches. Following ligation and removing 2–4 mm of the distal nerve
stumps of the tibial and common peroneal nerves, muscle and skin
were closed in two layers. In sham-operated animals, the surgical
procedure was identical, except that the tibial and common peroneal
nerves were not ligated or sectioned. After the surgery, the animals
were allowed to recover before the actual testing that was performed
either 1 or 8 weeks after the operation.
Behavioral veriﬁcation of neuropathy
Development of hypersensitivity was veriﬁed behaviorally in
animals habituated to the experimental conditions 1–2 h daily for 2
to 3 days. For assessment of tactile allodynia, the hind limb
withdrawal threshold was determined stimulating the sural nerve
area in the hind paw of the operated limb with monoﬁlaments. The
calibrated series of monoﬁlaments used in this study produced forces
ranging from 0.16 to 15 g (North Coast Medical, Inc. Morgan Hill, CA,
USA). Themonoﬁlaments were applied to the foot pad with increasing
force until the rat withdrew its hind limb. The lowest force producing
a withdrawal response was considered the threshold. The threshold
for each hind paw of each rat was based on three separate
measurements and the median of these values was considered to
represent the threshold. Threshold values b1 g were considered to
represent hypersensitivity. It should be noted that the currently used
strain of rats delivered by Harlan (Horst, the Netherlands) has an
exceptionally low withdrawal threshold to monoﬁlament stimulation
in baseline (unoperated) condition: in ten unoperated control animals
the lowest withdrawal threshold was only 4 g and therefore, the
criterion for hypersensitivity was set to as low as b1 g in this study as
we did earlier with the same strain of animals (Gonçalves et al., 2007).
Electrophysiological recordings
For electrophysiological recordings the anesthesia was induced by
pentobarbitone at a dose of 50mg/kg i.p. and the animal was placed in
a standard stereotaxic frame according to the atlas of Paxinos and
Watson (1998). Anesthesia was maintained by infusing pentobarbi-
tone (15–20 mg/kg/h). The level of anesthesia was frequently
monitored by observing the size of the pupils and by assessing
withdrawal responses to noxious stimulation. When necessary, the74infusion rate of pentobarbitone was adjusted to keep the level of
anesthesia steady. Although a change in the level of anesthesia may
signiﬁcantly inﬂuence neuronal responses, anesthesia is not likely to
explain differences among different experimental groups and drug
treatments in the present study. This is because anesthesia was
induced and maintained in an identical manner in all experimental
conditions. The rats were spontaneously breathing. A warming
blanket was used to maintain body temperature within physiological
range. Peripheral perfusion was checked by evaluating the color of
ears and extremities. The skull was exposed and a hole drilled for
placement of recording electrode in the RVM. The desired recording
site in the RVM was 1.8–2.3 mm posterior from the ear bar, 0.4–
0.9 mm lateral from the midline, and 8.9–10.7 mm ventral from the
dura mater (Fig. 1).
Single neuron activity was recorded extracellularly with lacquer-
coated tungsten electrodes (tip impedance 3–10 MΩ at 1 kHz) and
then ampliﬁed and ﬁltered using standard techniques. Data sampling
was performed with a computer connected to a CED Micro 1401
interface and using Spike 2 software (Cambridge Electronic Design,
Cambridge, U.K.).
Actual recordings did not start until the animal was under light
anesthesia; i.e., the animals gave a brief withdrawal response to
noxious pinch, but the pinch did not produce any longer lasting motor
activity, nor did the animals have spontaneous limb movements.
Neurons were classiﬁed based on their response to noxious pinch of
the tail with a hemostatic clamp (Fig. 2). This stimulus was painful
when applied to the ﬁnger of the experimenters. Neurons giving
excitatory responses to pinch were considered ON-cells, those giving
inhibitory responses were considered OFF-cells and neurons showing
no or only a negligible (b10%) change in their discharge rates as a
response to pinch were considered NEUTRAL-cells. This classiﬁcation
scheme of medullary neurons was modiﬁed from that described by
Fields et al., (2006). A noteworthy difference is that we did not verify
whether pinch-evoked responses of RVM neurons were associated
with spinal reﬂex responses as in the original classiﬁcation scheme
(Fields et al., 2006). Therefore, the populations of ON- and OFF-cells in
this studymay not be identical with those in a study inwhich cells are
classiﬁed strictly according to the classiﬁcation scheme of Fields et al.,
Fig. 2. Examples of an RVM ON-cell (upper graph) and OFF-cell (lower graph) response
to noxious pinch of the tail in a neuropathic animal. P P indicates the duration of
noxious tail pinch. The horizontal bars indicating tail pinch represent 5 s and the
vertical calibration bars for the peristimulus time histograms represent 50 impulses/s.
The insets show the shapes of the action potential.
68 O.B. Ansah et al. / Experimental Neurology 216 (2009) 66–74(2006). Our previous results suggest, however, that there is only a
little difference in the classiﬁcation of RVM neurons whether or not
spinal reﬂex responses are concurrently measured in lightly anesthe-
tized animals (Pertovaara et al., 2001).
Intracerebral drug injections
The animals had a guide cannula for drug administrations into the
amygdala ipsilateral to the spared nerve injury or sham-operated limb
(left side), except for one group that had the cannula contralateral to
the nerve injury (right side), and a control group that had the cannula
in the hippocampus. Additionally, a group of animals tested in
behavioral experiments only had a bilateral guide cannula for drug
injections into the central nucleus of the amygdala. For placement of
the guide cannula (26 gauge), the skull was exposed and a hole drilled
for its placement. The desired injection site was in the central nucleus
of the amygdala: 7.12 mm anterior from the ear bar, 3.40 mm lateral
from the midline, and 8.00 mmventral from the dura mater. A control
injection site in a group of neuropathic animals was in the
hippocampus, ipsilateral to nerve injury: 6.20 mm anterior from the
ear bar, 1.00 mm lateral from the midline, and 3.20 mm ventral from
the dura mater. The tip of the guide cannula was positioned 2 mm
above the desired injection site. The cannula was ﬁxed into the skull
using a dental screw and dental cement. Drug administration to the
brain and experimental protocols were performed 1 week after
ﬁxation of the guide cannula to the skull. When testing animals at the
one-week postoperative time point, the guide cannula for amygdala
injections was installed in the same operating session as sham or
nerve surgery. When testing animals at the eight-week postoperative
time point, the guide cannula was installed in a separate session at
least 1 week prior to electrophysiological recordings.Drugs or saline control were microinjected into the amygdala
through a 33-gauge stainless steel injection cannula inserted through
and protruding 2 mm beyond the tip of the guide cannula. The
microinjection was made using a 10 µl Hamilton syringe that was
connected to the injection cannula by a length of polyethylene (PE-10)
tubing. The volume of injection was 0.5 µl. At this volume, the spread
of the injected drugs within the brainwas at least 1mm (Myers,1966).
The efﬁcacy of injectionwas monitored by watching the movement of
a small air bubble through the tubing. The injection lasted 30 s and the
injection cannula was left in place for an additional 30 s to minimize
ﬂow of the drug solution back up the injector track. At the completion
of the experiment, the microinjection sites were histologically veriﬁed
and plotted on a standardized section derived from the stereotaxic
atlas of Paxinos and Watson (1998).
Course of the electrophysiological study
There were four groups of animals that were included in the
electrophysiological study and had a guide cannula for amygdala
injections ipsilateral to nerve injury or sham operation: i) sham group
tested 1 week after operation, ii) sham group tested 8 weeks after
operation, iii) SNI group tested 1 week after operation, and iv) SNI
group tested 8 weeks after operation. Additionally, there was a ﬁfth
group of SNI animals tested 1 week after operation that had the guide
cannula for amygdala injections contralateral to nerve injury, and a
sixth group of animals with neuropathy of 1 week duration that had
the guide cannula for drug injections into a control site in the
hippocampus ipsilateral to nerve injury. In each of these groups,
neuropathic hypersensitivity was veriﬁed with the monoﬁlament test
(see above) before the start of the electrophysiological experiment.
After induction of anesthesia, the microelectrode was lowered to
the RVM. After ﬁnding a single cell, it was ﬁrst classiﬁed based on its
response to noxious tail pinch (see above) and then its spontaneous
activity was recorded for 2 to 3 min. Next, one of the studied drugs or
saline control was administered in a varied order to the amygdala and
the spontaneous activity was recorded for up to 30 min (except with
glutamate and MK-801 for 6 min). One to two drug conditions were
tested in one cell, and one to four cells were tested in each animal. The
minimum interval to the next drug testing condition was 30 min
following saline or glutamate, while it was 60 min following other
drugs, except for MK-801 that was always the last drug tested in each
animal. When attempting to reverse the effect induced by the
glutamatergic agonist DHPG, the antagonist was injected into the
amygdala immediately (MPEP) or 15min (CPCCOEt) before the agonist.
In the data analysis, the discharge rate before injection was compared
with the discharge rate determined after the injection. This was done
by subtracting the mean post-injection discharge frequency during
1 min at various time points following microinjection from the mean
discharge frequency before microinjection; i.e., a positive value
represents increase of activity in the RVM by amygdala injection, and
vice versa.
Assessment of aversive avoidance behavior and its modulation
by glutamatergic receptors of the amygdala
Place avoidance test was performed, as described earlier (LaBuda
and Fuchs, 2000), to obtain a measure of affective pain induced by
mechanical stimulation of the neuropathic hind paw. Before testing,
the animals were habituated to the test conditions by spending 1 to
2 h daily for 2 days in the test box. In the actual testing, the rat was
placed within a Plexiglas chamber (60×30×30 cm; one half of which
was painted black on the external surface) placed upon an elevated
metal grid. The rats were placed over the midline of the chamber and
stimulation of the plantar surface of the hind paw initiated with a 60 g
monoﬁlament once every 15 s for 15 min. When residing within the
dark side of the chamber the injured or sham-operated hind paw was75
Fig. 3. Spontaneous discharge rates of RVM ON-cells (a) and OFF-cells (b) in nerve-
injured (SNI) and sham-operated animals. 1 and 8 weeks refer to the postoperative time
point of testing. ⁎Pb0.05 (reference: the corresponding value in the sham-operated
group at the same postoperative time point). +Pb0.05, +++Pb0.005 (Student-Newman-
Keuls test; reference: the corresponding value at an earlier postoperative time point).
Error bars represent S.E.M. (n=19–29).
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when residing within the light side of the chamber. Throughout the
30 min test period rats were allowed unrestricted movement
throughout the chamber. The percent time spent in the light side of
the chamber during the 30 min observation period was determined in
each condition for each animal. It is assumed that the more aversive
the mechanical stimulation of the hind paw, the more the animal
spends time in the light side of the chamber; i.e., the place avoidance
test is considered to assess affective-emotional pain behavior (LaBuda
and Fuchs, 2000).
Three experimental groups of rats were tested in the place
avoidance test: i) SNI animals with amygdaloid injections ipsilateral
to the nerve injury ii) SNI animals with bilateral amygdaloid
injections, iii) sham-operated animals with amygdaloid injections
ipsilateral to the sham operation. In the bilateral treatment group, the
drug conditions were saline, DHPG at the dose of 5 nmol or 10 nmol/
amygdala (10 nmol or 20 nmol/animal, respectively), and CPCCOEt at
the dose of 20 nmol or 40 nmol/amygdala (40 nmol or 80 nmol/
animal/respectively). In the ipsilateral treatment groups, drug condi-
tions were saline, 10 nmol of DHPG, or 40 nmol of CPCCOEt. In all
experimental conditions, drugs were administered into the amygdala
immediately before the start of the place avoidance test. In each
experimental group, each drug condition was assessed in a separate
day, 1 to 2 weeks following nerve or sham injury. Each animal
participated in three to four drug testing sessions, the interval in
testing different drug conditions in one animal was at least 2 days. The
order of testing different drug conditions was varied within the
groups to avoid serial effects.
Drugs
(S)-3,5-Dihydroxyphenylglycine (DHPG; an mGluR1 and mGluR5
agonist), (RS)-2-Chloro-5-hydroxy (CHPG; an mGluR5 agonist), 6-
Methyl-2-(phenylethynyl)pyridine (MPEP; an mGluR5 antagonist),
(+)-MK-801 hydrogen maleate (MK-801; an NMDA-R antagonist) and
glutamate were purchased from Sigma (St. Louis, MO) and 7-
Hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester
(CPCCOEt; an mGluR1 antagonist) was purchased from Tocris (Bristol,
U.K.). Physiological saline (OrionPharma, Espoo, Finland) was used for
control injections. Drugs were dissolved in saline, except for CPCCOEt
that was dissolved in DMSO.
Previous studies indicate that DHPG and CPCCOEt at the currently
used dose of 10 nmol have proved effective in activating group I
mGluRs within the currently used observation period of 30 min
following intracerebral administration in the rat (e.g., Kim et al., 2007;
Renoldi et al., 2007). Previous studies indicate that the currently used
doses of glutamate (50 nmol) and MK-801 (3 nmol) induce a
signiﬁcant antinociception (Zhuo and Gebhart, 1997) or antiallodynia
(Pertovaara and Wei, 2003), respectively, following supraspinal
microinjection. The maximum antinociceptive effect induced by
central injection of glutamate has been obtained within 2 min (Zhuo
and Gebhart, 1997), whereas the maximum antiallodynic effect
induced by central injection of MK-801 was reached within 15 min
(Pertovaara and Wei, 2003). Thus, the currently used observation
period of 6 min following the injection of glutamate in the amygdala
was appropriate for detecting the maximum effect induced by
glutamate but only a submaximal effect induced by MK-801.
At the completion of the study, an electrolytic lesion was made in
the recording site, the animals were given a lethal dose of
pentobarbitone and the brains removed for veriﬁcation of recording
and microinjection sites.
Statistics
Data are presented as mean±S.E.M. One- or two-way ANOVA
followed by Student-Newman-Keuls test or t-test (differences76between two groups) were used for assessing differences between
the experimental conditions. Grubb's test was used to exclude
potential outliers (www.graphpad.com/quickcalcs/). Pb0.05 was
considered to represent a signiﬁcant difference.
Results
Response characteristics of RVM neurons
Spontaneous activity of RVM ON-cells was signiﬁcantly inﬂu-
enced by SNI (F1,131=4.79, P=0.030; 2-w-ANOVA) and postoperative
time point of testing (F1,131=4.19, P=0.043; 2-w-ANOVA). Post hoc
tests indicated that the spontaneous discharge rate of ON-cells was
increased in the SNI group 1 week after nerve injury, while 8 weeks
following injury it was reduced to the same level as in sham
controls (Fig. 3a). Spontaneous activity of RVM OFF-cells was
inﬂuenced by postoperative time point of testing (F1,100=8.0,
P=0.0057; 2-w-ANOVA), and this time-dependent effect varied
with the experimental group (SNI versus sham; F1,100=4.50,
P=0.036; 2-w-ANOVA). Post hoc tests indicated that the discharge
rate of OFF-cells was signiﬁcantly decreased 1 week following nerve
injury, while 8 weeks following injury it was at the same level as in
sham controls (Fig. 3b). In the present sample of neurons,
postoperative time point of testing (one versus 8 weeks) had no
signiﬁcant inﬂuence on spontaneous discharge rates of ON- or OFF-
cells in the sham control group (Fig. 3).
Discharge rates of RVM cells following amygdaloid administration of
glutamatergic compounds
When studying the inﬂuence of glutamatergic compounds on
discharge rates of RVM cells, the studied compounds were micro-
injected at a volume of 0.5 µl into the amygdala ipsilateral to nerve
injury or sham operation, except for one group inwhich it was injected
Fig. 4. Inﬂuence of DHPG (10 nmol; left column) or saline (right column) injection into the amygdala on the discharge rate of an RVM ON-cell in a neuropathic animal 1 week
following the nerve injury. Time point of testing before and after the injection is shown above each row. The horizontal calibration bar represents 10 s and the vertical one
50 impulses/s.
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DHPG, an agonist of group I metabotropic glutamate receptor
(mGluR) subtypes mGluR1 and mGluR5, at a dose of 10 nmol
produced a signiﬁcant increase in the discharge rate of RVM ON-Fig. 5. Discharge rates of RVM ON-cells in nerve-injured (SNI) animals following administr
to the nerve injury. (a) Time course of the effect by DHPG (10 nmol), an mGluR1 and mG
Reversal of the DHPG-induced increase in the discharge rate by MPEP (50 nmol), an mG
CPCCOEt (40 nmol), anmGluR1 antagonist.1 and 8weeks refer to the postoperative time point o
or CPCCOEt co-administeredwithDHPG. ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.005 (Student-Newman-Ke
group. In c and d, reference is the DHPG group). Error bars represent S.E.M. (nsal=16, nDHPG_
horizontal line) represents the pre-injection discharge rate.cells in the SNI group (Fig. 4). DHPG induced the maximum increase
in the discharge rate of ON-cells within 5 min, and the increase was
of equal magnitude 1 and 8 weeks following nerve injury (Figs. 5a,
b). The increase in the discharge rate of RVM ON-cells by 10 nmol ofation of group I metabotropic glutamatergic compounds into the amygdala ipsilateral
luR5 agonist. (b) The effect by DHPG versus CHPG (10 nmol), an mGluR5 agonist. (c)
luR5 antagonist. (d) Reversal of the DHPG-induced increase in the discharge rate by
f testing. Sal=saline.MPEP=MPEPalone, CPCCO=CPCCOEt alone, +MPEP or +CPCCO=MPEP
uls test; in a, reference is the corresponding pre-injection value. In b, reference is the saline
1wk=8, nDHPG_8wk=14, nCHPG=4, nMPEP=5, n+MPEP=6, nCPCCO=10, n+CPCCO=8). 100% (dotted
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amygdala ipsi- (n=14) as contralateral (n=4) to the nerve injury in
animals that were operated 8 weeks before time point of testing
(F=0.05; 2-w-ANOVA; not shown). CHPG, an mGluR5 agonist
(10 nmol), failed to inﬂuence the discharge rate of RVM ON-cells
in nerve-injured animals (Fig. 5b). The DHPG-induced increase of
ON-cell activity in nerve-injured animals was completely reversed
by pretreatment of the amygdala with MPEP, an mGluR5 antagonist,
at a dose of 50 nmol that produced no signiﬁcant effect when
administered alone (Fig. 5c). The DHPG-induced increase of ON-cell
activity in nerve-injured animals was also completely reversed by
pretreatment of the amygdala with CPCCOEt, an mGluR1 antagonist,
at a dose (40 nmol) that failed to produce a change in ON-cell
discharge rate when administered alone (Fig. 5d). Administration of
DHPG at the dose of 10 nmol into a control site, the hippocampus,
failed to produce any signiﬁcant change on the discharge rate of ﬁve
ON-cells (not shown) in neuropathic animals, while in one ON-cell
DHPG administration into the hippocampus was followed at a
15 min post-injection time point by a sudden increase of the
discharge rate from the pre-injection baseline rate by 384% (not
shown). According to Grubb's test, the RVM ON-cell with a sudden
increase in the discharge rate 15 min following hippocampal
injection of DHPG was a signiﬁcant outlier (Pb0.05) and therefore,
it was not included in the statistical assessment of the over-all
effect.
DHPG (10 nmol) in the amygdala failed to inﬂuence OFF-cell
activity in the SNI group, independent of postoperative time point
(Fig. 6a). Moreover, DHPG (10 nmol) in the amygdala had no
signiﬁcant effect on discharge rates of ON- or OFF-cells in the sham
group (Fig. 6b).
Microinjections of glutamate at a dose of 50 nmol or MK-801, an
NMDA receptor (NMDA-R) antagonist, at a dose of 3 nmol failed to
produce signiﬁcant changes in the discharge rates of ON- or OFF-cells
in the SNI or sham group (Fig. 7).Fig. 6. (a) Discharge rates of RVM OFF-cells in nerve-injured (SNI) animals following
administration of saline (Sal) or DHPG (10 nmol), an mGluR1 and mGluR5 agonist,
into the amygdala. (b) Discharge rates of RVM ON- and OFF-cells in sham-operated
animals following amygdaloid administration of saline or DHPG. 1 and 8 weeks refer
to the postoperative time point of testing. Error bars represent S.E.M. (In a, nSal=6,
nDHPG_1wk=9, nDHPG_8wk=6. In b, nSal=8, nDHPG_ON-cell =8, nDHPG_OFF-cell =5). 100%
represents the pre-injection discharge rate.
Fig. 7. Discharge rates of RVM cells following administration of glutamate (50 nmol) or
MK-801 (3 nmol), an NMDA-R antagonist, into the amygdala. (a) ON-cells in nerve-
injured (SNI) animals. (b) OFF-cells in nerve-injured animals. (c) ON- and OFF-cells in
sham-operated animals. 1 and 8 weeks refer to the postoperative time point of testing.
Sal=saline Error bars represent S.E.M. (n=6–10). 100% represents the pre-injection
discharge rate.
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DHPG or CPCCOEt
A behavioral place avoidance paradigmwas used to assess whether
amygdaloid administration of DHPG or CPCCOEt inﬂuences aversive
quality of mechanical stimulation of the neuropathic hind paw. In
sham-operated animals, mechanical stimulation of the operated hind
paw induced no or negligible avoidance behavior, independent
whether saline or DHPG (10 nmol) was injected into the ipsilateral
amygdala (Fig. 8). In nerve-injured animals, mechanical stimulation of
the neuropathic hind paw induced a marked avoidance behavior (as
revealed by increased time spent in light) that was increased by
administration of DHPG into the amygdala: while the increase of
avoidance behavior induced by ipsilateral injection of 10 nmol of
DHPG was short of signiﬁcance, bilateral administration of DHPG
produced a dose-related increase in place avoidance (F2,14=8.7,
Pb0.01; 1-w-ANOVA) that was signiﬁcant at a dose of 10 nmol of
DHPG/amygdala, corresponding to 20 nmol of DHPG/animal (Fig. 8a).
In contrast, avoidance behavior was reduced by administration of
CPCCOEt in the amygdala: while the decrease of avoidance behavior
was short of signiﬁcance following ipsilateral administration of
40 nmol of CPCCOEt, bilateral administration of CPCCOEt produced a
Fig. 8. Behavior in aversive place-conditioning test following administration DHPG, an
mGluR1 and mGluR5 agonist (a), or CPCCOEt, an mGluR1 antagonist (b), into the
amygdala in nerve-injured (SNI) or sham-operated animals. An increase in time spent
in light is considered to reﬂect an increase in affective pain induced by monoﬁlament
stimulation of the hind paw. ipsi=amygdaloid injection was performed only ipsilateral
to the nerve injury/sham operation, bilat=amygdaloid injection was performed
bilaterally. In the Y-axis, doses represent the dose/side; e.g., the dose 10 nmol
represents 10 nmol/animal with ipsilateral injections and 20 nmol/animal with
bilateral injections. ⁎Pb0.05 (Student-Newman-Keuls test; reference: the correspond-
ing saline condition). Error bars represent S.E.M. (In a, nSNI-ipsi=9, nSNI-bilat=5, nSham-ipsi=5.
In b, nSNI-ipsi=4, nSNI-bilat=4, nSham-ipsi=5).
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ANOVA) that was signiﬁcant at a dose of 40 nmol of CPCCOEt/
amygdala (Fig. 8b).
Discussion
In the present study, amygdaloid administration of DHPG, an
mGluR1/5 agonist, increased the discharge rate of presumably
pronociceptive ON-cells in the RVM of nerve-injured but not
sham-operated animals. This enhanced pronociceptive effect was
at least due to action on the amygdaloid mGluR1, since DHPG, an
agonist of the mGluR1 and mGluR5, but not CHPG, an mGluR5
agonist, increased discharge rates of RVM ON-cells and this DHPG-
induced effect was reversed by CPCCOEt, an mGluR1 antagonist.
However, since MPEP, an mGluR5 antagonist, applied at a high dose
also reversed the DHPG-induced increase of the ON-cell discharge
rate, we cannot exclude contribution of the mGluR5 to the DHPG-
induced pronociception. Administration of DHPG into a control site,
the hippocampus, failed to produce a change in the discharge rate of
RVM ON-cells in neuropathic animals. Amygdaloid administration of
DHPG also failed to inﬂuence discharge rates of presumably
antinociceptive OFF-cells of the RVM indicating that the nerve
injury-induced change was selective for the pronociceptive cell type.
Since amygdaloid administration of NMDA-R or group I mGluR
antagonists alone failed to inﬂuence discharge rates of pro- or
antinociceptive RVM cells, the amygdaloid NMDA-R or group I
mGluRs may not contribute to tonic maintenance of neuropathic
pain and hypersensitivity.In behavioral experiments of the present study, affective pain of
nerve-injured animals was increased by amygdaloid administration
of DHPG and decreased by CPCCOEt. Since the aversive place-
conditioning test used in assessing affective pain-related behavior
(LaBuda and Fuchs, 2000) provides an emotional challenge putatively
activating the amygdala, the decrease of affective pain by amygdaloid
administration of an mGluR1 antagonist is in line with the hypothesis
that emotions processed by the amygdala may enhance pain in
nerve-injured animals, due to action on the amygdaloid mGluR1.
Interaction between the amygdala and pain
Psychophysical studies suggest that emotions presumably pro-
cessed by the amygdala produce signiﬁcant changes in human pain
reactivity (Craig, 2006). The direction of the change has varied from
pain facilitation in anxious subjects to suppression of pain sensitivity
in subjects with intense fear (Rhudy and Meagher, 2000 & 2003). In
line with this, previous studies in non-neuropathic animals have
shown that the amygdala has a dual role in the regulation of
nociception varying from pronociception to antinociception (see the
Introduction). There is accumulating evidence indicating that sus-
tained pain induces plastic changes in the amygdala (Neugebauer,
2006). Pain-induced neural plasticity of the amygdala may inﬂuence
its pain regulatory action as indicated by a recent study showing that
activation of the extracellular signal-regulated kinase in the amygdala
contributes to inﬂammatory hypersensitivity (Carrasquillo and Ger-
eau, 2007). In addition to inﬂammation, peripheral neuropathy
induces neural plasticity in the amygdala as shown by the ﬁndings
that postsynaptic currents evoked by ascending inputs in the central
amygdala were enhanced (Ikeda et al., 2007) and new amygdala
neurons were generated (Gonçalves et al., 2008) following periph-
eral nerve injury. While the enhanced synaptic responses to
ascending signals indicate that the relay of pain-related signals to
the amygdala is facilitated in neuropathy (Ikeda et al., 2007), these
previous results still leave open whether the amygdala-induced pain
regulation is changed by peripheral nerve injury.
In neuropathic animals, not only pain processing within the
amygdala (Ikeda et al., 2007) but also pain regulatory inﬂuence of the
amygdala may be changed as suggested by the following ﬁndings.
Amygdaloid administration of a GABAA receptor agonist suppressed
aversive pain-related behavior and hypersensitive spinal reﬂex
responses in nerve-injured animals (Pedersen et al., 2007). This
behavioral ﬁnding suggests that the amygdala may contribute to
regulation of neuropathic hypersensitivity, possibly through action on
descending pathways relaying in the RVM. Also, amygdaloid admin-
istration of glutamate suppressed presumably antinociceptive neu-
rons in the noradrenergic locus coeruleus of nerve-injured but not
sham-operated animals suggesting that activation of the amygdala
may have a pronociceptive effect in peripheral neuropathy (Viisanen
and Pertovaara, 2007). In line with this, the present results suggest
that activation of the group I mGluR in the amygdala of nerve-injured
animals promotes activity of presumably pronociceptive neurons in
the RVM. Together these results suggest that the amygdala-induced
pain modulation is changed in neuropathy. In neuropathic animals,
activation of the amygdala may promote hypersensitivity by, at least,
two different types of actions on brain regulatory nuclei of the
brainstem: by facilitating pronociceptive neurons in the RVM and by
inhibiting antinociceptive neurons in the locus coeruleus. While the
pronociceptive inﬂuence by the amygdala may be partly tonic in
peripheral neuropathy (Pedersen et al., 2007), the present results with
amygdaloid administrations of speciﬁc receptor antagonists alone
suggest that the amygdaloid NMDA-R or group I mGluR do not explain
the tonic pronociceptive action of the amygdala.
Interestingly, while the enhancement of synaptic currents evoked
by afferent inputs to the amygdala occurred predominantly in the
central nucleus of the amygdala contralateral to peripheral nerve79
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RVM was obtained following its amygdaloid administration ipsi- as
well as contralateral to peripheral nerve injury. This result is in line
with the earlier ﬁnding that activation of the amygdala ipsilateral to
nerve injury attenuated presumably antinociceptive locus coeruleus
neurons (Viisanen and Pertovaara, 2007) and it also ﬁts the ﬁnding
that the amygdala receives ascending nociceptive inputs from the ipsi-
as well as contralateral body half (Bernard et al., 1996). It may be
proposed that the enhancement of contralateral afferent inputs in the
amygdala (Ikeda et al., 2007) and the pronociceptive change in the
amygdala-induced pain regulatory effect that was observed also
ipsilateral to nerve injury (Viisanen and Pertovaara, 2007; the present
results) have, at least partly, different underlying mechanisms.
Glutamatergic receptor types sensitized in the amygdala
Earlier results indicate that in arthritis, the responses of multi-
receptive neurons in the central nucleus of the amygdala are
sensitized to administration of DHPG, an mGluR1 and mGluR5 agonist
but not to CHPG, an mGluR5 agonist (Li and Neugebauer, 2004b;
Neugebauer et al., 2003). This ﬁnding suggests that the amygdaloid
mGluR1 plays a role in arthritic pain-related sensitization (Li and
Neugebauer, 2004b; Neugebauer et al., 2003). The present results on
the amygdaloid inﬂuence on the RVM and affective pain-related
behavior extend this earlier ﬁnding by showing that a change in the
function of the amygdaloid group I mGluR, and particularly the
subtype mGluR1, may contribute to pain-related sensitization in
peripheral neuropathy as well as in arthritis. In contrast, while the
NMDA-R contributes to pain-related sensitization of amygdala
neurons in arthritis (Li and Neugebauer, 2004a), a recent study
indicated that sensitization of amygdala neurons in peripheral
neuropathy is not dependent on the NMDA-R (Ikeda et al., 2007). In
line with this, amygdaloid administration of an NMDA-R antagonist
failed to induce a change in the discharge rate of RVM neurons in
nerve-injured animals of the present study. While studies performed
in non-neuropathic animals have provided evidence suggesting that
the central nucleus of the amygdala plays a signiﬁcant role in
promoting affective pain behavior induced by noxious visceral
stimulation, its lesion has attenuated place aversion induced by
noxious cutaneous stimulation, too (Tanimoto et al., 2003), a ﬁnding
which is in line with the present results. It should be noted, however,
that the currently administered injection volume of 0.5 µl into the
central nucleus of the amygdala is likely to spread also to immediately
adjacent areas (Myers, 1966), particularly other amygdaloid subnuclei.
Therefore, we cannot exclude the possibility that the group I mGluRs
e.g. in the basolateral nucleus of the amygdala contribute to the DHPG-
induced pronociceptive effect in the present study. In a distant control
site, the hippocampus, DHPG, however, had no pronociceptive effect
indicating that the pronociceptive effect was region-speciﬁc.
Inﬂuence of the amygdala on discharge rates of RVM cells
An earlier study showed that microinjection of morphine into the
basolateral nucleus of the amygdala produced antinociception that
was accompanied by a decrease in the discharge rate of RVM ON-cells
and an increase in the discharge rate of RVM OFF-cells, while
morphine in the central or lateral nuclei of the amygdala failed to
inﬂuence pain-related behavior or discharge rates of RVM ON- or OFF-
cells (McGaraughty and Heinricher, 2002). Since the main amygdaloid
output nucleus is the central nucleus receiving convergent informa-
tion from various amygdaloid nuclei (Pitkänen et al., 1997), the
antinociceptive effect by morphine in the basolateral nucleus was
likely to be relayed to the RVM via the amygdaloid central nucleus. In
the present study, DHPGwas microinjected into the central nucleus of
the amygdala, although the results do not allow excluding that group I
mGluRs in adjacent amygdaloid subnuclei contributed to its prono-80ciceptive effect. Together, earlier (McGaraughty and Heinricher, 2002)
and the present results indicate that the amygdala has an inﬂuence on
neuronal discharge rates in the RVM, a major pain regulatory region
(Gebhart, 2004). The pain-regulatory effect originating in or relaying
through the amygdala may have been mediated to the RVM directly
(Hermann et al., 1997) or indirectly through the periaqueductal gray
(Rizvi et al., 1991). Moreover, efferent pathways other than those
projecting directly or indirectly to the RVM may contribute to pain
regulation by the amygdala. It should also be noted that the increased
affective pain response to mechanical stimulation of the neuropathic
limb in the aversive place-conditioning task by the amygdaloid
mGluR1 may reﬂect increased afferent barrage evoked by the
mechanical test stimulus due to increased RVM ON-cell activity, a
distinct mechanism facilitating affective pain, or both.
Spontaneous discharge rate of RVM cells following nerve injury
Increase in the ongoing discharge rate of RVM ON-cells and a
decrease in the ongoing discharge rate of RVM OFF-cells have been
associated with sustained hyperalgesia induced by inﬂammation
(Kincaid et al., 2006). The cumulative results of the present and our
preceding study (Gonçalves et al., 2007) support the hypothesis that
an increased spontaneous discharge rate of RVM ON-cells and a
decreased discharge rate of RVM OFF-cells contribute to maintenance
of hypersensitivity also during the early phase (ﬁrst week) of
peripheral neuropathy in animals with SNI. During the late phase
(eighthweek) of neuropathy, the discharge rates of RVMON- and OFF-
cells were returned to control levels indicating that an abnormality in
the ongoing discharge rate of RVM ON- or OFF-cells may not explain
hypersensitivity induced by SNI. The return of the ongoing discharge
rate to control levels during the late phase of SNI-induced neuropathy,
however, does not exclude the possibility that the RVM ON- or OFF-
cells contributed to maintenance of hypersensitivity through a change
in the synaptic efﬁcacy of their efferent connections. A change in the
ongoing discharge rates of RVM ON- and OFF-cells is not pathognomic
for the early phase of peripheral neuropathy in all experimental
models as indicated by observations made in animals with ligation of
the spinal nerves (Carlson et al., 2007; Pertovaara et al., 2001) or
chronic constriction of the sciatic nerve (Luukko and Pertovaara,
1993). Additionally, peripheral nerve injury may induce enhanced
responses of RVM cells to peripheral stimulation that potentially
contributes to abnormal feedback regulation of ascending nociceptive
signals (Carlson et al., 2007; Gonçalves et al., 2007).
Conclusions
Present results indicate that group I mGluRs in the amygdala may
promote nociception in nerve-injured animals. This was shown by
increased excitation of pronociceptive RVM ON-cells following
amygdaloid administration of a group I mGluR agonist in neuropathic
animals. Since the amygdala has a key role in processing emotions and
since the administration of glutamatergic compounds into the
amygdala potentially mimics emotional activation of the amygdala,
it may be proposed that activation of the amygdaloid group I mGluR,
provides a possible mechanism for emotional enhancement of nerve
injury-related hypersensitivity and pain. This proposal is supported by
the behavioral ﬁnding indicating that amygdaloid administration of an
mGluR1/5 agonist increased and that of an mGluR1 antagonist
decreased affective pain-related behavior when the nerve-injured
animal was exposed to an emotional challenge provided by the
aversive place-conditioning test.
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ABSTRACT (271 words) 
 
The amygdala (AMY) receives nociceptive inputs from the periphery and central modulatory 
influence from various limbic sites, including the anterior cingulate cortex (ACC). However, the 
influence of neuropathic pain on AMY neurons is poorly known. We determined the response 
characteristics of AMY nociceptive neurons to peripheral stimulation and their modulation by ACC 
manipulation following induction (1 week - 1W) or sustained (8 weeks – 8W) spared nerve injury 
(SNI) neuropathy. Additionally, in order to determine behavioural correlates for neuronal findings, 
the aversive quality of noxious stimulation was evaluated.  
After 1W, but not 8W SNI, ACC inhibition with the NMDA-receptor antagonist MK-801 
decreased the aversive behaviour resulting from noxious stimulation of the lesioned hindpaw. 
Concerning the activity of nociceptive neurons from basolateral (BLA) and central (CeA) AMY 
nuclei: (I) their spontaneous activity generally increased in both nuclei following 1W and 8W 
neuropathy; (II) after 1W SNI, the peripherally-evoked activity of ipsilateral BLA neurons 
decreased more strongly and that of CeA neurons less  strongly following all types of noxious 
stimuli, when compared with Sham group, whereas in contralateral SNI neurons the decrease of 
the activity was the opposite in BLA and CeA neurons; (III) ACC glutamate stimulation increased 
neuronal activity of ipsilateral BLA neurons after 8W SNI, an effect that was reverted by MK-801 
block of the ACC.. 
Results indicate that SNI results in (i) alterations of BLA and CeA neuronal activity from a 
short to a sustained neuropathic period and in (ii) opposite neuronal changes in the activity of 
BLA / CeA and ipsilateral / contralateral AMY neurons. These alterations are discussed 
integrating the different modulatory roles of BLA and in pain processing. 
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INTRODUCTION (591 words) 
 
Pain is a multidimensional experience with sensitive-discriminative and motivational-affective 
components. While encoding of the sensory quality of pain is conveyed by the “lateral pain 
system” through specific thalamocortical connections, pathways implicated in the emotional 
processing of pain are far from being firmly established (Treede et al, 1999; Craig, 2003). This 
“medial pain system” relays diffusely in intralaminar and midline thalamic nuclei (Cliffer et al, 
1991) and projects massively to areas like the amygdala (AMY; Su & Bentivoglio, 1990) and 
anterior cingulate cortex (ACC; Hoover & Vertes, 2007), major telencephalic areas implicated in 
pain processing (Rainville, 2002; Lowe et al, 2007). 
The rostral ACC has been implicated in the encoding of the affective component of pain or 
unpleasantness of noxious stimulation, as its integrity is necessary for the “aversiveness” 
reaction to nociception (Johansen et al, 2001) and the negative affect associated with 
neuropathy-induced hypersensitivity (LaGraize et al, 2004, LaBuda and Fuchs, 2005) without 
inducing changes on sensory processing. Since the ACC receives and integrates nociceptive 
information to regulate behaviour, it is a potential source of descending nociceptive modulation. 
Accordingly, the ACC has a pain facilitating effect mediated by projections to the medullary dorsal 
reticular nucleus (Zhang et al, 2005), an area reciprocally connected with the spinal cord and 
implicated in nociceptive facilitation (Lima & Almeida, 2002). The ACC role in pain modulation 
seems to be mediated, at least in part, by NMDA-receptors (Lei et al, 2004; Tang et al, 2005; 
Zhang et al, 2005). 
There is considerable evidence that the amygdala is involved in fear conditioning (LeDoux, 
1995; Maren et al., 1996), consolidation of inhibitory avoidance memory (Malin et al, 2007), 
pain processing (Bernard and Besson, 1990; Neugebauer and Li, 2002) and pain modulation 
(Manning & Mayer, 1995). The BLA is a storage site for affective information, including negative 
pain affect (Tanimoto et al, 2003), and fear-related memories (LeDoux, 2000), whereas the CeA 
projects to the brainstem and controls arousal and response systems (Cardinal et al, 2002). The 
AMY modulatory role upon the supraspinal control system is mediated by projections to the 
brainstem, which contains centres of descending circuitries that facilitate or inhibit nociception 
(Xu et al, 2003; Han & Neugebauer, 2005; Han et al, 2005). The AMY is also associated with the 
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synaptic plasticity underlying painful memories as nociceptive inputs innervating the lateral and 
capsular regions of the CeA (Bernard et al. 1993) undergo long-term changes following persistent 
peripheral pain (Neugebauer & Li, 2003; Neugebauer et al, 2003; Ikeda et al, 2007). 
Additionally, structural neuroplasticity of the BLA and CeA associated to depressive-like behaviour 
was shown to develop following a peripheral neuropathy (Gonçalves et al, 2008). 
The ACC and AMY are integrated in the limbic corticostriatal loop regulating emotions 
(Cardinal et al, 2002). The ACC terminate on AMY interneurons that are largely inhibitory and 
regulates AMY emotional responses through conscious evaluation, whereas AMY projections back 
to ACC influence directly cortical output (Hariri et al, 2003). The anatomical (Gabbott et al, 2005; 
Hoover & Vertes, 2007) and functional (Malin et al, 2007) interactions between the ACC and 
AMY should contribute to the regulation of the endogenous pain modulatory systems (Rainville, 
2002). However, little is known about the close interaction between these higher centres for 
controlling the emotional component of pain. 
The objective of the present study was to analyse (I) alterations in the activity of BLA and CeA 
amygdalar neurons resulting from a one-week (induction) or 8-weeks (sustained) peripheral 
neuropathy and (II) the influence that the rostral ACC may have in these alterations, by local 
cortical glutamate stimulation or NMDA-antagonist inhibition. 
 
MATERIAL AND METHODS 
 
Animals 
All procedures were performed in adult, male Hannover-Wistar rats weighing 180–190 g at 
the beginning of the experiment (Harlan, Horst, The Netherlands). The experimental protocol was 
accepted by the Institutional Ethics Committee and the experiments were performed according to 
the guidelines of European Communities Council Directive of 24 November 1986 (86 ⁄ 609 ⁄ 
EEC) and IASP ethical guidelines for pain experimentation in awake animals (Zimmerman, 1983).  
 
Neuropathy induction 
Neuropathy was induced through the Spared Nerve Injury (SNI) model, as described earlier by 
Decosterd & Woolf (2000). Briefly, the sciatic nerve and its three terminal branches were 
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exposed through a small surgery, followed by the ligation and removal of 2–4 mm of the distal 
nerve stumps of the tibial and common peroneal nerves and leaving the sural nerve intact. The 
surgery was performed only after the animals were anaesthetised with pentobarbitone (50 mg ⁄ 
kg i.p.). In Sham-operated animals, the surgical procedure was identical, except that the tibial 
and common peroneal nerves were not ligated or sectioned. 
 
Placement of cannulas in the rACC 
A cannula was placed in the rostral anterior cingulate cortex (rACC) of all animals, under light 
anaesthesia, according to the atlas of Paxinos & Watson (1998; coordinates 1.56 mm 
rostrocaudally from Bregma, 0.0 mm laterally and 2.0–3.0 mm dorsoventrally). In the group 
submitted to one week neuropathy, surgical implantation of a cannula was performed in the 
same operation as ligation of nerves. In those animals subjected to 8 weeks experiment, surgical 
implantation of cannulas was performed 5 weeks after SNI induction.  
 
Nociceptive tests 
Nociceptive tests were performed a day before (baseline) and every two days after the surgery 
procedure, in order to verify the development of hypersensitivity. For assessment of tactile 
mechanical allodynia, the hind limb withdrawal threshold was determined by stimulating the hind 
paw of the operated limb with von Frey monofilaments in the area innervated by the sural nerve. 
The calibrated series of monofilaments used produced forces ranging from 0.16 to 15 g (North 
Coast Medical, Inc. Morgan Hill, CA, USA) and were applied to the foot pad with increasing force 
until the rat withdrew its hind limb. The lowest force producing a withdrawal response was 
considered the mechanical nociceptive threshold. For assessment of tactile mechanical 
hyperalgesia, the sural nerve area in the hind paw of the operated limb was briefly stimulated 
with a safety pin with an intensity sufficient to touch but not penetrate the skin (Pin Prick test). 
The duration of paw withdrawal was measured, with an arbitrary minimal time of 0.5 seconds 
(sec) (for the brief normal response) and maximal cut-off of 20 sec (for tissue protection) (Tal and 
Bennett, 1994).  
  
Place escape/avoidance test  
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The place escape/avoidance testing (LaBuda and Fuchs, 2000a,b, 2001, 2005; LaGraize et 
al., 2003a,b, 2004a,b, 2006) was performed 1 week after surgical implantation of a cannula in 
the rACC. No training is necessary for this behavioural test. Animals were placed within a 
16×40.5×30.5 cm Plexiglas chamber that was positioned on top of a grid. One half of the 
chamber is transparent (light area), and the other half of the chamber is painted black (dark 
area). During behavioural testing, animals were allowed unrestricted movement throughout the 
test chamber for the duration of a 30min test period. The animal is placed inside the chamber, 
between the two areas and the test begins following pre-microinjection withdrawal threshold 
testing and drug administration (saline, glutamate and MK-801), starting afterwards the 
suprathreshold mechanical stimulation (0.07g von Frey monofilament) applied to the plantar 
surface of the hindpaws at 15seconds intervals. The mechanical stimulus was applied to the right 
paw (ipsilateral to ligation) when the animal was within the preferred dark area of the test 
chamber and the left paw (contralateral to injury) when the animal was within the non-preferred 
light area of the test chamber. Sham-ligated animals were mechanically stimulated in an identical 
manner as the experimental group. The location of the animal at each 15-s interval when it is 
stimulated is recorded and converted to the percentage of time spent in the light side of the 
chamber.  
 
Electrophysiological recordings 
For electrophysiological recordings, the animals were lightly anaesthetized with 
pentobarbitone at a dose of 50mg⁄kg i.p., and maintained anaesthetized by infusing 
pentobarbitone (15–20 mg⁄kg⁄h). The level of anaesthesia was frequently monitored by 
observing the size of the pupils and by assessing withdrawal responses to noxious stimulation. 
When necessary, the infusion rate of pentobarbitone was increased. The rats were spontaneously 
breathing. A warming blanket was used to maintain body temperature within the physiological 
range. Peripheral perfusion was checked by evaluating the colour of ears and extremities. The 
animals were placed in a standard stereotaxic frame, the skull was exposed and holes drilled for: 
placement of recording electrodes in the basolateral (BLA; coordinates -2.28 mm rostrocaudally 
from Bregma, 5 or -5 mm laterally and 8.6 mm dorsoventrally, according to the atlas of Paxinos 
& Watson, 1998) and central amygdala (CeA; coordinates -2.16 mm rostrocaudally from Bregma, 
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4.2 or -4.2 mm laterally and 8.2 mm dorsoventrally) nuclei, and a guide cannula placed at the 
rACC (coordinates 2.7 mm rostrocaudally from Bregma, 0.5 or -0.5 mm laterally and -1.5 mm 
dorsoventrally), but kept 2 mm above the target. Single neuron activity was recorded 
extracellularly with lacquer-coated tungsten electrodes (tip impedance 3–10 MW at 1 kHz) and 
then amplified and filtered using standard techniques. Data sampling was performed with a 
computer connected to a CED Micro 1401 interface and using Spike 2 software (Cambridge 
Electronic Design, Cambridge, UK). Actual recordings did not start until the animal was under 
light anaesthesia; that is, the animals gave a brief withdrawal response to a noxious pinch, but 
the pinch did not produce any longer-lasting motor activity, and nor did the animals have 
spontaneous limb movements.  
 
Peripheral stimulation and drug administration 
In electrophysiological experiments, heat stimuli (peak stimulus temperature, 40ºC; baseline 
temperature, 35ºC; rate of stimulus temperature increase, 4ºC⁄s; duration of the peak 
temperature of 40ºC, 10 s) and cold stimuli (peak stimulus temperature, 4ºC; baseline 
temperature, 35ºC; rate of stimulus temperature decrease, 4ºC⁄s; duration of the peak 
temperature of 4ºC, 10 s) were applied with a feedback-controlled Peltier device (LTS-3 
Stimulator; Thermal Devices Inc., Golden Valley, MN, USA) to the lateral side of the lesioned hind 
paw innervated by the sural nerve. Whereas some models of neuropathy may be associated with 
significant skin temperature changes that provide a confounding factor to assessment of thermal 
responses, particularly when using radiant heat for stimulation (Luukko et al., 1994), applying 
thermal stimuli with a contact thermo-stimulator and starting from a standard adapting 
temperature reduces the possibility that a neuropathy associated change in skin temperature will 
influence the results (Gonçalves et al., 2007). Mechanical stimulation of the skin consisted of 
applying a haemostatic clamp to the tail for 5 seconds. When applied to the experimenter’s hand, 
this stimulus produced a painful pinch sensation. Noxious visceral stimulation consisted of 
colorectal distension (CRD) at a noxious intensity (80 mmHg) (Ness et al., 1991). CRD was 
applied for 10 seconds by inflating with air a 7–8-cm flexible latex balloon inserted transanally 
into the descending colon and rectum. The pressure in the balloon was controlled by an 
electronic device (Anderson et al., 1987). Administration of glutamate (5 nmol; Sigma, St.Louis, 
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MO) and the NMDA-receptor antagonist MK-801 (3 nmol; Sigma, St.Louis, MO) into rACC was 
performed by an injection syringe inserted through the guide cannula, but 2 mm longer than the 
latter in order to reach the target. Neuronal recording started immediately after glutamate 
injection and during 5 minutes, and 5 min after MK-801 injection, during 10 minutes. When the 
stimulus-evoked responses were analysed, the baseline discharge frequency recorded during a 
corresponding period just before the stimulation was subtracted from the discharge frequencies 
determined during stimulation; that is, positive values represent excitatory responses evoked by 
peripheral stimulation and negative ones inhibitory responses.  
 
Course of the study  
Four groups of animals were included in the electrophysiological study: (i) Sham group tested 
1 week after surgery (1W Sham); (ii) sham group tested 8 weeks after surgery (8W Sham); (iii) 
SNI group tested 1 week after surgery (1W SNI); and (iv) SNI group tested 8 weeks after surgery 
(8W SNI). In each of these groups, behavioural assessment of sensitivity to monofilament and 
pin-prick stimulation was performed before the surgery, every two days then forward and before 
the start of the electrophysiological experiment. After induction of anaesthesia, the 
microelectrode was lowered to the ipsilateral or contralateral BLA. After a single cell had been 
found, its spontaneous activity was recorded for 2–3 min. Then, cold stimulation was applied to 
the sural nerve area in the operated limb followed by pinch of the tail and CRD at 1-min intervals. 
The testing procedure, including the order of testing different sub-modalities of nociception, was 
the same in all experimental groups.  
To minimize serial effects, every other animal tested in this series belonged to the Sham group 
and every other to the SNI group. At the completion of the study, an electrolytic lesion was made 
in the recording site, the animals were given a lethal dose of pentobarbitone and the brains were 
removed for verification of recording and microinjection sites. 
 
Statistic analysis 
Data are presented as mean ± standard deviation (S.D.). For evaluation of differences 
between Sham, 1W SNI and 8W SNI groups, in the avoidance paradigm test, ANOVA and Tukey 
post-hoc test were performed. In the evaluation of the differences of the activity of various types 
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of neurons in different experimental conditions, the t-test was used. p< 0.05 was considered to 
represent a significant difference.  
 
RESULTS 
 
1. Avoidance paradigm test 
 
The emotional component of pain-like behaviour was evaluated by the time spent by the 
animals in the light chamber (Fig. 1). Although it is clear that Sham animals preferred the dark 
chamber in all three experimental situations, neuropathic animals showed different results when 
evaluated after 1 or 8 weeks of SNI. After 1 week neuropathy, SNI animals spent most of the 
time in the light chamber after saline and glutamate injection in the rACC. However, after MK-
801 injection in the rACC, the behaviour changed drastically and the animals spent most of the 
time in the dark chamber (decreased avoidance behaviour to pain). The group tested 8 weeks 
after the SNI surgery still preferred the light side of the chamber and was not affected byMK-801 
administered to the ACC (Fig. 1). 
 
2. Changes in BLA and CeA neuronal activity induced by SNI 
 
The activity of nociceptive BLA and CeA AMY neurons was recorded in a baseline state 
(spontaneous activity), after different somatic and visceral peripheral stimulation and after 
pharmacological stimulation of the rACC.  
 
2.1.1. Spontaneous neuronal activity of AMY neurons 
Spontaneous activity in BLA neurons recorded in SNI animals is changed, when compared 
with Sham animals. In the ipsilateral side, neuronal activity in SNI animals with 1 week 
neuropathy increased significantly, while in the 8 week SNI group the spontaneous activity was 
significantly decreased. In the contralateral side, the activity of the neurons of SNI animals was 
significantly increased only after a 8 week neuropathy (Fig. 2A). Concerning the spontaneous 
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activity of CeA neurons recorded in SNI groups, it was always significantly increased, when 
compared with Sham groups (Fig. 2B).  
 
2.1.2. Peripherally-evoked neuronal activity 
AMY neurons decreased their activity after peripheral noxious stimulation. After 1W SNI, 
contralateral BLA neurons showed a clear higher response than corresponding neurons in the 
sham group to any type of peripheral stimulation (Fig. 3A), whereas the opposite occurred in 
neurons recorded in the contralateral CeA (Fig. 3B). Peripheral stimulation induced a stronger 
decrease in the activity of ipsilateral BLA neurons of SNI animals than in Sham to most of the 
noxa (cold, tail-pinch, CRD and von Frey) (Fig 3C), whereas the opposite occurred after cold 
noxious stimulation (Fig. 3D) in the CeA. 
After a prolonged neuropathy (8W), almost no differences were present between SNI and 
Sham neuronal responses to peripheral stimuli in the 8 week group of contralateral BLA neurons 
(Fig. 4A), whereas concerning contralateral CeA neurons, SNI neuronal responses were variable, 
showing a significantly higher response after cold and tail-pinch stimuli and a weaker one after 
CRD stimulation (Fig. 4B). On the other side of the AMY, after 8W SNI, the BLA neuronal 
responses were variable, being weaker than Sham group after heat and tail-pinch stimuli, and 
weaker than Sham group after cold and CRD stimuli (Fig. 4C)     
In what concerns CeA neurons, 1 week group ipsilateral neuropathic neurons responded less 
strongly, specially to cold stimuli, than Sham neurons (Fig. 3D), whereas 8 week group 
neuropathic neurons responded with higher activity to peripheral stimuli than Sham neurons, 
with differences being significant after thermal (heat and cold) stimulation (Fig. 4D). 
Contralaterally, CeA neuronal responses to peripheral stimulation 1 week after the surgery were 
significantly stronger in the neuropathic than in Sham animals (Fig. 4C).  
 
3. Changes in BLA neuronal activity induced by rACC manipulation 
 
3.1. Effect on neuropathic BLA neurons after Glutamate injection in the rACC 
In 8W SNI neuropathic animals, BLA ipsilateral neurons responded to glutamate activation of 
the rACC with a progressive greater increase than correspondent Sham neurons (Fig. 5A), 
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reaching its maximum 2-5 minutes after the beginning of the injection and returning to control 
levels after 6 minutes.  
 
3.2. Effect on neuropathic BLA neurons after MK-801 injection in the rACC 
The injection of the glutamate NMDA-receptor antagonist MK-801 in the rACC in 8W SNI 
animals resulted in a constant decreased activity of BLA neurons during the entire recording 
period, when compared with BLA neurons of Sham-operated animals (Fig. 5B).  
 
DISCUSSION (1912 words) 
In this study we analysed the changes induced by neuropathic pain upon spontaneous and 
peripherally-evoked neuronal activity of BLA and CeA amygdalar nuclei, and also the influence 
that the rACC has in these alterations following a short (1W) or prolonged (8W) neuropathic 
condition. Neuropathic pain increased the emotional aversive behaviour after both 1W and 8W 
SNI, with a NMDA-receptor pathway centred in the ACC mediatingthis behaviour (LaGraize et al, 
2004; Lei et al, 2004) only at the initial (1W SNI) neuropathic period. At the cellular level, there 
was an increased spontaneous activity of ipsilateral BLA neurons from 1W SNI rats and ipsi- and 
contralateral CeA neurons from 1W and 8W SNI, when compared with neurons recorded from 
Sham-operated animals. Additionally, the response activity of these AMY neurons to peripheral 
noxious stimulation was also significantly changed in the passage from 1W to 8W SNI, not only 
when SNI and Sham animals were compared but also between SNI ipsilateral and contralateral 
BLA/CeA neurons of SNI. These alterations may reflect the morphological and functional plastic 
changes occurring in the AMY following chronic pain (Neugebauer at al, 2003; Ikeda et al, 2007; 
Gonçalves et al, 2008). Finally,manipulation of NMDA receptors in the ACC revealed an influence 
of these receptors in modulating the activity of BLA neurons after 8W SNI, which was not 
relevant, however, to drive the aversive pain behaviour at this SNI period. This suggests that after 
8W SNI, other brain areas or other neurotransmitter systems in the ACC should mediate the 
aversive behaviour induced by the place escape/avoidance test (LaBuda and Fuchs, 2000). 
 
Aversive behaviour induced by SNI is partly modulated by the rACC 
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In order to measure the aversive nature of neuropathic pain, the avoidance of a preferred 
location was analyzed using the place avoidance paradigm test (LaBuda and Fuchs, 2000). This 
test evaluates the affective-motivational component of pain, rather than the 
sensory/discriminative dimension. This is a relevant approach for the present study, as the 
amygdala is mainly associated with behavioural responses to emotional stimuli (Davis and 
Whalen, 2001; Han and Neugebauer, 2001; Neugebauer and Li, 1992), and is also deeply 
involved in nociceptive modulation (Manning and Mayer, 1995; Manning, 1998; Manning et al., 
2001). There is evidence that the rACC is involved in modulating the storage of emotional events 
and aversive learning and direct connections between the rACC and BLA suggest that these 
areas may interact in consolidating aversive memories In this test, both 1W and 8W SNI animals 
remained more time in the light area after both saline and glutamate injection in the rACC. These 
results are in accordance with literature, since SNI animals seem to prefer the light chamber to 
the dark one, with the intention of avoiding the noxious stimulus (LaBuda and Fuchs, 2000). 
However, after MK-801 injection into the rACC, the response of 1W and 8W SNI animals was 
different. While the 8W group still remained more time in the light chamber, blocking rACC 
NMDA-r in 1W SNI animals inverted the aversive effect of pain to sham levels, as they stayed now 
more time in the dark chamber. It has been previously described that NMDArs in the ACC play 
an important role in the induction and expression of neuropathic pain (Zhuo M, 2004). These 
receptors are probably activated in an activity-dependent manner or via abnormal neuronal 
activities triggered under pathological conditions (Zhuo, 2006) that result in permanent 
alterations in the CNS, including structural changes in the ACC (Zhao et al, 2006) and AMY 
(Gonçalves et al, 2008). Accordingly, we hypothesize that the lack of effect of rACC NMDA-r 
manipulation after 8Wdeveloping neuropathic pain, central mechanisms may have changed in 
such a way that: (i) rACC influence in the “neuropathic pain system” is diminished, (ii) NMDArs 
number in the rACC is reduced, (iii) NMDArs functional role in the rACC is diminished, or (iv) 
other brain areas have now a major role in the control of the aversive pain behaviour.  
 
Spontaneous activity of AMY nociceptive neurons increases with SNI 
Electrophysiological recordings revealed that the spontaneous activity of BLA and CeA 
nociceptive neurons was higher in SNI group after 1 and 8W neuropathies, with the only 
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exception of 8W ipsilateral BLA recordings.  In the BLA nucleus, the major changes observed 
were in the ipsilateral side. Interestingly, there was a shift from great increase to great decrease 
in this ipsilateral BLA, from 1 week to 8 weeks after surgery. After 1 week of SNI surgery, 
neuropathy signs were already present, as mechanical allodynia and hyperalgesia are clearly 
perceptible. BLA is responsible for the facilitation of memory consolidation produced by moderate 
emotional arousal (McGaugh et al., 2002; Wingard and Packard, 2008). BLA heavily projects to 
the hippocampus, main responsible for memory formation and preservation (Petrovich et al., 
2001). It was described that after an emotionally arousing event, the firing rate of BLA neurons 
increases for several hours (Pelletier et al., 2005; Popescu et al., 2007), which may be seen in 
our ipsilateral neurons recordings, 1 week after surgery. On the contrary, the neuronal activity of 
ipsilateral BLA neurons recorded 8 weeks after the surgery is decreased. We think this may turn 
out because after a long-term time neuropathy, pain memory is already consolidated. The 
increased activity of contralateral BLA neurons may reflect ongoing nociceptive input arriving 
polyssynaptically to the BLA (Barnett et al, 1995). Concerning the increase of CeA spontaneous 
activity obtained in SNI animals, it is in accordance with literature, as it has been previously 
described (i) an increase in the input and output of neurotransmission at the pontine 
parabrachial area (PB)-CeA synapse (indicative of plasticity and enhanced processing of incoming 
signals to the CeA) and (ii) an increase in neuronal excitability (increased action potential 
frequency) of CeA neurons in neuropathic models (Han and Neugebauer, 2004). 
 
Peripherally-induced activity of AMY neurons changes differently after 1 or 8W SNI 
After 1W sham or SNI, the peripheral-induced activity of virtually all recorded neurons was 
diminished, comparatively to baseline activity. At this time point, in SNI animals, contralateral 
BLA neurons showed an increase of activation and contralateral CeA neurons were deeply 
inhibited following most types of noxious stimuli when compared with Sham group neurons, 
whereas in ipsilateral BLA and ipsilateral CeA SNI group neurons the opposite occurred. 
Nociceptive information reaching the AMY involves (i) the polymodal information arriving from the 
thalamus and cortex that reaches the lateral-BLA nuclei (McDonald, 1998; Neugebauer et al, 
2004) and the spino-parabrachio-AMY pathway and the ascending input from the spinal dorsal 
horn, both targeting the contralateral CeA (Cliffer et al, 1991; Garieu and Bernard, 2002, 2004). 
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The CeA is also the major output source of AMY projections to brainstem nuclei linked to the 
supraspinal pain control system, such as the periaqueductal gray matter (PAG), parabrachial 
nuclei (PBN), locus coeruleus (Pitkänen, 2000) and dorsal reticular nucleus (DRt; Almeida et al, 
2002), which make it a major regulator of endogenous nociception. Since the BLA projects to 
CeA (Swanson and Petrovich, 1998), it would be expected that, after peripheral stimulation, the 
response of neurons in both nuclei was similar. However, not only the CeA receives input from 
other brain areas (Swanson and Petrovich, 1998) that could had a overcome input, but also it 
has been described that the projections BLACeA can be inhibitory (Rosenkranz et al., 2006; 
Royer et al 1999) by the presence of intercalated cell masses (ICM; Royer et al 1999; Sun et al 
1994), a band of  -aminobutyric acid (GABA)-containing inhibitory neurons present between the 
BLA and the CeA. Furthermore, CeA neurons targeting autonomic regions are GABAergic- (Batten 
et al 2002; Jia et al, 2005) and more likely to inhibit downstream targets that mediate affective 
responses. Thus, it is possible that the BLA output suppresses CeA neuronal activity and that this 
suppression of activity allows disinhibition of downstream targets. This would allow the 
production of an affective response and justify the opposite activity shown by BLA and CeA 
neurons following peripheral stimulation, mainly after 1W SNI. Interestingly, neuronal recordings 
in the AMY showed that approximately the same percentage of CeA neurons were excited and 
inhibited (46/34%) after peripheral noxious stimulation (Bernard et al., 1992). On the other hand, 
after 8W SNI the response of both BLA and CeA nociceptive neurons was clearly changed, with 
the disappearance of the opposite interaction between BLA and CeA neuronal activity. These 
alterations may represent the consequence of plastic changes occurring in the AMY following the 
same period of neuropathic pain induced by the SNI model (Gonçalves et al., 2008). 
 
rACC-induced activity of BLA neurons is NMDA-r mediated after 8W SNI 
Glutamate stimulation of the rACC showed an increase in neuronal activity of ipsilateral BLA 
neurons in SNI animals 8 weeks after the surgery, an effect that was reduced by MK-801 activity 
in the ACC. Since the ACC has a major projection to the BLA (McDonald, 1998), we can 
conclude that a rAACBLA pathway mediated by NMDA-r is still present after 8W SNI. However, 
an MK-801 injection into the rACC did not affect aversive behaviour after this neuropathic time 
period (8W; see above); this suggests that, although NMDA receptors in the anterior cingulate 
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cortex mediate pain-related aversion (Lei et al, 2004) probably through the BLA (Deyama et al, 
2007), alterations induced by prolonged chronic pain may have altered modulatory pain 
pathways. In accordance with this hypothesis, an enhanced synaptic transmission of nociceptive 
specific inputs (PBCeA synapse) and polymodal sensory inputs (BLACeA synapse) has been 
demonstrated already in a persistent pain model of arthritis (Neugebauer et al, 2003). CeA 
neurons from arthritic rats developed also increased excitability compared with control CeA 
neurons, as synaptic plasticity in the CeA was accompanied by increased presynaptic mGluR1 
function and upregulation of mGluR1 metabotropic glutamate receptors (Neugebauer et al, 
2003). These plastic changes probably explain the lack of effect of rACC administration of MK-
801, a NMDA ionotropic glutamate receptor, in emotional pain-like behaviour after 8W SNI (see 
above). However, we cannot exclude that other neurotransmitters acting in the BLA same area, 
or other brain areas can influence the results observed in the avoidance paradigm test. In fact, 
the ACC is known to project to the AMY (McDonald, 1998), but also to exert descending pain 
modulatory actions through the DRt (Zhang et al., 2005) and areas that have been consistently 
implicated in the pain facilitation that is associated with neuropathic pain, namely the RVM 
(Calajesan et al, 2000 Burgess et al, 2002). Further studies are needed to elucidate this 
essential point of neuroplasticity in the higher processing of nociceptive information observed 
between 1 and 8 weeks of neuropathic pain. 
 
Conclusion 
BLA and CeA neuronal basal activity is increased in animals with peripheral neuropathy, 1 
and 8 weeks after the SNI model induction. This result was somehow expected, due to the known 
neuronal hyperexcitabilty that is present in neuropathic pain (Bleakman et al., 2006). However, 
as far as we know, the neuronal basal activity at these amygdalar nuclei in animal models of 
neuropathy has not been described before. The peripheral induced activity revealed that, not only 
the BLA influence over the CeA is inhibitory, but also that the BLA is not the strongest influence 
in the CeA in this neuropathy model. These effects are not so linear in the longest period of time 
here analysed. This observation, together with the behaviour results and previous experimental 
work published by our and other groups (Gonçalves et al., 2008) lead us to believe that, after a 
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long period of time developing neuropathy, there are central changes in the pain modulatory 
system, which is subsequently expressed in other systems.   
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FIGURES 
 
 
 
 
Figure 1 – The aversive nature of neuropathic pain was assessed in SNI and Sham groups, 1 and 8 weeks after 
surgery, by the place escape/avoidance test following the injection of saline, glutamate or MK-801 in the rACC. Note 
that the time spent by both 1W and 8W SNI groups in the light chamber was similar, but significantly higher when 
compared with Sham group after saline or glutamate injection in the rACC (ANOVA<0.05; 1W SNI x Sham, p<0.05; 
8W SNI x Sham, p<0.05, Tukey tests); on the other hand, after MK-801 injection in the rACC, a significantly higher 
avoidance behaviour was still observed in 8W SNI animals when compared with Sham group, but this aversive 
behaviour was reverted to Sham levels in 1W SNI animals (ANOVA<0.05; 1W SNI x 1W SNI, p<0.05; 1W SNI x 
Sham, p>0.05; 8W SNI x Sham, p<0.05, Tukey tests). The symbols and error bars represent mean ± S.D. in this 
and subsequent figures. 
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Figure 2 – Spontaneous activity recordings of amygdalar neurons. (A) Basal activity of ipsilateral BLA neurons is 
significantly increased 1 week after the SNI surgery (1W SNI BLAipsi x Sham, p<0.01, t-test) and significantly 
decreased 8 week after the surgery (8W SNI BLAipsi x Sham, p<0.05, t-test). In contralateral BLA, basal activity is 
increased after both 1 and 8 weeks SNI, with differences from BLA Sham neurons being statistically different only 
after a prolonged neuropathy  (1W SNI BLAcont x Sham, p=0.08; 8W SNI BLAcont x Sham, p<0.05,, t-tests) . (B) In the 
CeA nucleus, spontaneous activity was increased in both sides, at both time neuropathic periods (1W SNI CeAipsi x 
Sham, p<0.05; 8W SNI CeAipsi x Sham, p<0.05; 1W SNI CeAcont x Sham, p<0.05; 8W SNI CeAcont x Sham, p<0.01, t-
tests).  
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Figure 3 – Peripherally-evoked changes in basal activity of BLA and CeA neurons induced by somatic and visceral 
stimulation, 1 week after SNI or Sham surgery. Neuronal activity graphic representation is always compared with its 
relative basal (spontaneous) activity, shown in the graphs has a 0 (zero) Hz line. Note that the activity of most AMY 
neurons recorded, both from SNI or Sham animals, from any side of the brain or after 1W or 8W surgery, decreased 
after peripheral noxious stimulation when compared with their original basal activity. (A) Although the activity of 
contralateral BLA neurons decreased in both Sham and SNI groups, the SNI group changed the least after all the 
stimuli and were always more active than Sham neurons. The differences between Sham and SNI groups are 
statistically significant for all the stimuli (p<0.05, t-tests). (B) The activity of contralateral CeA neurons was almost 
unchanged in Sham animals following peripheral stimulation, whereas that of SNI neurons was significantly higher 
inhibited after any type of noxa applied (p<0.05, t-tests). (C) The activity of ipsilateral BLA neurons decreased in both 
Sham and SNI groups, with the strongest inhibition being that of SNI animals after all stimuli (p<0.05, t-test), with 
the exception of heat stimulation. (D) The activity of ipsilateral CeA activity decreased in both Sham and SNI groups, 
with no relevant differences between Sham and SNI groups, with exception of the cold stimulus response, where SNI 
neurons were higher activated than Sham cells (p<0.05, t-test) 
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Figure 4 – Peripherally-evoked changes in basal activity of BLA and CeA neurons induced by somatic and visceral 
stimulation, 8 weeks after SNI or Sham surgery. Neuronal activity graphic representation is always compared with its 
relative basal (spontaneous) activity, shown in the graphs has a 0 (zero) Hz line. Note that again, with very few 
exceptions, the activity of AMY neurons recorded, both from SNI or Sham animals, from any side of the brain or after 
1W or 8W surgery, decreased after peripheral noxious stimulation when compared with their original basal activity. 
Importantly, the response pattern of BLA and CeA neurons in 8W SNI versus Sham groups, did not remain as clearly 
similar along the different noxa as after 1W SNI (Fig. 3). (A) Contralateral BLA activity decreased in both Sham and 
SNI groups, with no relevant differences between Sham and SNI groups, with exception of the heat stimulus 
response, where SNI neurons showed a higher decrease (p<0.05, t-test). (B) Contralateral CeA activity decreased in 
both Sham and SNI groups to all the stimuli, except for neuropathic nerons responding to tail-pinch, where the 
evoked-activity was higher than the basal (spontaneous) one; the response of CeA SNI neurons was significantly 
higher than Sham after cold and tail-pinch stimuli (p<0.05, t-tests) and significantly decreased after CRD stimulation. 
(C) Ipsilateral BLA activity decreased in both Sham and SNI groups, with a significant stronger decrease of SNI 
neurons after heat and tail pinch stimuli (p<0.05, t-tests), whereas after cold and CRD stimulation SNI neurons were 
more activated than Sham (p<0.05, t-tests).  (D) Ipsilateral CeA activity decreased in both Sham and SNI groups, 
with significantly stronger decreases in the activity of SNI cells after heat and cold stimuli responses (p<0.05, t-tests).  
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Figure 5 – Microinjection of Glutamate and MK-801 into the rACC produces changes in BLA neuronal spontaneous 
activity, 8 weeks after SNI induction. (A) Glutamate produced a significant variation in SNI neuronal activity relatively 
to baseline (0 Hz), and, more importantly, a statistically different response when compared with Sham neuronal 
activity (p<0.05, t-test), which has a strongest response to the NMDArs agonist. (B) MK-801 also induced a 
significant variation in SNI neuronal activity relatively to baseline (0 Hz), and a statistically different response when 
compared with Sham neuronal activity (p<0.05, t-test). 
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The mechanisms underlying the development of neuropathic pain are far from being entirely 
revealed. Nonetheless, the state of the art provides a considerable amount of knowledge that 
contributes to the comprehension of this painful condition. In this thesis, the intention was to 
analyze changes in the interaction between the limbic and supraspinal pain control systems 
following a persistent neuropathic pain condition. The discussion focuses on evaluating the most 
significant anatomical, electrophysiological and behavioural results and how they may contribute 
to understand changes in supraspinal processing following the development of neuropathic pain.   
 
3.1 Neuropathy induces pain- and emotional-like behavioural alterations 
3.1.1 Sensory and emotional changes  
In this work we compared different behavioural parameters in neuropathic- and sham-
operated animals, using several different tests. These tests showed that neuropathic animals 
have both sensory and emotional components of pain-like behaviour altered: they consistently 
presented mechanical allodynia and hyperalgesia, depressive-like behaviour and an increase in 
emotional pain-like behaviour. However, no anxiety-like behaviour was detected.  
Clinical studies have shown that neuropathic pain has hallmark characteristics: spontaneous 
and evoked pain (such as allodynia, hyperalgesia; Jensen et al., 2001; Herrero et al., 2000). In 
rats, the spared nerve injury (SNI) model of neuropathy that we used (Decosterd and Woolf, 
2000) is characterized by a marked hypersensitivity to normally innocuous mechanical stimuli 
(allodynia), as well as a marked hyper-responsiveness to a suprathreshold pin-prick 
(hyperalgesia). Consequently, Von Frey and pin-prick tests were performed in every experiment to 
verify the presence of allodynia and hyperalgesia respectively, and they confirmed the success of 
the SNI surgery (Chapter 2.2). 
Although not all chronic pain patients develop affective disorders (McBeth et al., 2002), there 
is a high incidence of these emotional conditions, most notably depression and anxiety disorders, 
in chronic pain patients (Bennett et al., 1996). Clinical studies have shown clearly the importance 
of chronic painful physical conditions in subjects with major depressive disorder: chronic pain is 
strongly associated with major depressive disorder, whereas occurrence of chronic painful 
physical conditions increased the likelihood of having a major depressive disorder (Barsky et al., 
1986; Macfarlane et al., 1999; Ohayon and Schatzberg, 2003). We have shown here that a two 
month neuropathy resulted also in a depressive-like behaviour in the rat, measured by the forced-
swimming test (FST). The open field (OF) test confirmed that differences found in FST were not 
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due to neuropathy-induced motor impairments, as there were no changes in locomotor activity 
and exploratory behavior. As mentioned before, although depressive-like behaviour in rats has 
been extensively studied in association with several different factors (chronic mild stress, acute 
stress, drug addiction, maternal separation), there is a lack of information in what concerns 
depressive-like behaviour associated with pain in animals. Wistar-Kyoto (WKY) rats, used as 
preclinical model of depression, show mechanical allodynia (Zeng et al., 2008). In this study, 
intra-ACC administration of melatonin (used as antidepressant) decreased mechanical allodynia 
and depression-like behavior in WKY rats without changing the nociceptive response in normal 
Wistar rats. In this thesis, we observed depressive-like behaviour in rats, 8 weeks after 
neuropathy induction. Differently from Zeng and colleagues study, we observed neuropathic pain 
signs 2-6 days after surgery and depressive-like behaviour only 8 weeks after the surgery. 
Although it can be argued that we did not assessed depressive-like behaviour in animals at an 
earlier stage, a previous study by Kontinen and colleagues reported no depressive-like behaviour 
in animals subjected to the SNL model, 14 days after the nerve lesion (1999). Additionally, a 
more recent study showed, also with the SNL model, that changes in affective behaviour were 
detectable at 15 days and, more obviously, at 30 days after surgery (Suzuki et al., 2007). 
Consequently, we can conclude there is definitely a connection in the processing of neuropathic 
pain and depressive-like behaviour (Chapter 2.2). After our experiments and existent literature, 
we hypothesize that neuropathic pain leads to depressive-like behaviour in the rat. 
 
 Regarding anxiety assessment, however, no alterations were detected in the elevated plus-
maze or in the OF tests (Chapter 2.2). Although anxiety symptoms in neuropathic pain patients 
have been reported (Bair et al., 2008; Keller et al; 2008), studies that assess anxiety-like 
behaviour in different models of experimental neuropathy pain have shown different results. 
Hasnie and colleagues (2007) described a positive correlation between mechanical 
hypersensitivity and anxiety-like behaviour in a rat model of varicella zoster virus (VZV)-associated 
pain. However, in the same study, it is shown that while animals subjected to VZV and spinal 
nerve transection (SNT) models presented anxiety-like behaviour, the same was not true to those 
subjected to partial sciatic nerve injury (PSNI) model (Hasnie et al., 2007). Furthermore, anxiety-
like behaviour was observed in a rodent model for human immunodeficiency virus (HIV)-related 
neuropathic pain (Wallace et al., 2007) and in animals subjected to chronic constriction injury 
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(CCI), whereas in partial nerve ligation (PNL) animals no anxiety-like behavior was observed. As 
far as we know, herein we present the first results concerning anxiety behaviour assessment in 
animals subjected to SNI model. As previously described before (see Introduction, section 
1.1.1.6), the existent animal models for neuropathic pain develop and express differently and do 
not superimpose totally with humans states.  
 
3.1.2 Pharmacological basis for increased emotional pain 
In order to measure the aversive nature of neuropathic pain, the avoidance of a preferred 
location was analyzed using the place avoidance paradigm (PAP) test (LaBuda and Fuchs, 2000). 
This test evaluates the affective-motivational component of pain, rather than the 
sensory/discriminative dimension. This is a relevant approach for the present study, as the 
amygdala (AMY) is mainly associated with behavioural responses to emotional stimuli (Davis and 
Whalen, 2001; Han and Neugebauer, 2005), and is also deeply involved in nociceptive 
modulation (Manning and Mayer, 1995; Manning, 1998; Manning et al., 2001). In the herein 
presented work, affective pain in nerve-injured animals was increased by amygdaloid 
administration of an mGluR1/5 agonist and decreased by an mGluR1 antagonist, whereas no effect 
was observed in Sham-operated animals (Chapter 2.4). These results point to a role of 
amygdaloid mGluR1 in mediating the increased emotional pain component observed in nerve-
injured animals and are in accordance with previous studies involving these receptors in 
amygdalar plasticity following neuropathic pain. In fact, metabotropic glutamate receptors have 
also been shown to modulate the induction and/or maintenance of central sensitization, through 
pre- or postsynaptic action (Armstrong and Gouaux, 2000). Group I metabotropic glutamate 
receptors (mGluRs), which comprise mGluR1 and mGluR5 subtypes, are involved in neuroplasticity 
associated with normal brain functions and with neurological and psychiatric disorders (Fundytus, 
2001; Neugebauer, 2001, 2002). Additionally, Neugebauer and colleagues (2003) reported that, 
in a model of arthritic pain, a group mGluR1/5 agonist potentiated synaptic transmission at the 
PBCeA synapse (a connection “par excellence” in nociceptive processing at the AMY), while a 
selective mGluR1 antagonist reduced transmission in CeA neurons.  
It has been reported that the rostral anterior cingulate cortex (rACC) is involved in the 
processing of the affective component of pain, as its integrity is necessary for the “aversive” 
reaction to nociception (Johansen et al, 2001) and to the negative affect associated with 
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neuropathy-induced hypersensitivity (LaGraize et al, 2004; LaBuda and Fuchs, 2005), but not to 
sensory processing. Also part of the limbic system, the ACC is strongly reciprocally connected 
with the basolateral amygdala (BLA; Gabbott et al, 2005; Hoover & Vertes, 2007). It has been 
shown that NMDA receptors play important roles in various forms of plasticity in the nervous 
system (Dingledine et al., 1999; Hollmann and Heinemann, 1994; Malenka and Nicoll, 1999), 
and in disorders affecting and in peripheral and spinal pain mechanisms (Carlton, 2001; 
Fundytus, 2001; Schaible et al., 2002; Varney and Gereau, 2002). The rACC is involved in pain-
related fear memory and in pain-related aversive behaviours through NMDA-receptors (Lei et al, 
2004; Tang et al, 2005; Zhang et al, 2005). 
There is evidence that the rACC is involved in the storage of emotional events and aversive 
learning (Farr et al., 2000; Johansen and Fields, 2004) and direct connections between the rACC 
and BLA suggest that these areas may interact for the consolidation of aversive memories (Malin 
et al., 2007). In the place avoidance paradigm (PAP), SNI animals remained more time in the 
light area after both saline and glutamate injection in the rACC, when compared with sham 
operated rats, both after 1W or 8W neuropathy (Chapter 2.5). These results are in accordance 
with literature, since SNI animals seem to prefer the light chamber to the dark one, with the 
intention of avoiding noxious stimulation (LaBuda and Fuchs, 2000). These data suggest an 
association between depressive-like behaviour of SNI animals (see above) and an increase in the 
emotional component of the pain response. This is in accordance with increasing evidence that 
the emotional state of a patient with chronic pain increases the possibility of an associated 
depressive condition, as deeply depressed patients have pain as an important associated 
symptom (Peveler et al., 2006). Contrary to glutamate/saline rACC injection, the administration 
of an NMDAr antagonist to the rACC resulted in a different behavioural response of SNI animals 
one (1W) versus eight (8W) weeks after injury: while the 8W group still remained more time in the 
light chamber, the 1W SNI animals inverted the aversive effect of pain in comparison with sham 
levels, by preferring the dark chamber. It has been reported that NMDA receptors (NMDArs) play 
important roles in nervous system plasticity and various forms of disorders (Dingledine et al., 
1999; Hollmann and Heinemann, 1994; Malenka and Nicoll, 1999), and in peripheral and spinal 
pain mechanisms (Carlton, 2001; Fundytus, 2001; Schaible et al., 2002; Varney and Gereau, 
2002). NMDAr activation in the ACC mediates excitatory synaptic transmission (Sah and Nicoll, 
1991; Wei et al., 1999, 2001) and mediates pain-related aversion (Lei et al, 2004). Importantly, 
while MK-801 is a specific antagonist for NMDArs, glutamate activates not only NMDAr, but also 
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AMPA and kainate receptors (Gong et al., 2005). AMPA receptor-mediated synaptic inputs are 
involved in descending facilitatory pathways from AMY and ACC to the periaqueductal grey (PAG) 
and the RVM (Huang et al., 2006), while kainate participate in  pain signaling in the BLA (Li et 
al., 2001). Curiously, the occurrence of central sensitization in chronic pain seems to occur 
mostly within the glutamatergic pathways in supraspinal nociceptive regions (Huang et al., 2006) 
and to be primarily expressed as alterations in the biophysical properties of ionotropic glutamate 
receptors (NMDA, AMPA and kainate receptors) and/or promotion of AMPA receptor trafficking to 
the postsynaptic membrane (Bleakman et al., 2006). Furthermore, as the metabotropic 
glutamate receptors (mGluRs) present in the in the ACC also play an important role in pain 
regulation (Tang et al., 2005; Calejesan et al., 2000), and analyzing in our results, we cannot 
exclude the contribution of the mGluRs in pain regulation originating in the ACC. Hence, we 
propose that our data showing differences of NMDAr-antagonist effect on pain behaviour after 1W 
but not 8W is based on the effect of preferential activation of non-NMDA ionotropic glutamate 
receptors in the ACC after prolonged neuropathy (8W), when major plastic changes have also 
occurred in other brain areas (Chapter 2.5); on the contrary, after a shorter period neuropathy 
(1W), ionotropic glutamate receptors in the ACC probably activate preferentially the NMDArs. 
 
3.2 Neuropathy induces brain neuroplasticity towards pronociception  
3.2.1 Alterations in the supraspinal pain control system - the RVM  
The evidence of endogenous pain-modulating mechanisms is well established, but during 
decades research has been concentrated in the descending antinociceptive system (Basbaum 
and Fields, 1984). Although the presence of descending nociceptive facilitating pathways is now 
perfectly accepted (Almeida et al., 2002; Porreca et al., 2002; Vanegas and Schaible, 2004), the 
exact mechanisms by which descending projections facilitate pain transmission are not yet 
clarified (Watkins and Mayer, 1982; Mason et al., 1999; Vanegas and Schaible, 2004; Suzuki et 
al., 2002). Nonetheless, the presence of pain facilitation mechanisms emphasizes the fact that 
their abnormal sustained activity should contribute to the development of chronic pain (Vanderah 
et al., 2001). 
One of the main observations of this thesis is that hypersensitivity to peripheral stimulation is 
predominantly observed in ON-cells of the RVM, considered to have a pronociceptive role, by 
increasing pain perception through facilitation of spinal nociceptive transmission (Chapter 2.1). 
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This is in accordance with the hypothesis that ON-cells are involved in promoting neuropathic 
hypersensitivity to peripheral stimulation. Previous studies have shown that lidocaine 
microinjections in RVM blocked persistent nerve injury-induced pain (Pertovaara et al., 1996; 
Kovelowski et al., 2000). These and other studies have provided evidence for the hypothesis that 
it is the tonic activity of descending facilitatory cells that mediates nociceptive descending 
facilitation (Fields et al., 1991; Fields, 1992). ON-cells have been previously accountable for the 
descending facilitation of nociception, having their pericarya within the RVM and descending 
axons projecting to the spinal dorsal horn (Fields et al., 1991; Heinricher et al., 1992; Fields et 
al, 1995).  
As mentioned before, after nerve injury there are changes in central processing, with an increase 
of nociceptive barrage to the dorsal horn (Lu et al., 2007). This, in turn, leads to alterations in 
brainstem processing, which eventually contributes to the increased activity of RVM ON-cells 
(Burgess et al., 2002; Carlson et al., 2007), and the resulting selective descending action upon 
the spinal cord that is dependent on the type of peripheral input (Bee and Dickenson, 2008). As 
our results showed that SNI produces a different hypersensitivity to cold and mechanical stimuli, 
we conclude that they are in accordance with the hypothesis that descending facilitatory neurons 
discriminate between stimulus modality (Bee and Dickenson, 2008).  
This is also supported by earlier behavioural studies showing that nerve injury-induced 
hypersensitivity to mechanical stimulation (Pertovaara, 2000; Porreca et al., 2002) and cold 
(Urban et al., 2003) is dependent on descending facilitatory influence from the RVM. Additionally, 
clinical studies have shown that hypersensitivity to mechanical stimulation and cold are frequent 
and prominent symptoms after nerve injuries, whereas hyperalgesia to heat occurs only 
occasionally after neuropathic conditions (Scadding & Koltzenburg, 2006). Hypersensitivity to 
cold and mechanical stimulation is also a prominent finding in rats with the SNI model of 
neuropathy (Decosterd & Woolf, 2000). Therefore, we conclude that our data are in accordance 
with the existence literature and reinforce the fact that, after prolonged neuropathy, sensitivity 
and its enhancement varies with the submodality of stimulation (Chapter 2.1). 
 
3.2.2 Alterations in the limbic system - the AMY 
3.2.2.1 Physiological plasticity 
CeA receives highly processed polymodal sensory information from other AMY nuclei and 
from the thalamus and cortex via the BLA (Paré et al., 2004), as well as nociceptive-specific 
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information from the spino-PB pathway via the PB tract (Bernard and Besson, 1990; Jasmin et 
al., 1997; Gauriau and Bernard, 2002; Neugebauer et al., 2004). Importantly, the CeA is the 
output nucleus for major amygdala functions and regulates behavior through widespread 
projections to forebrain and brainstem areas (Bernard et al., 1996; Davis, 1998; LeDoux, 2000). 
The latero-capsular part of CeA is defined as the ‘nociceptive amygdala’ due to its high content in 
neurons implicated in nociceptive processing (Bernard et al., 1996; Neugebauer et al., 2004). 
Previous studies have shown increased neurotransmission activity in the PB-CeA synapse, which 
is indicative of plasticity and enhanced processing of incoming signals to the CeA and leads to an 
increased activity of CeA neurons and an enhancement of the nucleus outputs (Han and 
Neugebauer, 2004). Synaptic transmission at the BLA-CeA synapse was shown not to be 
significantly altered in the visceral pain state (Han and Neugebauer, 2004). In the arthritis pain 
model, however, enhanced synaptic transmission was measured both at the PB-CeA synapse and 
the BLA-CeA synapse (Neugebauer et al., 2003). Finally, Ikeda and colleagues found that 
unilateral neuropathic pain potentiated contralateral PB–CeA transmission and, to a lesser 
extent, bilateral BLA–CeA transmission (2007). Taking together, these results indicated that pain-
related synaptic plasticity in the CeA, although depending both on the type of pain and on 
pathway, always converges to an augmented output activity of the central nucleus. In the present 
work, CeA spontaneous (basal) activity was increased bilaterally in animals with peripheral 
neuropathy in both time points (1W and 8W), while BLA spontaneous activity was increased only 
at the ipsilateral side after 1W and on the contralateral side after 8W SNI. These observations are 
partially in accordance with Ikeda and colleagues results (2007), which stated that there is a 
consolidation of the PB-CeA synapse in persistent neuropathic pain; the increase of CeA activity 
is most probably due to PB–CeA synapses and less to the BLA–CeA transmission, since BLA and 
CeA activities changed with different patterns. Additionally, our observations showed an increase 
in ipsilateral CeA activity at 8W that might be due to an increase in PB–CeA transmission, as the 
ipsilateral BLA activity, at that time point, was decreased. Finally, our results show not only that 
the highest significant increase in CeA neuronal basal activity after 8W was on the contralateral 
side, but also that, after peripheral stimulation, contralateral CeA neurons showed all significant 
changes recorded at both time points (Chapter 2.5).  
We found that all peripherally evoked stimuli did not activate the BLA, but resulted in a 
decrease in the activity of BLA and CeA neurons of SNI neuropathic animals. Previous studies 
revealed the involvement of several different brain regions in the processing of mechanical and 
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cold allodynia, such as insular cortex, ACC, S1 and S2, thalamus, cerebellum, parietal 
association areas and the midbrain, but not the AMY (Bushnell et al., 1993; Craig et al., 2000; 
Davis et al., 1998; Tracey et al., 2000; Seifert and Maihöfner, 2007). Curiously, in an fMRI study 
of imagined allodynia, Krämer and colleagues have shown activation of AMY and other limbic 
structures, only if subjects had a previous knowledge of the allodynic sensation (2008). In 
summary, there seems to be no specific AMY activation during cold or mechanical allodynia 
stimulation in neuropathic pain (Chapter 2.5). 
 
3.2.2.1 Structural plasticity  
In addition to physiological alterations of amygdalar nociceptive neurons, a profound structural 
plasticity in the AMY was also found, mainly in BLA and CeA. Human studies have previously 
shown changes in different brain areas, usually related with different conditions: stress-related 
increase of hippocampus volume (Czéh et al., 2001), bilateral volume reduction of insular cortex 
gray matter in first-episode patients with schizophrenia (Lee et al., 2002), volume reduction in left 
temporal pole gray matter and absence of normal left-greater-than-right asymmetry gray matter in 
first-episode psychosis groups (Hirayasu, et al., 1999), and increased AMY volumes measured by 
structural magnetic resonance in patients with depression and anxiety (Frodl et al., 2002; Tebartz 
van Elst et al., 2000). Clinical data also reveal that prolonged pain conditions are associated with 
a high incidence of emotional disorders, including anxiety and depression (Rasmussen et al., 
2004; Campbell et al., 2003; Baliki et al., 2003). As our results showed depressive-like 
behaviour in rats after prolonged neuropathic pain, we decided to evaluate AMY structural 
changes. We found a significant increase in the volume of BLA and CeA nuclei after 8 weeks of 
neuropathy. The 3D morphological analysis showed that this increased volume in SNI animals 
was not due to differences in pericarya size, dendritic length or spine number, but to the 
presence of newly proliferating cells in these AMY nuclei. Furthermore, double-immunoreactions 
(BrdU+NeuN) confirmed that the increased number of newborn cells in SNI animals were 
neurons, demonstrating that these neurons were responsible, at least in part, for the higher cell 
number and the increase of AMY volume of SNI- in comparison with Sham-operated animals. 
This was the first time that newborn neurons were observed in association with the development 
of a neuropathic pain condition (Chapter 2.2). Importantly, these new neurons reach synaptic 
integrity within the neuronal network, as shown by the present of BrdU+Calb double-labeled cells 
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in the AMY of neuropathic animals (Figure 3). Although we cannot establish a clear link between 
persistent neuropathic pain and depressive-like behaviour associated to neuroplasticity of the 
AMY, it is also the first time that these three characteristics are observed simultaneously in 
animals where plasticity in the AMY is described.  
An additional novelty presented in this study is given by our most recent results, which 
indicate that cell divisions originating new neurons in the AMY of neuropathic rats occurred inside 
the limits of the AMY (Chapter 2.3). It is known that doublecortin (DCX), present in migrating 
neuroblasts and young neurons, promotes microtubule polymerization (Gleeson et al. 1999; 
Francis et al. 1999) and can serve as a marker of adult neurogenesis in the hippocampus (von 
Bohlen und Halbach, 2007). Hence, the observation of DCX+Ki-67-positive cells in the BLA and 
CeA only in SNI animals, show that the cell division had occurred recently. Supporting our 
observations, Shapiro and colleagues observed DCX-positive cells not only in the AMY, but also in 
other “non-neurogenic” areas, in naive rats (2009). Also in the adult brain, the polysialylated 
form of the neural cell adhesion molecule (PSA-NCAM) is only present in regions that are 
undergoing some kind of structural plasticity, such as the hypothalamo-neurohypophyseal system 
(Theodosis et al., 1994), the olfactory bulb (Miragall et al., 1988) or the piriform and entorhinal 
cortices or the hippocampus (Seki and Arai, 1991a,b). PSA-NCAM has also been previously 
observed in the adult AMY, confirming structural plasticity associated to memory consolidation 
(Nacher et al., 2002). In our results, the presence of PSA-NCAM only in SNI animals reflects both 
structural plasticity, and the formation of new neurons.  Finally, nestin-positive newborn cells are 
known to identify cells involved in neurogenesis (Doyle et al. 2001; Yue et al. 2006), and nestin-
positive cell spheres are thought to differentiate into neurons and glial cells (Figure 3; Itoh et al. 
2006). Additionally, it is also known that only nestin-positive but not the astrocyte (GFAP)-positive 
precursors are involved in neurogenesis (Cao et al. 2006), since GFAP expression is restricted to 
astrocyte (glial cells). On the other hand, there are reports of nestin expression in many cell types 
in the CNS, including non-neural cells (Nakagawa et al., 2004). All together, we propose that our 
observations, point to the fact that cell proliferation giving rise to new neurons in the AMY of 
neuropathic animals occurred inside AMY borders (Chapter 2.3).  
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Adapted from Bohlen and Halbach, Cell Tissue Res (2007) 329:409–420 
 
Figure 3 - Stages of adult neurogenesis in the dentate gyrus (DG) and expression pattern of specific markers. 
Generation of new neurons within the granular layer of the DG can be subdivided into five developmental stages. A 
stem cell might be located outside the SVZ (1, blue). The generated precursors start to proliferate and give rise to 
transient amplifying cells (2, green), which differentiate into immature neurons. At stage 3 (3, yellow), the immature 
neurons migrate over a short distance to reach the granular layer of the DG. During stage 4 (4, orange), the 
immature and postmitotic neurons extend their axons toward the pyramidal layer of the hippocampal area CA3 and 
send their dendrites in the direction of the molecular layer of the DG. By stage 5 (5, red), the new granule cells are 
synaptically integrated into the network of the hippocampal formation, receiving inputs from the entorhinal cortex 
and sending outputs to the hippocampal area CA3 and the hilus.  
 
 
3.2.3 Alterations in the interaction between limbic and pain control systems 
As mentioned before (see section 3.1.2), mGluR1/5 are involved in the main processes of 
neuropathic pain development. In the present work, after mGluR1/5 agonist administration in the 
CeA, the discharge rate of pronociceptive ON-cells in the RVM increased in neuropathic animals 
only, an effect reversed by an mGluR1 and by an mGluR5 antagonist. It has been reported that the 
systemic administration of selective mGluR1 or mGluR5 blockers reduces mechanical allodynia in 
the CCI and SNL models of persistent pain (Varty et al., 2005; Zhu et a., 2004), and that an 
mGluR5 antagonist completely reverses thermal hyperalgesia in the SNL (Dogrul et al., 2000). 
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These data add evidence to the already present notion that the amygdala contributes to the 
modulation of neuropathic hypersensitivity and to the pronociceptive effect in peripheral 
neuropathy, namely through action on descending pathways relaying in the RVM: Pedersen and 
colleagues showed suppression of aversive pain-related behavior and hypersensitive spinal reflex 
responses in nerve-injured animals after injecting a GABA-A receptor agonist in the AMY (2007); 
also, glutamate administered in the AMY suppressed antinociceptive neurons in the 
noradrenergic locus coeruleus of nerve-injured but not sham-operated animals (Viisanen and 
Pertovaara, 2007). Accordingly, our results propose that activation of the group I mGluR in the 
amygdala of SNI animals enhances ON-cells activity in the RVM, indicating the occurrence of 
neuropathic changes in the interplay between the limbic and pain control systems following 
neuropathic pain (Chapter 2.4). 
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With this work we have established that: 
 
1. The activity of both RVM ON- and OFF-cells, located in a major centre of pain modulation is 
altered towards pronociception in neuropathic animals. However, ON-cells appear to be the 
main responsible for the increased hypersensitivity of SNI animals, as their activity increases 
greatly during hyperalgesia and allodynia. 
 
2. Neuropathic pain induces changes in CeA and BLA, main afferent and efferent nuclei of a 
major area implicated in both emotional and pain processing. Neuroplasticity was present as 
an increased AMY volume resulting, at least in part, from the generation of newborn neurons. 
Importantly, AMY plasticity is paralleled with depressive-like behaviour.  
 
3. Emotional pain-related behaviour increases in neuropathic animals. At the pharmacological 
level, this behaviour is mediated, at least in part, by the activation of NMDArs in the ACC and 
mGluR1/5 in the CeA. The activation of mGluR1 in the CeA induces an increase in RVM ON-cells 
activity and, therefore, an increase in hypersensitivity, which may constitute a mechanism 
contributing to emotional pain. 
 
4. BLA and CeA neuronal basal activity are increased in neuropathic animals. Since these nuclei 
project to the RVM, this may contribute to the increase of basal hypersensitivity observed in 
animals with peripheral nerve injury.   
 
 
Although we consider that this work has given answers to most of the questions that we had 
at the beginning of the project, this study also raised many new questions. Therefore, in the 
future, one of the priority goals is to verify if the newborn neurons also result from the 
proliferation of neural stem cells located outside the AMY. Additionally, we intend to evaluate if 
the administration of antidepressants to animals subjected to the SNI model reverses the 
neuropathic pain signs, the depressive-like behaviour, and/or the formation of new neurons and 
structural changes of the AMY. Finally, it will be very interesting to analyze if the expression of 
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different glutamate receptors is altered in, at least, the ACC, the AMY, and the RVM during 
neuropathy, and how it would be reverted with antidepressant therapy. 
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